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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
SI “Inches” Forward. 1.
The Base Units and Some Derived Units
The past several years have seen 
moves to convert the North American 
continent from the British imperial 
system of weights and measures to the 
system of standard international units 
— SI units (Systeme international d’u- 
nites). The Canadian Journal of Surgery 
is now moving further in this direction 
by employing SI units for most, but 
not all, measurements, and our readers 
will be required to understand these 
units in order to comprehend the ideas 
presented.
Starting with volume 22, instructions 
to Journal contributors stipulate that 
whenever possible measurements shall 
be reported in standard international 
units, accompanied by the imperial or 
other units only when necessary. The 
current Canadian move to metrifica- 
tion, with realignment of measurement 
methods and thought processes, requires 
time and effort, and success will ulti­
mately be ensured only when the ad­
vantages of SI units are obvious. In 
those areas where metrification is an 
impediment to clear thinking its ac­
ceptance will obviously be delayed. Our 
journal is attempting to “metrify”, but 
wishes to make sure that clarification 
rather than confusion is achieved in 
the process.
Le Systeme international d’unites 
utilizes seven base units from which 
there are 15 derived SI units with 
special names. The seven base units 
are: time, temperature, length, mass, 
amount of substance, electricity and 
light (Table I). The means whereby 
each of the standards is defined may 
be found among the reference works 
listed. Our journal attempts to deal 
with metrification in accordance with 
some of the principles and thoughts 
described below.
Base U nits
Time
For the past 150 years the basic unit 
of time has been the second, and in the 
Systeme international this has been re­
tained. Unlike all other basic units the 
factors with which the second is mul­
tiplied to derive larger dimensions of 
time are not in decimal (10s), but 
duodecimal terms (12s), which permit 
use of the conventional terms of min­
utes, hours and days. The Journal will 
continue to use these terms for time 
measurements greater than seconds. 
For time measurements less than sec­
onds, the subdimensions now common­
ly accepted are in decimal terms that 
are powers of ten, 10~3 or 10-6 (milli­
seconds or microseconds), and our 
journal will so report them without 
further comment.
Temperature
Public conversion to the Celsius 
scale is now fairly complete. Suffice it 
to say that normal body temperature 
is 37 ±  0.3 °C and all temperatures will 
now be reported in Celsius terms with­
out a Fahrenheit comparison. Although
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the official SI unit is the kelvin, public 
policy has recognized the Celsius 
(centesimal) scale —  each degree of 
which is a kelvin and is reported as the 
degree Celsius (x°C).
Length
The SI unit of length is the standard 
metre and whenever possible all length 
measurements will be reported as the 
metre or its commonly accepted mul­
tiples (kilometre, decimetre, centimetre 
or millimetre) with occasional com­
parison in inches or feet when and if 
it seems appropriate.
Mass
The basic unit of mass is the inter­
national prototype kilogramme — a cyl­
inder of platinum-iridium alloy— and 
the Canadian Journal of Surgery will 
report mass in terms of the kilogram 
or its derived subunits, the gram, the 
milligram or the microgram. Biological 
literature rarely requires multiples of 
the kilogram, and generally speaking it 
is the gram that is used as the reference 
point, with subdivisions of 10~3 (milli­
grams) and 10-6 (micrograms).
Amount of Substance
The mole was adopted in 1971 as a 
basic unit useful in scientific work and 
is the molecular weight of a substance 
expressed in grams (gram molecular 
weight). The number of particles or 
molecules contained in a mole is Avo- 
gadro’s constant, approximately 6.023 
X 1023. It is specifically related to the 
number of atoms in 0.012 kg (12 
g) of carbon-12. The units of electric 
current and luminous intensity will be 
discussed at a later time.
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Derived U nits of Special I nterest
in Biology and Medicine
Volume
When the metric system was estab­
lished in 1875 the litre was defined as 
the volume of water that weighed 1 kg. 
It was hoped and expected that the 
litre would occupy exactly 1 cubic 
decimetre (dm3), but it turned out to 
be 1.000028 dm3, explaining why most 
of us have long known that the 
centimetre and the millilitre were 
close to being identical but not exact­
ly so. In 1964 the Conference ge­
neral des poids et mesures (CGPM) 
redefined the litre as the volume of 
water in one cubic decimetre (1 dm3); 
now the litre (1) is referenced to 
the standard of length rather than the 
standard of mass. Although the litre’s 
usefulness for measuring volume is 
recognized, it is considered a term 
slightly less pure than the cubic de­
cimetre. Volume measurements are 
complicated because there have been 
two reference units for volume—one 
derived from the length standard (the 
metre) and one from the mass standard 
(the kilogram). When volume is derived 
from the standard of length it is re­
ported in terms that signify the cubic 
function of some units of length (e.g., 
the cubic centimetre, the most frequent­
ly used length-volume term). Rarely do 
we use cubic decimetres (dm3) or cubic 
metres (m3). Problems that have arisen 
by using units of length to define 
volume have caused a reversion to the 
more customary definition of volume 
— the litre — a measurement original­
ly based on the standard of mass. For 
convenience the Journal will use the 
litre (1), decilitre (dl) or millilitre 
(ml) terminology. Although the volume 
occupied by a kilogram of water, a litre 
and a cubic decimetre of water are so 
close to being identical that they may 
be considered synonymous for the 
biological and medical professions, we 
have chosen litre (1") rather than metre 
(mn) terminology because the litre 
seems to be a more acceptable refer­
ence term than the cubic decimetre. 
The symbol dl will replace the cus­
tomary 100 cc, 100 ml or x%. The 
symbol ml will replace the cc or cm3.
Concentration
With respect to biological concepts 
and medical use, the concentration of 
materials in solution poses the greatest 
difficulty in conversion to SI units. 
Biological reporting problems arise 
because purists expect that concentra­
tions of substances will be reported as 
mole functions rather than as mass 
functions when in a specified volume 
of solution. Even though the terms by
which volume will be reported (litre, 
decilitre or millilitre) have been agreed 
upon, there is no agreement as to 
whether or not the amount of sub­
stance will be reported by mass (grams 
or milligrams) or by number of mole­
cules (moles or millimoles). This leads 
to a difficult decision as to whether or 
not the Canadian Journal of Surgery 
will report 5.5 mmol of glucose/1 
rather than 100 m g/100 ml, 100 mg% 
or 100 mg/dl and likewise whether or 
not it will report 9 mmol/i of urea 
nitrogen rather than 25 mg% or 25 
mg/dl.
If the number of particles of one 
substance per litre were related to the 
number of particles of another sub­
stance per litre, mol/1 would be im­
portant. By this means the relationship 
could be acknowledged and the inter­
action established, as is done with the 
milliequivalent terms in which plasma 
electrolytes are reported. Strong argu­
ments could thus be made for the con­
version from mg% to mmol/1. If these 
relationships do not exist between such 
items as urea, urea nitrogen, ketones, 
lactate, creatine, phosphate, sulfates, 
etc. then conversion to the mmol/1 ter­
minology does not add to usefulness or 
flexibility in the understanding of these 
molecular interrelationships and only 
creates the necessity to relearn free­
standing numbers. Although the func­
tional interrelationship of these com­
pounds in terms of their molecular con­
centration is not immediately apparent 
it is possible and probable that the 
osmotic properties of these compounds 
may become significant in the future. 
If so, the usefulness of reporting them 
as millimoles per litre rather than milli­
grams per decilitre (mmol/1 versus mg/ 
100 cc, mg% or mg/dl) will become 
apparent. In the immediate future the 
Journal will report these concentrations 
using both terms for the amount of 
substance — mole and gram.
Compounds like glucose and urea 
which are simple molecules are easy to 
convert to moles because their chem­
ical structure is precisely known, but 
we are far from realistically expressing 
the g% of hemoglobin as mol/dl or 
mol/1 because of an imprecise knowl­
edge of the hemoglobin molecule or 
even of its derived bilirubin molecules. 
This problem becomes even more com­
pounded when dealing with albumin 
and globulins, no\V reported as g%, 
which cannot be converted to mol/1 
because the molecular structures and 
characteristics are insufficiently clari­
fied. In the case of these complex 
molecules we await a more exact 
chemical molecular determination in 
order to catch up to the precise SI 
means of expression. This journal, at 
least for the time being, will continue
to express these quantities as mass/unit 
volume (e.g., g% or g/dl of hemo­
globin) rather than mole/unit volume 
(mol/1).
C.B. Mueller 
Coeditor
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Traditional treatments have all involved a significant risk of dose-related toxicities. The introduction of 
PYOPEN'(carbenicillin) was an important therapeutic advance, providing the safety of penicillin, combined with 
bactericidal effectiveness against Pseudomonas aeruginosa and other gram-negative organisms.
“...it would appear that carbenicillin is effective in modifying the course of a Pseudomonas 
surface culture in bum patients.”1
In severe and overwhelming Pseudomonas infections so often found in burn patients, PYOPEN provides a logical choice 
of therapy—effectiveness without dose-related toxicities and the traditional margin of safety common to all penicillins. 
So, for the treatment of Pseudomonas infections in burns... consider PYOPEN.
1. Copeland, Charles E., C arbenic illin  therapy in burn patients, Burn Unit, General Surgery, M ercy Hospital,
P ittsburgh, Pa, U.S.A. Proceedings o f the  Symposium New York, N.Y. Ju ly  12 ,1969,Excerpta Medica Foundation.
For brief prescrib ing in form ation  see page
I “ “ A C I I I -Reg'd
Made in Canada by arrangement with BEECHAM, INC.
AYERST LABORATORIES
Division of Ayerst, McKenna & Harrison Limited 
Montreal, Canada
Ayerst Quality has no substitute
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Pyopen
(carbenicillin)
Medical Responsibility?
CONTRAINDICATIONS: Carbenicillin 
should not be used in patients with a 
history of penicillin or cephalosporin 
allergy. Carbenicillin is hydrolyzed by 
staphylococcal beta-lactamase and is, 
therefore, contraindicated in infections 
caused by beta-lactamase-producing 
staphylococci. PRECAUTIONS: The 
same as for penicillin G. Resistant 
organisms have arisen during treat­
ment. Adequate dosage should there­
fore be maintained and intermittent sen­
s itiv ity  tests carried out. One g of 
PYOPEN contains 6.5 mEq of sodium 
ion. Therefore, large doses of the drug 
should be administered with caution to 
patients with congestive heart failure, 
severe hypertension, or edema. 
ADVERSE REACTIONS: Similar to those 
reported w ith  p e n ic illin  G. Also 
reported: pain and rashes at site of i.m. 
injection; thrombophlebitis after pro­
longed i.v. administration; pruritus; 
eosinophilia; nausea; occasional rise in 
SGOT and alkaline phosphatase levels; 
anicteric hepatitis; one case of an unex­
plained drop in hemoglobin level; one 
case of seizure in a hemiplegic patient 
on high doses and one case of increased 
muscle weakness in a patient with 
myasthenia gravis have been reported. 
Prolonged bleeding time has been 
reported in 22 of a series of 30 patients 
receiving between 500 and 750 mg/kg 
daily of PYOPEN during 14 days (giving 
blood levels of 200-400 pg/ml). Aggrega­
tion of platelets by adenosine diphos­
phate was decreased in all 30 patients. 
The defect appeared within 12 hours 
after starting therapy and took from 3 to 
7 days to disappear after discontinuing 
the drug. Two women receiving 30 g of 
PYOPEN daily developed hypokalemia 
a fte r 7 and 9 days respective ly. 
Potassium levels were 2 and 1.5 mEq/l. 
Oral potassium chloride rapidly cor­
rected the electrolyte disorder.
DOS AG E:Rel ati vel y h igh dose s  of 
carbenicillin are required in the treat­
ment of severe Pseudomonas infec­
tions. ADULTS—Severe and overwhelm­
ing infections (septicemia, extensive 
burns and wounds, pneumonia, men­
ingitis, peritonitis): 12 to 30 g daily in­
travenously or by infusion with or 
without 1 g of probenecid orally 3 times 
daily. In moderately severe infections: 
ig  every 4 hours for 5 to 10 days. 
CHILDREN—Dosage, according to 
weight, age and severity of infec­
t io n ,  may vary from  100-300 mg/ 
kg/body weight.AVAILABILITY: Vials 
containing: 1 g or 5 g carbenicillin. 
C om plete prescrib ing info rm ation and 
re ferences available on request.
Ayerst Qualify has no substitufe
AYERST LABORATORIES
Division o f Ayerst, McKenna & Harrison Limited 
Montreal, Canada
Made in Canada by arrangement with 
BEECHAM, INC.
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Mtween
Modern technology through its ad­
vances in engineering, manufacture 
and marketing has made available a 
number of powered devices for mass 
consumption. Many of these devices 
have been in existence for many years, 
but until recently remained in the 
domain of highly expert users for 
whom or by whom the prototypes were 
developed. Most of these powered de­
vices are highly practical labour saving 
machines, so that when they become 
generally available they are eagerly 
sought after. The inexperience of 
casual users, however, leads to a multi­
plicity of applications, some unex­
pected, and these casual users do not 
suspect that there might be dangerous 
quirks inherent in the machine that 
may result in potentially devastating 
injury. Also, the ease with which they 
can be used leads to abuse, such as 
operation of the device when the user’s 
judgement is impaired by alcohol or 
drugs or in the presence of such natural 
phenomena as failing light.
Many series of injuries have been 
documented in the medical literature, 
injuries caused by misuse of woodwork­
ing tools, both portable and fixed in 
home workshops, power lawn mowers, 
high pressure spray guns, snowmobiles, 
mopeds, snow blowers, chain saws, 
motor cycles and, by far the most com­
mon, the automobile. In all of these 
examples the unexpected devastation 
has resulted in some degree of control 
by one or more of the following; (a) civil 
law suit by the consumer based on the 
law of tort,1 (b) consumer education, 
(c) setting of standards by manufac­
turers and private organizations such 
as the Canadian Standards Association 
or Underwriters Laboratories of Can­
ada, and (d) government legislation in 
the form of acts or regulations. Only 
the last-mentioned action results in 
mandatory control; all the others result 
in indirect pressure for change in 
design or safety features to avoid law­
suit or undesirable publicity, which 
results in financial loss. The standards 
associations are very active, but the 
standards they set are not enforce­
able unless the standards are already 
covered by legislation, such as the 
Motor Vehicle Safety Act, the Elec­
tricity Inspection Act or the Hazardous 
Products Act. Thus, the standards as­
sociations constitute a form of moral
persuasion encouraged by the Standards 
Council of Canada Act, but the stand­
ards they set do not necessarily result 
in enforceable legislation and the pro­
ducts available to the consumer do not 
necessarily meet these standards.
The article by Dr. Bruce Rigg in this 
issue (page 149) describing and analys­
ing severe facial injuries that result 
from chain-saw kickback is an example 
in point. Other articles have appeared 
in the medical literature; one in 1976, 
documented five cases, two of which 
were fatal because of soft tissue dam­
age to the neck, which included major 
vessel disruption.2 The Canadian Stand­
ards Association has a book detailing 
standards for chain saws.3 Safety de­
vices have been developed, such as tip 
protectors and chain brakes, which are 
built into some machines and which 
are available to be added to others not 
so equipped.
Still one can buy chain saws without 
any safety devices and the only warn­
ing in the owner manual is to avoid 
kickback because it results in loss of 
control of the machine. The application 
of available safety devices is seldom 
mentioned let alone encouraged!
It is a “preventive medicine” obliga­
tion of the medical profession to recog­
nize trends of injury and to create suf­
ficient pressure to reverse these trends, 
by whatever means, as soon as possible. 
The Ontario Medical Association com­
mittee on accidental injury is one 
means, but consumer education, by 
way of media publicity, is probably the 
quickest method of influencing con­
sumer attitudes towards both purchas­
ing and use.
Or v il l e  J. M ir e h o u s e , m d , frcs [c]
Department of surgery,
McMaster University Medical Centre, 
Hamilton, Ont.
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REVIEW ARTICLE
Highly Selective Vagotomy and Truncal Vagotomy and 
Pyloroplasty for Duodenal Ulcer: A Clinical Review
Robin S. McLeod, b sc, md and Zane Cohen, md, frcs[c]
A review was conducted of the 
operations of highly selective vagotomy 
(HSV) and truncal vagotomy and pylo­
roplasty (TVP) performed for peptic 
ulcer disease. Gastric acid output was 
reduced equally after both procedures: 
basal acid output was reduced by 80% 
and maximal acid output by 50% to 60%. 
Not surprisingly, therefore, the recur­
rence rates were similar (6.6% after 
HSV compared to 5.6% after TVP). How­
ever, the mortality following HSV was 
0% compared with 0.7% after TVP.
The incidence of all side effects was 
lower following HSV, so that the results 
in 86% of patients who underwent this 
operation were considered excellent 
or very good (Visick grades I and II). 
The authors conclude that HSV 
should be considered the primary 
conservative procedure in the surgical 
management of peptic ulcer disease.
On a passe en revue les techniques 
de vagotomie hyperselective (VHS) 
et de vagotomie tronculaire avec pylo- 
roplastie (VTP) utilisees dans I'ope- 
ration de I'ulcere gastro-duodenal.
Le debit chlorhydrique a ete abaisse 
d'egale fagon par les deux interventions: 
le debit acide basal horaire a ete 
diminue de 80% et le taux maximum 
d’acide chlorhydrique a ete reduit de 
50% a 60%. II n'est done pas etonnant 
que les taux de recidive aient ete 
similaires (6.6% apres une VHS 
comparativement a 5.6% apres une 
VTP). Toutefois, le taux de mortality 
n’a ete que de 0% apres une VHS 
alors qu'il a ete de 0.7% apres une 
VTP. La frequence de tous les effets 
secondaires a egalement ete plus 
faible apres une VHS, de sorte que
From the department of surgery, 
University of Toronto, and the division 
of general surgery, Toronto General 
Hospital, Toronto, Ont.
Reprint requests to: Dr. Z. Cohen, Ste. 
C\V 1-102, Toronto General Hospital, 
Toronto, Ont. MSG 1L7
les resultats chez 86% des patients 
qui ont subi cette operation etaient 
excellents ou tres bons (categories 
I ou II de la classification Visick).
Les auteurs concluent que la VHS 
devrait etre consideree comme une 
intervention conservative primaire dans 
le traitement chirurgical de I'ulcere 
gastro-duodenal.
Despite the high prevalence of peptic 
ulcer disease, there is persistent con­
troversy as to the most suitable form 
of surgical management. Over the 
years surgeons have sought a simple, 
yet effective operation for its relief. 
The evolution of operative procedures 
has kept pace with our understanding 
of the disease. Pyloroplasty and pos­
terior gastroenterostomy were popular 
in the first half of this century.1 They 
were designed to reroute the gastric 
contents to overcome pyloric obstruc­
tion. Originally the rationale for pos­
terior gastroenterostomy was to neu­
tralize the acid secretion of the stomach 
by the alkaline duodenojejunal con­
tents. Instead, the upper jejunum was 
bathed with gastric acid secretion and 
stomal ulceration resulted. The first 
definite attack on the acid-pepsin as­
pect of peptic ulcer disease began with 
the advent of subtotal gastrectomy. The 
resections first performed were in­
adequate, making the recurrence rate 
unacceptably high. Once the technical 
difficulty was overcome the rate of 
recurrence fell to an acceptable level; 
however, the morbidity and mortality 
remained undesirably elevated.
In 1943 Dragstedt and Owens2 in­
troduced vagotomy as a safe procedure 
that would adequately lower acid 
pepsin secretion. Studies of their pa­
tients with duodenal ulcer had revealed 
a high nocturnal and basal gastric acjd 
output. Since it was known that basal 
acid secretion was under neurogenic 
control, vagotomy seemed logical in 
order to reduce gastric acid output. 
However, the initial consequences pro­
duced a great deal of scepticism about
the value of the operation. When un­
accompanied by a drainage procedure, 
gastric stasis developed, causing recur­
rence in some patients and a sensation 
of epigastric fullness and heartburn in 
others.
In 1953 a review of the experience 
with vagotomy alone at the Massachu­
setts General Hospital disclosed a 25% 
failure rate (i.e., the development of 
obstruction, bleeding or proven recur­
rence with pain).1 In addition most of 
those without recurrence complained 
of epigastric fullness, so that results 
were classified as only moderate to 
good. In the early 1950s reports of the 
results obtained from vagotomy and 
drainage began to appear in the liter­
ature and recurrence rates of 20% 
were cited.1 Later, as technical exper­
tise increased, fewer recurrences were 
noted and better results were obtained. 
Now, 25 years after its inception, 
vagotomy and drainage (either pyloro­
plasty or gastroenterostomy) is a 
widely accepted and safe surgical me­
thod of treatment for duodenal ulcer. 
It combines a low operative mortality 
and morbidity with an acceptable re­
currence rate. In addition, it is an 
operation which the average general 
surgeon can perform with competence.
In order to improve still further the 
results of truncal vagotomy and drain­
age, and believing a more physiologic 
procedure could be performed, John­
ston and Wilkinson3 in England and 
Amdrup and Jensen4 in Denmark in 
1969 independently added highly se­
lective vagotomy to the surgical reper­
toire. It was devised to decrease acid 
output by denervating the gastric 
parietal cell mass. The procedure cir­
cumvents the added risks and side 
effects of the drainage procedure by 
leaving undisturbed the vagal supply of 
the antrum and pylorus. It, too, has 
been greeted with both enthusiasm and 
scepticism.
We propose to review and compare 
the results of truncal vagotomy and 
pyloroplasty (TVP) and highly selective
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vagotomy (HSV) in elective situa­
tions.5’21
Anatomy and Surgical Technique
In truncal vagotomy the anterior 
and posterior vagal nerves are divided 
along the esophagus subdiaphrag- 
matically. Thus it is a total abdominal 
vagotomy which severs the entire intra­
abdominal parasympathetic nerve sup­
ply. Because the stomach is totally 
denervated a drainage procedure must 
be added.
Highly selective vagotomy (the term 
that will be used in this review) is also 
known as parietal cell vagotomy, 
proximal gastric vagotomy, ultraselec- 
tive vagotomy, acidosecretive vagoto­
my, selective vagotomy of the parietal 
cell mass and selective proximal vago­
tomy. In it only the acid-secreting 
proximal two thirds of the stomach is 
deprived of its vagal supply. The an­
terior and posterior nerves of Latarjet 
(Fig. 1) are preserved as they course 
along the lesser curvature. Therefore 
the innervation of the antrum and 
pylorus remains completely intact, ob­
viating the necessity for a drainage 
procedure.
Approximately 2 to 3 cm below the 
esophageal hiatus the anterior vagus 
nerve gives off the hepatic branch, 
which courses through the lesser omen­
tum to the liver. The anterior trunk 
then continues as the anterior nerve of 
Latarjet (Fig. 1) running parallel to, 
and approximately 2 cm from, the 
lesser curvature of the stomach. From 
this position it gives off small branches 
to the lesser curvature. At the antrum 
the anterior nerve of Latarjet fans out 
into a “crow’s foot”. Similarly the 
posterior vagus nerve gives off the 
celiac branch and then continues as 
the posterior nerve of Latarjet. Its 
position is posterior to that of the an­
terior nerve along the lesser curvature.
While the basic concepts of Amdrup 
and Jensen4 and Johnston and Wilkin­
son3 are the same, the details of the
F IG . 1— Surgical anatomy of vagal 
nerves and nerves of latarjet.
operative technique differ. The Copen­
hagen group is very precise in deter­
mining the antral corporal border (non- 
acid-secreting/ acid-secreting demarca­
tion). At the operation an intragastric 
pH probe is used to determine this line 
so that denervation can begin from 
this point. In 93 (70%) of 126 patients 
this was possible.22 In the remainder a 
small gastrotomy was made and the 
acid-secreting mucosa was identified 
using Congo red. In contrast the Leeds 
group merely notes where the nerves of 
Latarjet end (Fig. 1) and begins dissec­
tion proximal to their termination.23 
The difference in technique means that 
the Copenhagen group begins its 
dissection an average of 9 cm from 
the pylorus, compared with 7 cm 
in the case of the Leeds group. De­
spite the differences in technique, 
the results obtained by the two 
groups are comparable in all respects, 
except for the occurrence of a sensa­
tion of epigastric fullness. This was 
noted in 31% of the Leeds patients14 
but in none of the Copenhagen pa­
tients.13 The more extensive dissection 
may account for the difference, but 
the authors concerned believe that it 
may reflect dietary habits.22 At present 
the Leeds group now arbitrarily 
chooses a point 2 cm proximal to the 
termination of the nerves of Latarjet 
to begin dissection.23 Amdrup13,22 still 
believes that precise marking with the 
pH probe is warranted but no longer 
advises gastrotomy and localization 
with Congo red.
A meticulous dissection is essen­
tial.23'25 The anterior and posterior 
vagal trunks are first isolated at the 
esophageal hiatus. The dissection is 
started distally 2 cm above the crow’s 
foot. The main nerves of Latarjet are 
identified and preserved, leaving the 
antrum innervated. All vagal branches 
to the parietal cell mass are suc­
cessively ligated along the edge of the 
lesser curvature. Since the nerves are 
contained within a neurovascular bun­
dle the dissection, in effect, severs the 
left gastric vascular supply to the 
stomach. When ligating the individual 
neurovascular branches, extra caution 
is needed to prevent bleeding which 
could lead to the hasty clamping of
tissue including the main nerves of 
Latarjet. Careful dissection is carried 
proximally to include the vagal bran­
ches across the distal esophagus and 
proximal stomach. This appears to be 
the crucial area in determining com­
pleteness of HSV. The entire procedure 
takes an average of 1 to 1V2 hours.23
Physiology
Altered gastric physiology following 
surgical intervention for peptic ulcer 
disease affects gastric acid output, 
gastrin production and gastric motility.
The vagus nerve plays the main role 
in the etiology of peptic ulcer disease.26 
It provides the major control for gastric 
acid secretion and influences gastrin 
release. Excessive acid production cer­
tainly is important in the pathogenesis 
of ulcers and therefore adequate re­
duction in acid secretion is the primary 
objective in any procedure designed to 
effect their cure. This can best be 
assessed postoperatively by measuring 
both basal and stimulated acid produc­
tion.27 Basal acid output (BAO) is the 
amount collected in 1 hour by naso­
gastric suction after a 12-hour over­
night fast.28 In Caucasians BAO aver­
ages 1.5 mmol/h in females and 2.5 
mmol/h in males.28 To measure stimul­
ated gastric acid secretion patients are 
given pentagastrin either subcutaneous­
ly, intramuscularly or by infusion and 
gastric aspirates are collected for 1 to 
2 hours. Maximal acid output (MAO) 
and peak acid output (PAO) are terms 
that are used almost interchangeably; 
MAO is defined as total gastric acid 
output over 1 hour, while PAO is the 
highest value found during any two 
15-minute periods in a 1-hour test mul­
tiplied by two. Histamine may be sub­
stituted for pentagastrin as the stimulus 
(augmented histamine test).29,30
The Leeds and Copenhagen groups 
have followed up 63 of their HSV 
patients with preoperative and serial 
postoperative studies of gastric acid 
output (Table I).29-31-33 Initially BAO 
decreased by 92%; over the next 12 to 
24 months this decrease was reduced 
slightly to 80% but there was no fur­
ther change in acid output. Immediat­
ely postoperatively MAO decreased by
Table 1—Results of Gastric Acid Output Studies 
and Hollander Tests in Leeds-Copenhagen Patients
Time
postoperatively
Reduction 
in basal 
acid output, %
Reduction 
in maximal 
acid output, %
Positive 
Hollander test 
result, %
lw k 92 51 3
2 -  3 mo 86 68 30
6 -12 mo 87 55 56
12 -  24 mo 80 55 57
2 -  4 yr 90
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51% and remained fairly constant over 
the ensuing months. Similarly Kron- 
borg and Madsen16 reported a 60% to 
70% decrease in BAO and a 50% 
decrease in MAO immediately post- 
operatively. Grassi and associates34 re­
ported decreases of 80% to 85% in 
BAO. Wastell and colleagues35 found 
a 58% decrease in MAO and Jordan15 
noted that BAO decreased by 57% and 
MAO by 53%. These figures compare 
favourably with those obtained follow­
ing truncal vagotomy. Both Kronborg11 
and Kennedy and colleagues12 reported 
a 60% decrease in MAO in the im­
mediate postoperative period following 
TVP. Over the years of follow-up there 
was no significant change in BAO or 
MAO, even though some Hollander 
test results, which were negative origin­
ally, subsequently became positive.30'36,37 
Both HSV and TVP reduced BAO and 
MAO to similar values. This confirms 
the premise that an adequate ulcer 
operation can be performed leaving the 
antrum intact.
The Hollander test is the standard 
method of determining the complete­
ness of vagotomy. Insulin-induced 
hypoglycemia stimulates gastric acid 
secretion through the vagus nerve. A 
test is said to be positive if, after an 
intravenous injection of 0.2 units/kg of 
insulin and a decrease in blood sugar 
to 40 mg/dL (2.2 mmol/L), the gastric 
acid output is increased within 2 hours 
by 20 mmol/L above basal levels or 10 
mmol/L in an achlorhydric patient.28 
As seen in Table I, the number of posi­
tive Hollander test results in the Leeds- 
Copenhagen series38 increased from 
3% at 1 week postoperatively to 90% 
after 2 to 4 years. Despite the conver­
sion, both the BAO and MAO values 
remained low. In this group MAO in 
response to insulin was 3.9 mmol/h 
compared with 33 mmol/h preoper- 
atively. Also there was no significant 
increase in MAO response to penta- 
gastrin stimulation. Other reports after 
total vagotomy have shown a similar 
change from Hollander-negative to 
Hollander-positive test results in the 
course of 1 to 2 years.36 Gillespie and 
colleagues39 found that 50% of tests 
initially negative later became positive. 
Again, however, there was no increase 
in BAO or MAO and the amount of 
acid secreted in response to insulin 
was substantially lower than the 
amount secreted preoperatively. Why 
a negative response to the Hollander 
test should be converted to a posi­
tive response is unknown. The most 
likely reason is that there is re­
generation of some vagal fibres.39 It 
also has been postulated that the 
parietal cell mass becomes more sen­
sitive to humoral stimuli,38 or that there 
is a temporary neurapraxia after sur­
gery.38,39 In any case, despite the later 
conversion to a positive Hollander test 
result, there is no notable change in 
acid secretion.
The role of gastrin in the production 
of acid and in the pathogenesis of 
peptic ulcer disease is unclear. It is 
known that serum gastrin concentra­
tions are raised to a comparable degree 
after vagotomy of any type, be it 
truncal or highly selective.40'43 It is 
evident that gastrin release is primarily 
controlled by gastric acidity.41 Begin­
ning at a pH of 3.0 and maximally at a 
pH of 1.5 to 1.0, gastrin release is 
effectively inhibited. Direct vagal con­
trol of gastrin release is secondary. 
Therefore, provided that the antrum is 
in continuity with the remainder of the 
stomach, even though its innervation is 
intact, gastrin secretion will not be 
excessive.41 The elevated gastrin con­
centrations can apparently be explained 
on the basis of increased gastric pH 
following vagotomy. However, this is 
only part of the explanation. After 
vagotomy, basal gastrin concentrations 
are higher than those that can be 
achieved by continuous intragastric 
neutralization. Therefore, up to half of 
the gastrin may be derived from other 
sources, possibly the duodenum.41 It 
appears that extragastric gastrin does 
not play a crucial role in peptic ulcer 
disease. Although small variations in 
gastrin values following HSV and TVP 
do occur, there is no difference in 
gastric acid output after either proce­
dure. It can therefore be concluded 
that denervation of the parietal cell 
mass is of utmost importance in render­
ing the parietal cell less responsive to 
gastrin.44,45 The exact role of gastrin, 
despite its high concentrations follow­
ing peptic ulcer surgery, remains con­
troversial.
Storage and propulsion of food along 
the gastrointestinal tract are two of the 
major functions of the stomach. Be­
cause these functions are controlled by 
the vagus nerve, it is not surprising that 
gastric motility is altered by vagotomy 
of any type. It is least affected after 
HSV. The regular three-per-minute 
rhythm of electrical activity in the an­
trum is preserved following HSV but 
becomes disorganized after truncal vag­
otomy. Intragastric receptive relaxation 
is altered after HSV so that fluids leave 
the stomach slightly more quickly than 
normal. However, the transit time of 
solids is not increased. Johnston and 
colleagues40,43,46 studied gastric transit 
time in patients after HSV using radio­
paque food and barium. They demon­
strated a pattern of emptying similar to 
that observed preoperatively in patients 
with duodenal ulcer and one that was 
significantly (P <  0.002) slower than
in patients subjected to TVP. Truncal 
vagotomy and pyloroplasty affects the 
stomach in two ways. First, because 
the stomach is completely denervated 
there is no propulsive action. Second, 
a drainage procedure must also be 
performed, rendering the stomach “in­
continent” and causing an increase in 
dumping.47,48 Highly selective vagotomy 
avoids this potential complication. By 
leaving the pylorus and antrum inner­
vated, gastric emptying is regulated 
and dumping is less likely to develop. 
Gastric emptying is sufficient to 
prevent gastric stasis and a drainage 
procedure becomes unnecessary.46,49
Results
In assessing the results of surgery 
for peptic ulcer disease three ques­
tions are important: (a) What is the 
recurrence rate? (b) What is the 
mortality? (c) What is the morbidity? 
Answers to these questions determine 
the operative procedure to be used. 
Therefore we reviewed the results of 
TVP reported by nine authors5'12,21 
well known in this field and compared 
them with the results of HSV reported 
by another seven.13'19 The literature on 
TVP appeared between 1956 and 1976, 
allowing a comparison between the 
earlier and later results for this proce­
dure (Tables II and III). All opera­
tions were elective. Heineke-Mikulicz 
pyloroplasty was the drainage proce­
dure of choice accompanying truncal 
vagotomy. The literature reviewed was 
selected as a representative sample and 
includes 1831 patients who under­
went TVP between 1950 and 1976. 
The review of the results of HSV 
includes 601 patients, representing a 
maximum follow-up of 8 years.
What is the rate of recurrent ulcera­
tion after each procedure? In our re­
view, recurrence rates were based on 
“hard evidence”. That is, an ulcer was 
seen either radiologically, at gastroscopy 
or at re-exploration, or the patient pre­
sented with hematemesis or melena. In 
the nine series of TVP, the average 
overall recurrence rate was 5.6% 
(range 1.5% to 10.5%). Using similar 
strict criteria for patients undergoing 
HSV, the overall rate of recurrence 
was 6.6% but the range was from 
2% to 22% (Table IV). This may 
possibly reflect a particular surgeon’s 
skill in the technique. Thus as experi­
ence with this new procedure increases, 
results may become more uniform. 
This hypothesis is supported by 
Liedberg and Oscarson50 who initially 
reported a recurrence rate of 20% in 
patients following HSV after an 18- 
month follow-up. Insulin testing in­
dicated that in 83% the vagotomy was 
incomplete. Basal acid output dimin-
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ished by only 40% and MAO by only 
33%. However, after modifying their 
surgical technique, subsequent results 
revealed no further recurrences. The 
BAO had decreased by 80% and the 
MAO by 58%. Kronborg16 initially re­
ported a 22% frequency of recur­
rences (Table IV). Subsequently, after 
modifying the surgical technique, he 
reported the results in 150 more pa­
tients. The recurrence rate had dwin­
dled to only 8% in this group. 
In both these instances the tech­
nique was modified by extending 
the dissection to include the distal 
5 to 6 cm of the esophagus. This 
seems to emphasize two points: (a) 
an adequate HSV must include dener­
vation of the distal esophagus and 
(b) recurrence rates vary directly with 
the degree of completeness of the 
vagotomy. Contrary to the improve­
ment in results with improved surgical 
technique, recent reports of patients 
followed for more than 5 years show
an increased recurrence rate with time. 
The Leeds-Copenhagen group,51 after 
2 to 4 years’ follow-up, reported no 
recurrences in 117 patients. After 5 to 
8 years Goligher and colleagues14 now 
report an incidence of 4.3% proven 
ulcers and another 11.1% of patients 
with dyspeptic symptoms suggestive of 
recurrent ulceration. Patients in the 
series of Jensen and Amdrup13 had a 
recurrence rate of 9%. While it is likely 
that recurrence rates will decrease as 
surgical expertise improves, long-term 
follow-up must be awaited.
Hollander tests were performed in 
many patients to determine if the vago­
tomy was complete. In patients with 
recurrent ulceration following TVP 
the result of the Hollander test was 
positive in more than 70% (Table V). 
Only in Herrington’s series8 was this 
phenomenon not substantiated. In only 
one series were Hollander tests per­
formed on both asymptomatic patients 
and those with known recurrences6
(Table V). There was a striking dif­
ference. The number of positive Hol­
lander test findings was only 29.8% 
overall, compared with 100% in the 
recurrent-ulcer group. In addition, 
Kennedy and associates12 reported that 
of patients with a positive Hollander 
test result, the rate of recurrent ul­
ceration was 23.6% compared with 
only 1.6% in patients with a negative 
test result. Following HSV, the Leeds 
and Copenhagen groups51 initially re­
ported a 0% recurrent ulceration rate 
(although recurrence was suspected 
without “hard evidence” in 3% ). Con­
comitantly they reported 97% negative 
Hollander test findings in a group of 
100 patients 1 week postoperatively. 
Goligher and associates14 now report 
that of those patients with recurrences 
who had Hollander tests, 40% were 
positive (Table VI). Kronborg and 
Madsen16 reported in their initial 
series a positive Hollander test result 
in 71 % of patients who had recurrent
Table I I - Early Results of Truncal Vagotomy and Pyloroplasty
No. of Recurrent Visick grade. %
patients Follow-up, M ortality , ulceration,
Series (N  =  645) yr % % 1 II II I IV
Weinberg and associates, 19565 200 2 -  6 0.4 1.5 89.5 — 10*5Lloyd Davies, 1956° 132 4 -  7 1.5 4.5 47 36.5 7.5 9Herrington Jr, 1967“ 101 2 -  8 4.1 7.3 53 30 6 11
Schofield, Watson-Williams and
Sorrell, 19679 212 5 0.4 4.2 56 34 — 1 0 -
Mean 1.2 3.7 8 7 - — 1 3 -
Table I I I - Late Results of Truncal Vagotomy and Pyloroplasty
No. of Recurrent Visick grade. %
patients Follow-up, M ortality, ulceration, -
Series (N  =  1186) yr % % 1 II in IV
Dragstedt Jr and Lulu, 197410 100 1 -  10 0 2 Not analysed
Kronborg, 197511 370 6 -  8 __ 10.5 46 26 7 21
Kennedy and colleagues, 197312 204 2 + 0 4.8 88 — 4 8
O’Leary and colleagues, 197621 348 7 -1 7 1 4.9 __ 88 — 7 5
Goligher and associates, 19727 164 5 - 8 0.5 6.7 45 23 18 14
Mean 0.6 6.5 — 8 0 - 8 12
Table IV— Results of Highly Selective Vagotomy
No. of Recurrent Visick grade. %
patients Follow-up, M ortality , ulceration, —
Series (N  =  601) yr % % 1 II II I IV
Jensen and Amdrup, 197813 100 5 -  8 0 9 72 14 4 10
Goligher and associates, 197814 117 5 -  8 0 4.3 56 19 13 12
Jordan Jr, 197615 41 2 -  3 0 2.4 95 5 0 0
Kronborg and Madsen, 197516* 56 1 -  4 0 22 68 10 2 20Kennedy and colleagues, 197517 50 1 -  4 0 2 60 36 2 2
Stoddard, Vassilakis and Duthie, 197818 121 0.5 -  5 0 5.4 77 16 2 5
Dorricott and colleagues, 197819 116 1 -  4 0 4.3 55 27 7 a
Mean 0 6.6 66 20 5 9
•In  1977, the recurrence rate was reduced to 8% .
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ulceration (Table VI). This frequency 
was similar in both the recurrent and 
the nonrecurrent groups. In a series 
of 16 patients followed up to 1 year 
by Wastcll and associates35 2 (12.5%) 
had recurrent ulceration and over­
all 5 (31%) of the 16 had a posi­
tive Hollander test result (Table VI). 
In the two patients with recurrence, 
the Hollander test was positive in 
one and negative in the other. Clear­
ly this further emphasizes how the 
degree of completeness of vagotomy, 
as determined by Hollander testing 
influences the frequency of recurrent 
ulceration.
What is the mortality? Generally, 
elective ulcer procedures are safe. 
Vagotomy and pyloroplasty has been 
considered a conservative approach. 
In this series, the overall mortality for 
TVP was 0.7%. There was no oper­
ative mortality following HSV (Table 
IV). In 1975, Johnston52 polled all 
surgeons doing HSV and reported a 
worldwide operative mortality of only 
0.3% in 5539 procedures. In this group 
five deaths (0.1%) were attributed to 
necrosis of the lesser curvature, a com­
plication specific to HSV. The exact 
pathogenesis is unclear, but presum­
ably it is of ischemic origin, secondary 
to ligation of most of the left gastric 
arterial supply along the lesser cur­
vature.52 If devascularization is limited 
to branches of the left gastric artery 
such necrosis will not occur.
Maintaining the integrity of the
gastrointestinal tract is probably a 
factor in reducing operative mortality. 
There is no risk of anastomotic leak 
or perforation and postoperative mor­
bidity is reduced. Perez-Avila and 
Duthie53 found the frequency of wound 
infection to be 2.4% (1 of 41 patients) 
after HSV compared with 19% (15 of 
81 patients) after TVP. There were 
no cases of wound dehiscence or peri­
tonitis after HSV. In patients who had 
TVP 3.7% (3 of 81) and 2.5% (2 of 
81) respectively suffered from wound 
dehiscence and peritonitis. These find­
ings were confirmed by Stoddard, 
Vassilakis and Duthie18 and by Dorri- 
cott and associates.19
Does HSV succeed in diminishing 
side effects? The standard method of 
analysing results is by the modified 
Visick classification.7 Results in grades 
I and II are considered perfect or near 
perfect. Results in grade IV are un­
satisfactory (moderate or severe symp­
toms interfering with work or life­
style) and grade III patients still have 
persisting symptoms despite dietary 
modifications although the symptoms 
do not interfere with life-style. Eighty- 
six percent of patients who had HSV 
had grade I or II results (Table IV), 
compared with 82% of patients who 
had TVP (Tables II and III). Of the 
patients who underwent HSV 9% had 
a poor result (Table IV) compared 
with 10.8% of the patients who under­
went TVP (Tables II and III). The 
failures following HSV were due al­
most exclusively to recurrent ulcer. 
In Kronborg and Madsen’s16 series 
of HSV the result in 20% of patients 
was classified as poor (Table IV); 
all the failures were due to recur­
rent ulcer. All other patients except 
one had a grade I or II (excellent to 
very good) result. Twelve percent of 
Goligher’s14 patients were classified as 
grade IV. Of these 12 (85% ) of 14 
were due to proven or suspected re­
currence. Recurrent ulceration was the 
reason for a grade IV classification in 
three (75%) of four patients following 
HSV in Stoddard’s, series18 and six 
(67% ) of nine patients in Jensen and 
Amdrup’s series.13 In contrast Kron- 
borg’s results of TVP showed a 21% 
failure rate, of which only 10.5% of 
failures were due to recurrent ulcera­
tion (Table III) .11 Although he did not 
analyse the poor results as to cause, 
he did report 54 patients with severe 
or moderate dumping and 33 patients 
with urgency and diarrhea.11
The value of HSV was based on the 
premise that there would be a de­
creased frequency of dumping and 
diarrhea because a drainage procedure 
was not necessary.54 This was confirmed 
by our review. The frequency of dump­
ing and diarrhea was less than 10% 
(Table VII). Severe dumping symp­
toms were even more infrequent, rang­
ing from 0% to 4%. In all series of 
TVP a frequency of dumping and 
diarrhea of 9% or greater was reported 
(Table VIII). Lloyd Davies' reported 
dumping and diarrhea in 20% and 
28% of cases respectively and in the 
series reported by Goligher and as­
sociates7 the respective percentages 
were 14% and 22% (Table VIII). In 
most cases symptoms were mild to 
moderate but were still appreciably 
higher than after HSV. Kennedy and 
associates17 studied a control group in 
assessing the usefulness of HSV. In­
terestingly, in this group with no known 
gastrointestinal disease, there were as 
many abdominal complaints as in the 
HSV group. In both groups, there were 
complaints of nausea, vomiting, heart­
burn and flatulence. In the control 
group 71% of patients were classified 
overall as Visick grade I and 20% 
Visick grade II compared with 60% of 
HSV patients graded Visick I and 36% 
Visick II. This difference was not 
significant. Perhaps we can conclude 
that the minor side effects following 
HSV are not due to the surgery but 
are a manifestation of normal human 
variation. In any case, major side ef­
fects appear to be uncommon follow­
ing HSV.
Without a drainage procedure, there 
was concern that gastric stasis and 
secondary ulceration might occur. How­
ever, in his worldwide survey Johnston52
T a b le  V - -R e s u lts  o f H o lla n d e r  T e s ts  a f t e r  T ru n c a l 
V ag o to m y  a n d  P y lo ro p la s ty
S eries
P o s it iv e  H o lla n d e r  te s t  
r e s u lt  in  a l l  p a tie n ts ,
%
P o s it iv e  H o lla n d e r  te s t  
re s u lt  in p a tie n ts  w ith  
re c u r re n t  u lc e r ,  %
W e in b e rg  and c o lle a g u e s , 19565 N o t re p o rte d 71
L lo yd  D a v ie s , 19566 29.8 100
G o lig h e r  and  c o lle a g u e s , 19727 N o t re p o rte d 7 5 *
H e rr in g to n  J r, 1967* N o t re p o rte d 28
S ch o fie ld , W a ts o n -W illia m s  and  
S o rre ll ,  19679 N o t re p o rte d 8 2 f
’ H o lla n d e r  te s ts  done  on o n ly  16 o f 24 p a tie n ts  w ith  re c u rre n c e s . 
(H o l la n d e r  te s ts  d o n e  on o n ly  8 o f 11 p a tie n ts  w ith  re c u rre n c e s .
T a b le  V I - R e s u l t s  o f H o lla n d e r  T e s ts  a f te r  H ig h ly
S e le c tiv e  V ag o to m y
P o s it iv e  H o lla n d e r  te s t P o s it iv e  H o lla n d e r  te s t
re s u lt  in  a l l  p a tie n ts , re s u lt  in  p a tie n ts  w ith
S eries % re c u r re n t  u lc e r ,  %
G rassi and  c o lle a g u e s , 197334 2.5 100*
Jordan  J r , 197615 59 100
K ro n b o rg  and M ad sen , 1 97516 58 71
W a s te d  an d  c o lle a g u e s , 197235 31 5 0*
G o lig h e r  and  a s s o c ia tes , 197814 0 40
’ O n ly  1 p a tie n t.
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reported only a 0.1% incidence of 
immediate postoperative stasis requiring 
surgery; gastric stasis as manifested 
by bilious vomiting, epigastric fullness 
and heartburn was lower than, or equal 
to, the TVP group. Only in Goligher’s 
series14 was epigastric fullness unduly 
high (31% ) (Table VII). However, 
this was not associated with an in­
crease in vomiting or bile regurgitation 
Therefore, the authors believe that it 
was probably not related to stasis and 
theorize that it might be related to the 
English dietary habits.22
Finally, by comparing the data in 
Tables VII and VIII, we note that all 
side effects were less common after 
HSV than after TVP, supporting the 
principle of HSV, namely, that an in­
tact pylorus will regulate gastric emp­
tying, thereby decreasing diarrhea and 
dumping, while the innervated antrum 
prevents gastric stasis.
Discussion
The complexity of peptic ulcer di­
sease has been recognized for many 
years. Researchers and clinicians alike 
have realized that the etiology of duo­
denal ulcers is not merely excessive 
gastric acid production. The balance 
between neural and hormonal stimula­
tion and inhibition of gastric acid out­
put which is exact, obviously is dis­
rupted in peptic ulcer disease. Logic­
ally, therefore the most appropriate 
surgical intervention is the one that 
would remove the ulcerogenic factors
with the least interference to other 
functions in the gastrointestinal tract. 
On this basis HSV appears to be the 
procedure of choice. Innervation of 
the antrum and pylorus is preserved 
and continuity of the gastrointestinal 
tract maintained. This results in HSV 
being a safer procedure than others 
and having fewer side effects.
The question that remains unan­
swered is, will the long-term rate of 
recurrence after HSV be acceptable? 
To date, this rate compares favourably 
with that of TVP, but the longest fol­
low-up in this review was only 8 years. 
In an attempt to predict late results of 
HSV the early and late results of TVP 
were compared. The mortality dimin­
ished from 1.2% to 0.6% and there 
was only a small increase in the num­
ber of recurrences (3.7% to 6.5%). 
O’Leary and colleagues21 reported the 
results of TVP after a follow-up of 7 
to 17 years. The rate of recurrence 
was only 4.9%, and there were no re­
current duodenal ulcers after 5 years. 
From these results, one may predict 
that the long-term recurrence rate for 
HSV will be acceptable.
There is no doubt that successful 
ulcer surgery depends upon the com­
pleteness of vagotomy. The reliability 
of the Hollander test in assessing the 
degree of completeness of vagotomy is 
controversial. In the Leeds series38 the 
number of tests that gave a positive 
result increased from 3% at 1 week 
to 90% at 2 to 4 years (Table I).
Because of the increased number of 
positive results with time, Woodward 
and associates55 and Brooke56 maintain 
that insulin tests should be done some 
months after surgery. However, John­
ston and colleagues57 found that results 
of Hollander tests carried out in the 
first week after operation could best 
be correlated with the frequency of 
recurrent ulceration. Despite the tim­
ing of the test, from the results in these 
series there appears to be a strong 
relation between recurrent ulceration 
and positive Hollander tests. Kennedy 
and colleagues12 found that 23% of 
their patients who underwent TVP had 
recurrent ulceration if the result of the 
Hollander test was positive compared 
with only 1.6% in patients who had 
a negative result. Kronborg and 
Madsen16 reported that recurrent ul­
ceration developed in 8 (26.7%) of 
30 patients with positive Hollander 
test results in the HSV group compared 
with 3 (15%) of 20 patients with 
negative results. Grassi and colleagues34 
reported that 2 (2.4%) of 85 patients 
in their series had positive Hollander 
test results. One patient subsequently 
had a recurrent ulcer. There was no 
recurrent ulcer in patients who had a 
negative Hollander test result. Patients 
with positive Hollander tests post- 
operatively appear to run a greater 
risk of recurrent ulceration. In fact, 
according to Johnston (personal com­
munication, 1978), approximately 
50% of patients with positive Hollan-
Table VII—Side Effects of Highly Selective Vagotomy 
Reported in the Literature (Figures are Percentages)
Dumping
Series Diarrhea Mild Severe
Epigastric
fullness Nausea
Vomiting of 
food
Regurgitation 
of bile Heartburn Flatule
Jensen and Amdrup, 197813 1 1 2 _ _
Goligher and associates, 197814 5 1 ___ 31 15 9 6 13 19
Jordan Jr, 197615 5 17 ___ 0 2 0 5
Kronborg and Madsen, 197516 6 4 2 8 4
Kennedy and colleagues, 197517 
Stoddard, Vassilakis and Duthie,
4 8 0 — 10 10 2 14 18
197818 7 1 4 20 13 7 4 15 20
Dorricott amd associates, 197819 5 2 10
~
7 10
Table VIII—Side Effects of Truncal Vagotomy and Pyloroplasty 
Reported in the Literature (Figures are Percentages)
Series Diarrhea
Dumping
Gastric
retention
Epigastric
fullness
Vomiting of 
food
Regurgitation 
of bile Heartburn FlatulenceMild Severe
Lloyd Davies, 19566 28 20 — 6 _ _ 12 18
Goligher and associates, 19727 22 12 2 18 37 4 10 13 20
Herrington Jr, 1967s 12 25 1 — _ _
Schofield, Watson-Williams and
Sorrell, 1967° 13 21 _ _ _ _ 4
Dragstedt Jr and Lulu, 197410 14 9 — _ _ _
Kronborg, 197511 22 22 3 — 25 5 _ _ _
Kennedy and colleagues, 197312 27 25 1 — — _ 6 _ _
O'Leary and colleagues, 197621 16 11 5 55 14 — —
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der test results preoperatively may 
have recurrent ulcers, again empha­
sizing the necessity for a complete 
vagotomy.
We conclude that HSV is the proce­
dure of choice in the conservative sur­
gical management of duodenal ulcer. 
However, is HSV an adequate proce­
dure for the patient who has gastric 
hypersecretion? Truncal vagotomy and 
antrectomy have been shown to reduce 
both BAO and MAO by 90% 58 com­
pared with an 80% reduction in BAO 
and a 50% to 60% reduction in MAO 
following HSV or truncal vagotomy 
and a drainage procedure. Because 
the absolute acid concentration is cri­
tical in recurrent ulceration, it must 
be determined whether a 50% to 60% 
reduction in acid production will ade­
quately prevent recurrent ulceration 
in a hypersecreting patient. In 1972, 
Kronborg59 reported on 425 patients 
followed for 5 years after TVP. Pre­
operative studies of gastric acid secre­
tion were carried out in all. Ulcers 
recurred in 14% of males and 28% 
of females who had MAO values pre­
operatively greater than 46.4 mmol/h 
and 42.2 mmol/h respectively. Conver­
sely, patients with MAO below these 
values had recurrence rates of only 
1.7% and 1.1% respectively. He con­
cluded that the critical MAO value 
was 42 to 46 mmol/h. Patients with a 
greater acid output should be managed 
by truncal vagotomy and antrectomy. 
In addition, he found that there were 
no recurrent ulcers in patients whose 
postoperative MAO was less than 11.8 
mmol/h in males and 12.4 mmol/h in 
females. Robbs and associates'0 agreed 
with Kronborg but were of the opinion 
that the critical MAO concentration 
preoperatively was 25 mmol/h. They 
reviewed patients who had been treated 
with vagotomy and pyloroplasty or 
vagotomy and antrectomy. In the group 
of patients with TVP and preoperative 
MAO values of 25 mmol/h or higher 
the frequency of recurrent ulceration 
was 8.6%. A similar group of patients 
treated with vagotomy and antrectomy 
had no recurrent ulceration. Louw and 
Marks'1 reported similar results using 
30 mmol/h as the critical value in de­
termining a hypersecreting patient. If 
TVP is deemed inadequate for the hy­
persecreting patient, perhaps HSV is 
also inadequate. To date, no studies 
correlating recurrence rates with the 
results of acid studies have been pub­
lished. However, Johnston and col­
leagues'2 studied 40 hypersecreting pa­
tients (MAO >  40 mmol/h in males, 
50 mmol/h in females) and compared 
these to 60 normosecreting patients. In 
both groups the proportion with incom­
plete vagotomy as judged by Hollander 
testing was 6%. There were no proven
recurrences in a 2- to 6-year follow-up 
period. In each group, 7% of patients 
complained of ulcer-type pain. They 
concluded that HSV was adequate even 
in the hypersecreting patient. In light 
of the present evidence, we must await 
further follow-up studies to determine 
if HSV is an adequate procedure for 
hypersecreting patients.
Another important consideration is 
whether most general surgeons can 
capably perform HSV and obtain good 
results. There is little doubt that HSV 
is a more difficult and meticulous tech­
nical exercise than is TVP. The series 
reviewed are the results of operations 
performed in teaching hospitals by ex­
perts in this field. Several reports have 
shown that results of HSV vary directly 
with the experience of the operating 
surgeon.
Solhaug, Bjerkeset and Halvorsen63 
reported that in a group of patients 
operated on by junior surgeons, 60% 
of Hollander tests gave positive results 
postoperatively, whereas only 40% of 
Hollander test results were positive in 
the group operated on by senior sur­
geons. In each surgeon’s record, the 
failures occurred in the first few HSVs 
performed. In the series of Kronborg 
and Madsen,16 the rate of recurrence 
for four surgeons who had performed 
more than 25 such procedures each 
was 9% compared with 19% for 10 
less-experienced surgeons. It appears, 
therefore, that optimal results follow­
ing HSV will be attained as individual 
experience with the procedure in­
creases.
Summary
Preservation of antral innervation 
and pyloric function make highly se­
lective vagotomy (HSV) a more phy­
siologic surgical procedure than truncal 
vagotomy and pyloroplasty (TVP). 
The variable serum gastrin values after 
each of these procedures do not seem 
to influence the postoperative gastric 
acid output greatly. Basal acid output 
is decreased by 80% and maximal acid 
output by 50% to 60% after both pro­
cedures.
Highly selective vagotomy is a safer 
procedure than TVP. The mortality 
following HSV is 0% in this series and 
0.3% in a worldwide survey compared 
with 0.7% for truncal vagotomy and 
pyloroplasty. Clinical results following 
HSV are better. To this date the rate 
of recurrent ulceration has been ac­
ceptable and all side effects reported 
have been fewer than for TVP.
We conclude, therefore, that HSV 
should be considered the conservative 
operative procedure of choice in the 
surgical management of peptic ulcer 
disease.
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CARDIOVASCULAR SOCIETY PAPERS
Is Left Ventricular Decompression Necessary 
during Coronary Artery Surgery?
E.J.P. CHARRETTE, MD, FRCSfc], FACS AND T.A. SALERNO, MD, FRCS[C]
The use of the “no-vent technique" 
was studied prospectively in 91 con­
secutive patients undergoing coronary 
artery surgery. Analysis of the results 
indicates that left ventricular distension 
will not occur if cardioplegic arrest is 
effected, if the venous line is positioned 
in the right atrium and if left-sided 
pressures are monitored. The no-vent 
technique has shortened the operating 
time, simplified the pump layout and 
eliminated the hazards associated 
with venting.
L'emploi d'une “technique sans 
orifice” a ete evalue de maniere 
prospective chez 91 patients qui ont 
subi successivement une operation des 
arteres coronaires. L'analyse des 
resultats indique qu'il n’y aura pas de 
distension du ventricule gauche si 
un arret cardioplegique est effectue, 
si un catheter veineux est place dans 
I'oreillette droite et si les pressions 
de remplissage du ventricule gauche 
sont surveillees. La technique sans 
orifice a reduit le temps de (’inter­
vention, simplifie ('installation de la 
pompe et elimine les risques associes 
a la pratique d’un orifice.
After the introduction in our centre of 
routine cardioplegic arrest during oper­
ations on the coronary vessels, we
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elected to ascertain prospectively the 
feasibility of performing such surgery 
without any form of left ventricular 
(LV) decompression.
Patients and Methods
Ninety-one consecutive patients (84 
men, 7 women) undergoing coronary 
artery bypass grafting were included 
in the study. Their ages ranged from 
31 to 65 years (mean 58 years). The 
operation in 67 patients was elective 
and in 24 patients was performed as 
an urgent or emergency procedure for 
unstable angina or severe stenosis of 
the left main coronary artery.
No patient was excluded, irrespective 
of the status of LV function, distribu­
tion of coronary lesions or severity of 
pulmonary disease. Twelve patients had 
mild mitral valve insufficiency. The 
ejection fraction for the group ranged 
from 0.22 to 0.65 and the LV end- 
diastolic pressure ranged between 5 
and 14 mm Hg in 66 patients, between 
15 and 20 mm Hg in 18 and was more 
than 20 mm Hg in 7 patients. In two 
patients intra-aortic balloon pumping 
was introduced preoperatively as a 
prophylactic measure and kept in situ 
for 24 hours afterwards. The extent of
Tab le  1— C oro na ry  A r te ry  Bypass G ra ft 
P rocedures P erfo rm ed in  91 P a tie n ts *
No. o f g ra fts  
placed No. o f p a tie n ts
1 4
2 20
3 54
4 12
5 1
T o ta l 91
*The  average nu m ber o f g ra fts  placed fo r  each
p a tie n t w as 2.8.
coronary disease is reflected by the 
number of procedures performed, an 
average of 2.8 grafts per patient being 
necessary (Table I).
Operative Technique
In all patients normothermic cardio­
pulmonary bypass was instituted using 
aortic arch inflow and venous drainage 
through a single two-stage no. 51- 
French cannula inserted into the right 
atrium. A 16-gauge catheter was in­
serted through the right superior pul­
monary vein into the left ventricle 
where pressures were recorded before, 
during and for at least 24 hours after 
the bypass had been performed. Flows 
of 75 mL/kg body weight each minute 
were achieved. A full thickness biopsy 
specimen was taken with a Tru-cut 
biopsy needle (Travenol Laboratories 
Inc., Deerfield, IL) from the left ven­
tricle at the start of cardiopulmonary 
bypass, the aorta was then cross- 
clamped and 5 mL/kg body weight of 
cold cardioplegic solution (500 mL 
Ringer’s lactate solution containing 10 
mmol potassium chloride, 12.5 mmol 
sodium bicarbonate, 12 mL 2% lido- 
caine, 17 mL 50% dextrose and 125 
mg Solu-Cortef® [Upjohn], at a pH of 
7.7 and temperature of 4°C) was in­
fused into the aortic root. At 25 min­
utes 2.5 mL/kg body weight of the 
solution was reinfused. The heart itself 
was cooled topically with iced Ringer’s 
solution and the septal temperature 
monitored. Vein grafts were used for 
all patients. The distal anastomoses 
were performed during a single cross­
clamp period. No attempt was made to 
decompress the left ventricle. A second 
myocardial biopsy was taken just be­
fore the aorta was unclamped. The 
proximal anastomoses were then per­
formed on an excluded portion of the 
ascending aorta with the heart beating.
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Results
The time during which the cross­
clamp was applied to the aorta varied 
from 16 to 77 minutes (mean 45 min­
utes). The pump was in operation from 
39 to 128 minutes (mean 87 minutes). 
With this technique it was rarely neces­
sary to compress or internally occlude 
the coronary arteries to obtain a dry 
field for the anastomoses. The myo­
cardial temperature ranged from as low 
as 9°C during infusion to 22°C at 30 
minutes after infusion of the cardio- 
plegic solution.
One patient died unexpectedly of an 
acute myocardial infarction 8 days 
postoperatively. In two patients myo­
cardial infarction was documented dur­
ing the operation; both survived.
One patient with mediastinal infec­
tion recovered following drainage. Five 
patients required reoperation for bleed­
ing and one for sternal dehiscence. In 
five patients minor leg infections re­
quired drainage. Atelectasis was diag­
nosed in six patients but no other 
pulmonary complication could be at­
tributed to the “no-vent” technique.
With aortic cross-clamping the LV 
pressure ranged from 0 to 10 mm Hg 
(mean 6 mm Hg), as seen in Fig. 1. 
With infusion and reinfusion of car- 
dioplegic solution the LV pressure rose 
as high as 16 to 18 mm Hg but quickly 
fell to 0 to 10 mm Hg.
In three patients with retraction of 
the heart the bypass flow decreased, 
leading to a concomitant rise in the LV 
pressure. This was corrected by re­
positioning the venous line. In two 
other patients, despite a decrease in the 
pump flow and arterial pressure, the 
ventricular pressure did not rise. In the 
short period between removal of the 
clamp and resumption of sinus rhythm, 
the LV pressure remained low (Fig. 1). 
Ventricular fibrillation occurred in 
four patients after removing the clamp. 
In two of these the LV pressure rose 
to 25 mm Hg, but fell to normal im­
mediately after defibrillation. In the 
other two patients there was no eleva­
tion in LV pressure in the fibrillating 
hearts.
All patients were weaned easily from 
cardiopulmonary bypass without the 
need for pressor agents and all had 
smooth postoperative courses. Pre-
FIG. 1— Continuous monitoring of left 
ventricular (LV) pressure demonstrates no 
LV distension except during short period 
when cardioplegic solution was infused.
operative and postoperative left heart 
pressures were similar (Table II). In 
two patients intra-aortic balloon pump­
ing was continued for 24 hours after 
surgery.
In all biopsy specimens the integrity 
of the myocardial cells was preserved 
and only three patients had mild inter­
stitial myocardial edema when the 
cross-clamping was discontinued.
Discussion
Because of the threat of LV disten­
sion in a fibrillating heart, surgeons 
have been reluctant to perform cardiac 
surgery without LV decompression.1-4 
However, the hazards of venting are 
real and include air embolism,5 per­
foration of the left ventricle or atrium,6 
myocardial damage6 and bleeding and 
arrhythmias when the vent is removed. 
To avoid these risks some surgeons 
have described alternative, indirect me­
thods of decompressing the left ven­
tricle.610 The advent of cardioplegic 
arrest and the previous experience of 
others5,11,12 in performing coronary 
artery bypass grafting in a fibrillating 
heart without LV decompression 
prompted us to use cardioplegic arrest 
and the no-vent technique. By inserting 
a catheter into the left ventricle by way 
of the superior pulmonary vein, direct 
monitoring of LV pressure was pos­
sible. We have demonstrated that the 
fear of LV distension is unjustified 
during coronary artery bypass proce­
dures provided that the aorta is cross- 
clamped, that cardioplegic arrest is 
used, that the venous line is positioned 
in the right atrium and that LV 
pressures are monitored during the 
operation.
Left ventricular distension under 
these conditions does not occur because 
the coronary flow is eliminated by 
cross-clamping, and blood from the 
bronchial circulation flows in a retro­
grade fashion along the natural path­
ways through the lungs and into the 
pulmonary artery and right ven­
tricle.5,11,13
This technique has been used in a 
consecutive series of patients under­
going coronary artery bypass grafting. 
Patients with poor ventricular function
T a b le  I I — C om p ariso n  o f P re o p e ra t iv e  L e ft  
V e n tr ic u la r  E n d -D ia s to lic  P re s s u re  (L V E D P )  
a n d  P o s to p e ra tiv e  L e ft A t r ia l  P re s s u re  (L A P )
P re o p e ra tiv e  L V E D P , P o s to p e ra t iv e  L A P
m m  Hg (a n d  m e a n ), m m  Hg
5 -  14 8 - 1 3  (9 )
15 -  20 12 -  17 (1 4 )
>  20 4 h : 19 -  25 (2 1 )
24 h : 14 19 (1 7 )
or with pulmonary disease were 
treated no differently from the others 
and were found to behave in the same 
way.
We conclude that the no-vent tech­
nique in coronary surgery is safe when 
the conditions mentioned above are ob­
served.
We acknowledge the technical assistance 
of Mr. Winston Offord and Mr. Lou Gau­
thier (pump technicians), and the secre­
tarial help of Miss D. Judson.
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Bypass Grafting for Stenosis of the 
Left Main Coronary Artery
P. Bedard, md, frcs[c], M.G. Baird, md, frcp[c], Y . A kyurekli, md , frcs[c], M. Brais, md , frcs[c ]
AND W.J. KEON, MD, FRCS[C]
Between Oct. 1, 1973 and Dec. 31, 1976, 
112 (8.1%) of 1388 patients who 
underwent aortocoronary bypass surgery 
had stenosis of the left main coronary 
artery; the degree of stenosis was 
50% or greater. Preoperative functional 
classification (New York Heart As­
sociation) for angina was as follows: 
class I, 16 patients, class II, 23, class III, 
37 and class IV, 36 patients. In 16 
patients the operation was performed 
as an emergency procedure —  for 
cardiogenic shock (1 patient), acute 
myocardial infarction (5), unstable 
angina (5) and for severe stenosis 
(5 patients). A left ventriculogram was 
obtained in 108 patients: 27 ventri­
culograms were normal, 45 showed mild 
impairment of function (22 class I,
23 class II) and 36 showed severe 
impairment (29 class III, 7 class IV).
In all, 378 arteries were grafted 
(3.4 grafts per patient); 48 endarterec­
tomies were carried out on 42 
patients (39 on the right coronary 
artery). The average pump time was 
62.4 minutes and the average duration 
of normothermic cardiac arrest 
was 35 minutes.
All three operative deaths occurred 
in the operating room during emergency 
surgery for cardiogenic shock (one 
patient), acute myocardial infarction 
(one patient) and unstable angina (one 
patient). There were no operative deaths 
in the 96 patients operated on electively. 
There were five late deaths, four of 
which occurred in patients with severely 
impaired left ventricular function.
Intra-aortic balloon pump (IABP) 
assistance was used postoperatively 
only; three of the four patients 
requiring IABP support died.
The incidence of definite (new Q
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wave) postoperative myocardial in­
farction was 7.5%. Endarterectomy 
was associated with a higher incidence 
(14%) of such infarction. No patient 
operated on for unstable angina had 
a postoperative myocardial infarction.
Entre le 1" octobre 1973 et le 31 
decembre 1976, 112 (8.1%) des 1388 
patients qui ont subi un pontage 
aortocoronarien avaient une stenose 
de la coronaire gauche principale; le 
degre de stenose etait de 50% ou plus. 
La classification fonctionnelle pre- 
operatoire (selon la New York Heart 
Association) pour I’angine etait la 
suivante: classe I, 16, classe II, 23, 
classe III, 37, et classe IV, 36 patients. 
Chez 16 patients, I'operation a ete 
pratiquee d'urgence pour un choc 
cardiogene (1 patient), infarctus aigu 
du myocarde (5), angine instable (5) 
et stenose severe (5 patients). Un 
ventriculogramme gauche a ete obtenu 
chez 108 patients: 27 etaient normaux, 
45 montraient une legere deterioration 
de fonction (22 classe I et 23 classe 
II) et 36 presentaient une deterioration 
grave (29 classe III et 7 classe IV).
II y eut en tout, 378 greffes arte- 
rielles (3.4 greffons par patient); 48 
endarterectomies ont ete pratiquees 
chez 42 patients (39 sur la coronaire 
droite). Le temps de pompe moyen a 
ete de 62.4 minutes et la duree 
moyenne d'arret cardiaque normother- 
mique a ete de 35 minutes.
Les trois deces operatoires sont 
survenus dans la salle d'operation, 
durant une intervention d’urgence 
pour un choc cardiogene (un patient), 
un infarctus aigu du myocarde (un 
patient) et une angine instable (un 
patient). II n’y a eu aucun deces ope- 
ratoire parmi les 96 patients operes de 
facon non urgente. On a enregistre cinq 
morts tardives, dont quatre parmi 
les patients ayant une fonction 
ventriculaire gauche gravement 
deterioree.
La contre-pulsation diastolique par 
ballonnet intra-aortique (CDBI) a ete 
utilisee dans la periode postoperatoire 
seulement; trois des quatre patients 
qui ont eu besoin de la CDBI 
sont decedes.
La frequence des infarctus du
myocarde postoperatoires typiques 
(nouvelles ondes Q) a ete de 7.5%. 
L'endarterectomie a ete associee a 
une frequence plus elevee (14% ) 
de ces infarctus. Aucun patient opere 
pour angine instable n'a subi un 
infarctus myocardique postoperatoire.
The left main coronary artery supplies 
the major portion of blood to the ven­
tricular septum, the left ventricular free 
wall, the apex and a portion o f the in­
ferior aspect of the left ventricle. Oc­
clusion of this vessel is catastrophic, 
leading to massive myocardial infarc­
tion and often death. Many workers 
have reported a low survival rate in 
patients with a severely diseased left 
main coronary artery.Prelim inary re­
sults suggest that coronary artery by­
pass grafting has substantially improved 
the outcome in this group o f pa­
tients.2,5"7 Our purpose is to present the 
results of surgery in patients with sev­
ere stenosis of the left main coronary 
artery operated on at the University o f 
Ottawa cardiac unit. We have analysed 
the functional results and factors that 
could contribute to the mortality; we 
have also paid particular attention to 
the frequency and cause o f myocardial 
infarction perioperatively.
Patients and Methods
From Oct. 1, 1973 to Dec. 31, 1976, 
1388 patients underwent aortocoronary 
bypass procedures at the University of 
Ottawa cardiac unit. O f these, 112 
(8.1%) suffered from serious stenosis 
of the left main coronary artery. The 
degree of diameter stenosis was 50% 
to 74% in 58 patients and 75% to 
95% in 49 patients; in 5 patients there 
was complete obstruction o f the left 
main coronary trunk. Ninety-six pa­
tients had severe stenosis o f the right 
coronary artery, 42 having complete 
obstruction.
O f these 112 patients 105 were men 
and 7 were women. Their mean age 
was 50 years (range 27 to 73 years).
The patients were classified func­
tionally according to the New  York 
Heart Association (N Y H A ) classifica­
tion. Sixteen patients were asympto­
matic (class I ) ,  23 had symptoms on 
moderate exertion (class I I ) ,  37 had
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symptoms on mild exertion (class III) 
and 36 patients had symptoms at rest 
(class IV).
Ninety-six patients were operated on 
electively. There were 16 emergency 
operations, 1 because of myocardial 
infarction and cardiogenic shock, 5 be­
cause of unstable acute myocardial in­
farction, 5 because of unstable angina 
and 5 because of the severity of the 
left main coronary stenosis.
At heart catheterization left ventri­
cular function was assessed by meas­
uring the left ventricular end-diastolic 
pressure and by studying the left ven­
triculogram obtained in the right ante­
rior oblique position in 108 of the pa­
tients. The left ventricle was divided 
into four segments on the ventriculo­
gram (Fig. 1). If there was any dys­
function (i.e., hypokinesia, akinesia or 
dyskinesia) in one segment, the patient 
was considered as having a class I left 
ventricle. Similarly if there was dys­
function in four segments, the patient 
was classified as having a class IV 
ventricle. Generally, most patients with 
a class IV ventricle had an ejection 
fraction of 0.2 or less. There were 27 
normal left ventricles. Twenty-two pa­
tients had a class I ventricle (group I),
FIG. 1—Angiographic classification of 
ventricular contractility, right anterior 
oblique projection. Left ventricle is divided 
in four segments. If there is hypokinesia, 
akinesia or dyskinesia in one segment, 
ventricle function is considered as class I. 
Similarly if there is dysfunction in four 
segments, ventricle is considered as class 
IV.
23 class II (group 2), 29 class III 
(group 3) and 7 a class IV left ventricle 
(group 4).
A total of 378 grafts were inserted 
in the 112 patients (3.4 grafts per pa­
tient). Forty-eight endarterectomies 
were done on 42 patients, 39 of them 
of the right coronary artery. A left ven­
tricular aneurysm was repaired in eight 
patients, in five by plication ancT three 
by resection. One patient had mitral 
valve replacement. The average pump 
time was 62.4 minutes (range 15 to 123 
minutes) and the average duration of 
normothermic cardiac anoxia was 35 
minutes (range 13 to 61 minutes).
Results
The mean follow-up in this series 
was 35.8 months. The late mortality 
was 8% (nine patients). In patients 
operated on electively there were no 
operative deaths but there were five 
late deaths (Table I). In the 16 patients 
who underwent emergency surgery 
there were three operative deaths and 
one late death. One of the three pa­
tients who died at operation sustained 
a cardiac arrest while undergoing a 
cholecystectomy. The patient was re­
suscitated and brought to the cardiac 
operating room without being subjected 
to heart catheterization. Another pa­
tient had a cardiac arrest because of 
an acute myocardial infarction sus­
tained during heart catheterization. He 
was transferred immediately to the car­
diac operating room where coronary 
artery bypass grafting was carried out 
unsuccessfully. The third operative 
death was in a patient operated on be­
cause of unstable angina. Three endar­
terectomies had to be carried out be­
cause of severe diffuse coronary artery 
disease. Adequate flow could not be 
obtained in any of the grafts.
Perioperative myocardial infarction 
as diagnosed by the appearance of new 
Q waves on the electrocardiogram 
occurred in 7.5% of patients. En­
darterectomy was associated with a 
higher frequency (14%) of such infarc­
tion. The five patients operated on 
because of unstable angina did not 
show any new Q waves on the electro­
cardiogram.
T a b le  1 — R e s u lts  o f O p e ra tio n  on 112 P a t ie n ts
w ith  S ten o s is o f th e  L e f t  M a in  C o ro n a ry
A rte ry
M o rta lity
O p e ra tio n O p e ra tiv e  La te T o ta l
E m ergency  
(n  =  16) 
E le c tiv e
3 1 4
(n  =  96 ) 5 5
T o ta l 3 6 9
Intra-aortic balloon pump assistance 
was used only for postoperative sup­
port. Four patients required such as­
sistance. Three of them underwent 
emergency operations and died at the 
time of surgery. The fourth patient was 
operated on electively. He had class 
III (NYHA) function preoperatively 
and did survive the operation.
With respect to the functional re­
sults (Fig. 2), 70 patients are asymp­
tomatic and 25 have class II function. 
Seven of the 25 have no angina but 
have symptoms of congestive heart 
failure. One patient has class III func­
tion and one patient class IV. These 
two patients will be subjected to repeat 
angiography to evaluate their coronary 
circulation and the patency of the grafts 
and will undergo a second operation if 
necessary. Seven patients needed a 
second operation because of recurring 
symptoms.
Discussion
Of our patients receiving coronary 
artery bypass grafts 8.1% had serious 
stenosis of the left main coronary ar­
tery (greater than 50%). Such stenosis 
is reported as having been diagnosed 
at coronary arteriography in 2.5% to 
11.5% of patients.1,8 It is interesting 
that in our series of patients, 96 had 
greater than 50% stenosis of the right 
coronary artery and 42 of these had 
complete obstruction. Ninety-three pa­
tients needed at least one graft to the 
right coronary artery system.
Sixteen patients were asymptomatic. 
They underwent coronary arteriography 
either because the results of electro­
cardiography and the treadmill test 
were abnormal or because they were 
young and had evidence of coronary 
arteriosclerosis (previous myocardial 
infarction). Only two of these pa­
tients had a normal right coronary
Preop
FIG. 2—Postoperative functional clas­
sification (New York Heart Association) 
(106 patients).
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artery while seven had a complete 
obstruction. The left main coronary 
artery had 50% to 74% stenosis 
in nine and 75% to 95% stenosis in 
seven patients. Left ventricular func­
tion was normal or mildly impaired in 
11 patients (groups 1 and 2) and sev­
erely impaired (groups 3 and 4) in 
six patients. Oberman and colleagues9 
recommended coronary artery bypass 
grafting in asymptomatic patients as 
long as left ventricular function was 
not severely impaired.
In studying death associated with 
coronary artery bypass grafting, we10 
have found that severely impaired left 
ventricular function is associated with 
a poor prognosis. In this series there 
was only one late death in a patient 
with a normal left ventricle (Table II) 
while all the other deaths were in pa­
tients, operated on electively or ur­
gently, who had poorly functioning 
left ventricles. The left ventricular end- 
diastolic pressure in patients with a 
group 4 left ventricle varied from 25 
to 35 mm Hg. The mortality was also 
high in patients operated on because 
of unstable acute myocardial infarction.
The incidence of perioperative myo­
cardial infarction is not higher in pa­
tients with stenosis of the left main 
coronary artery but, as we showed pre­
viously," endarterectomy is associated 
with a higher frequency of such myo­
cardial infarction.
Intra-aortic balloon pumping was 
not used preoperatively. Although 
some12 recommend its use routinely 
preoperatively, our results lead us to 
conclude that intra-aortic balloon 
pumping is not mandatory before 
operation and should be used postoper- 
atively only under certain circum­
stances (e.g., difficulty in weaning the 
patient from cardiopulmonary bypass 
or when multiple endarterectomies have 
been done).
It is difficult to compare surgically 
and medically treated patients. There 
is, however, general agreement that 
the annual mortality associated with 
severe stenosis of the left main coronary 
artery varies from 15% to 35%.13"15 
Data from a randomized trial in the
Table II -Comparison of Left Ventricular
Function and Subsequent Death*
Ventricle No. of No. of
group patients deaths
Normal 27 1
1 22 —
2 23 —
3 29 3
4 7 4
*ln 4 patients left ventricular function was
not assessed;! patient died.
Veterans’ Administration cooperative 
study16 as well as data from com­
parable groups of patients studied by 
Oberman and colleagues,9 DeMots and 
associates17 and Scanlon and as­
sociates18 suggest that survival follow­
ing surgery is improved in patients suf­
fering from stenosis of the left main 
coronary artery compared with medi­
cally treated patients.
Conclusions
Patients with significant stenosis of 
the left main coronary artery can be 
operated upon with the expectation of 
a low mortality. The long-term survival, 
as for any patients operated on for 
coronary artery disease, is related to 
the degree of left ventricular dysfunc­
tion at the time of surgery. The inci­
dence of perioperative myocardial in­
farction is not higher than in the group 
of patients operated on for coronary 
artery disease in general. Intra-aortic 
balloon pumping is recommended only 
as a postoperative support in certain 
circumstances.
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NOTICES
Symposium on Breast Cancer
The 10th Symposium of Cancerology, 
organized by the bureau of continuing 
medical education of Laval University 
and the Hotel-Dieu de Quebec, and 
supported by the Royal College of 
Physicians and Surgeons of Canada will 
be held Apr. 5 and 6, 1979 at the 
Chateau Frontenac, Quebec City.
The symposium will cover in depth 
new acquisitions in knowledge and 
techniques as well as aspects of inves­
tigation, diagnosis, treatment and evalu­
ation of results in breast cancer.
For further information contact the 
bureau of continuing medical educa­
tion, Faculty of medicine, Laval Uni­
versity, Quebec, PQ G1K 7P4.
Orthopedic Days 1979
The division of continuing medical edu­
cation, Instructional Resources Centre, 
University of British Columbia will 
offer a course entitled “Orthopedic 
Problems of the Upper Extremity” at 
the G.F. Strong Rehabilitation Centre, 
4255 Laurel St., Vancouver, May 10 
and 11, 1979.
Further information may be obtained 
from the division of continuing medical 
education, Instructional Resources Cen­
tre, The University of British Columbia, 
Vancouver, BC V6T 1W5.
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Value of Nitroglycerin Intervention Angiography in 
Predicting Improvement in Left Ventricular Contraction 
following Aortocoronary Bypass Surgery
D avid R o t h , m d , W il l ia m  J. K o s t u k , m d , f r c p [c ] and A shok P a t e l , b sc , r t
It has been suggested that the results 
of administering nitroglycerin to 
patients with coronary disease may be 
of value in predicting the potential 
reversibility of abnormalities of left 
ventricular segmental wall motion. 
Previous studies, however, have not 
assessed the predictive value of 
nitroglycerin on normally contracting 
left ventricular segments supplied by a 
stenosed coronary artery. In 23 patients 
left ventriculograms were obtained in 
the 30° right anterior oblique projection 
preoperatively at rest, after the 
administration of nitroglycerin 
sublingually and after aortocoronary 
bypass grafting. Wall motion was 
assessed by the percentage of 
hemiaxial shortening of six chords. 
Abnormal contractility was defined as 
hemiaxial shortening of less than 25% 
and improved contractility as an increase 
of hemiaxial shortening equal to or 
greater than 10%. Of 47 segments 
with abnormal contractility, 16 were 
improved after the patient had been 
given nitroglycerin and 11 of 16 were 
improved after aortocoronary bypass.
Of the 31 abnormal segments unre­
sponsive to nitroglycerin administration 
only 5 improved with surgery. Of 91 
normally contracting, but diseased, 
segments, 20 improved after nitro­
glycerin administration and 13 of 20 
also improved after surgery. Only 9 of 
the 71 normal, but unresponsive, 
segments were improved by surgery. 
These results suggest that nitroglycerin- 
induced improvement in contractility 
is of predictive value in assessing the 
possible benefits of aortocoronary 
bypass surgery for diseased segments 
that demonstrate either normal or 
abnormal contractility at rest.
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On a suggere que la nitroglycerine 
administree a des patients souffrant 
de maladie cardiaque pourrait servir 
a predire la reversibilite potentielle 
des anomalies du mouvement seg- 
mentaire de la paroi du ventricule 
gauche. Des etudes anterieures n'ont 
toutefois pas evalue la valeur pre- 
visionnelle de la nitroglycerine sur 
des segments ventriculaires gauches 
dont les contractions sont normales 
mais qui sont irrigues par des arteres 
coronaires stenosees. Chez 23 patients, 
des ventriculogrammes gauches ont 
ete obtenus en position oblique ante- 
rieure droite a 30°, en position de 
repos et apres I’administration 
sublinguale de nitroglycerine avant 
I’operation, et apres pontage aorto- 
coronarien. Le mouvement de la paroi 
a ete evalue au pourcentage du 
raccourcissement hemiaxial de six 
cordes. Line contractilite anormale a 
ete definie comme un raccourcissement 
hemiaxal de moins de 25% et une 
amelioration de la contractilite, par 
une augmentation du raccourcissement 
hemiaxial egal a ou plus grand que 
10%. Sur 47 segments presentant une 
contractilite anormale, 16 ont ete 
ameliores apres que le patient eut recu 
de la nitroglycerine et 11 de ces 16 
ont ete ameliores apres pontage 
aortocoronarien. Sur les 31 segments 
anormaux qui n'ont pas reagi a 
i'administration de nitroglycerine, 5 
seulement se sont ameliores a la 
chirurgie. Des 91 segments malades 
dont les contractions etaient normales, 
20 ont enregistre une amelioration 
apres I'administration de nitroglycerine 
et 13 d'entre eux ont aussi ete 
ameliores par la chirurgie. Seulement 
9 des 71 segments normaux qui ne 
repondaient pas a la nitroglycerine ont 
ete ameliores par la chirurgie. Ces 
resultats suggerent que ('amelioration de 
la contractilite provoquee par la 
nitroglycerine possede une valeur 
previsionnelle dans 1'evaluation des 
benefices possibles du pontage aorto­
coronarien des segments malades qui 
montrent une contractilite normale ou 
anormale au repos.
Although aortocoronary bypass surgery 
relieves angina pectoris due to coronary 
atherosclerosis,1-4 it is less certain 
whether such surgery improves left 
ventricular function.5-8 Abnormalities of 
wall motion are common in patients 
with coronary artery disease. Unfor­
tunately, conventional ventriculography 
does not differentiate between the ab­
normalities caused by ischemia, which 
is potentially reversible, and those due 
to previous myocardial infarction and 
subsequent fibrosis which are irrever­
sible. Such differentiation is essential 
if aortocoronary bypass surgery is 
contemplated in patients with coronary 
artery disease. Previous studies have 
demonstrated improvement in wall 
motion abnormalities with such inter­
ventions as sublingually administered 
nitroglycerin,9-12 postextrasystolic poten­
tiation,13,14 epinephrine15 and aorto­
coronary bypass.16 These investigations 
support the hypothesis that chronic 
ischemia produces wall motion abnor­
malities and that such abnormalities 
may be reversible.
Although the use of nitroglycerin has 
been suggested to predict which wall 
segments with abnormal contractility 
will improve with bypass surgery, this 
has been substantiated in relatively few 
patients after aortocoronary bypass 
grafting.9 We therefore compared the 
preoperative ventriculographic changes 
observed after the administration of 
nitroglycerin sublingually with those 
observed following aortocoronary by­
pass grafting. The effect of these inter­
ventions was evaluated on two types of 
regional wall motion. The first con­
sisted of ventricular segments with ab­
normal wall motion associated with di­
seased coronary arteries and the second 
of segments with normal wall motion 
in the presence of diseased coronary 
arteries.
Patients and Methods
Twenty-three men with a mean age 
of 53 years (range 42 to 67 years) 
were studied. All had luminal narrow­
ing greater than 70% in two or more
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major coronary arteries. Sixteen pa­
tients had evidence of an old myo­
cardial infarction as documented by 
history and standard electrocardio­
graphic criteria. Cardiac catheteriza­
tion was performed without premedi­
cation and after jg-blockade and long- 
acting nitrates had been discontinued 
for at least 24 hours. Monoplane left 
ventriculography was performed in a 
30° right anterior oblique projection 
using 40 to 50 mL of Renografin-76® 
(Squibb). Ten to 20 minutes after the 
initial ventriculogram was obtained 0.6 
mg of fresh nitroglycerin was given 
sublingually. When the characteristic 
hemodynamic effects of nitroglycerin 
were observed, namely a fall in the 
left ventricular systolic and end-dia­
stolic pressures together with an in­
crease in heart rate,9,17,18 a second 
ventriculogram was obtained in a man­
ner similar to the first. Coronary 
angiography was performed using 
Judkins’ technique.19 Cineangiograms 
were recorded on a 25-cm X 15-cm 
dual field image intensified at 40 
frames per second using 35-cm film. 
The same studies were performed 
again at a median of 4 months (range 
2 weeks to 11 months) following aor­
tocoronary bypass surgery. In addition 
to the postoperative ventriculography, 
selective angiography was performed 
to determine the status of the native 
vessels and the venous bypass grafts. 
When a graft was occluded, an angio­
gram after aortic root injection was 
also obtained to verify the occlusion.
With superimposed tracings of the 
ventricular end-diastolic and end-sys­
tolic frames obtained from one of the 
first three sinus beats,20,21 quantitative 
computerized analysis of wall motion 
was performed. The long axis was deter­
mined using the apex and midaortic 
valve as fixed points. This long axis 
was quadrisected at right angles pro­
ducing six hemiaxial chords (Fig. 1). 
The percentage shortening for each 
chord was calculated using the follow­
ing formula:
EDL -  ESL
% shortening =  ----------------- X 100,
EDL
where EDL is end-diastolic length and 
ESL is end-systolic length. A compari­
son was made of the hemiaxial shorten­
ing of each of the six chords on the 
ventriculograms obtained at rest after 
sublingual administration of nitroglyc­
erin and after bypass surgery. The inter­
nal consistency of this method and 
norms were established in an ^aftier 
study.22 Chords 1 to 3 were correlated 
with the area supplied by the left ante­
rior descending coronary artery, chords 
4 and 5 with that supplied by the right 
coronary artery and chord 6 with the 
area supplied by the circumflex artery.
Chords were classified according to the 
criteria of Helfant and colleagues9 and 
Banka and associates.14 Less than 25% 
shortening of a hemiaxis was considered 
abnormal. A hemiaxis was considered to 
have improved contractility if the chord 
shortening increased by 10% or more 
from the initial resting value.9,14
Results
The 23 patients had a total of 60 
grafts inserted and 52 (87%) of these 
grafts were patent at the time of re­
study.
Abnormal Chords
In the initial preoperative ventriculo­
gram, 47 abnormal chords were iden­
tified (Fig. 2). Sixteen of these chords, 
from seven different patients, showed 
improved contractility after the patient 
had received nitroglycerin. After by­
pass surgery contractility was improved 
in 11 of these 16 chords while 5 Were 
unchanged. In 10 of the 11 chords that 
had improved motion appropriate 
grafts had been placed and the graft 
patency was 90%. It is likely that a 
false positive result was obtained for 
the two chords that had improved con­
tractility without graft patency, as their 
opposite hemiaxis showed greater dete­
rioration than expected. Of the five ab­
normal chords that showed improved 
contractility after nitroglycerin ad­
ministration but not after bypass graft­
ing, only two of four grafts were 
patent. The two chords in which grafts 
were occluded exhibited abnormal 
shortening as expected. In a third ab­
normal chord, the graft was patent. 
However, an electrocardiogram ob­
tained postoperatively showed evidence 
of ischemia, which may explain the 
lack of improvement after bypass 
grafting.
Contractility in 31 of the 47 abnor­
mal chords was unchanged after the 
patient received nitroglycerin. However, 
five of these chords showed improved
FIG. 1— End-diastolic (solid line) and 
end-systolic (dotted line) outlines of left 
ventriculogram in right anterior oblique 
projection showing long axis and chords 
measured. Percentage shortening was cal­
culated by expressing difference between 
systolic and diastolic chord lengths and 
dividing by diastolic chord length.
shortening after bypass surgery and 
three of four chords had patent grafts.
Normal Chords
Preoperatively 91 chords were nor­
mal (Fig. 3). Twenty (from 12 different 
patients) showed increased wall motion 
after nitroglycerin had been given. 
Moreover, 13 of these 20 chords main­
tained the increased chord shortening 
after bypass surgery; 12 of the 13 
chords were supplied by patent grafts. 
In the one chord with an occluded 
graft, but improved contractility, the 
opposite hemiaxial chord was falsely 
depressed suggesting pseudoimprove­
ment of this segment. Although the 
remaining seven chords that had im­
proved shortening after nitroglycerin 
administration did not improve with 
bypass grafting, five retained normal 
shortening, while two developed ab­
normal hemiaxial shortening. In one 
patient, in whom chord shortening be­
came abnormal, perioperative infarction 
had occurred. The other chord, which 
became abnormal appeared to be fal­
sely depressed because its opposite 
hemiaxis showed greater improvement 
than expected.
The contractility of 71 normal
F IG . 2— Outcome of abnorm al chord 
segments following interventions o f n itro ­
glycerin (NTG) administration and  ao r­
tocoronary bypass (ACB) grafting, g r — 
grafts, pat =  patent, pts =  patients.
F IG . 3— Outcome of norm al chord seg­
ments following interventions of n itro ­
glycerin administration and aortocoronary  
bypass grafting.
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chords was unchanged by giving nitro­
glycerin. However, nine of these chords 
did improve following bypass surgery 
and all nine chords had patent grafts. 
Of the remaining 62, 52 of the chords 
remained normal after surgery and the 
other 10 showed abnormal shortening. 
In one instance, perioperative infarc­
tion had occurred while in another two, 
involving four chords, ischemic changes 
were noted on the postoperative elec­
trocardiogram even though the grafts 
to these regions were patent. In two 
other cases global left ventricular func­
tion became severely depressed even 
though the grafts were patent. In an­
other chord in this group of 10 graft­
ing was not technically feasible. There 
was no plausible explanation for ab­
normal shortening in the remaining 
two chords in this group.
Overall, 36 of the 138 chords showed 
improved contractility when nitrogly­
cerin was given (Fig. 4). Of these 36 
chords, 24 (67%) had improved short­
ening after bypass surgery, 6 were 
unchanged and 6 were worse.
Discussion
The results of our study support 
Helfant’s suggestion that angiography 
after the administration of nitroglycerin 
is useful in deciding which abnormally 
contracting wall segments may improve 
after aortocoronary bypass surgery.9 
The value of this intervention may also 
include regions that are supplied by 
diseased coronary arteries, but exhibit 
normal wall motion at rest. We found 
that 67% of the chords that had im­
proved contractility after nitroglycerin 
was given to the patient, including those 
that were either abnormal or normal at 
rest, were improved with bypass sur­
gery. We found no significant dif­
ference in the frequency of patent 
grafts between regions that were im­
proved by giving the patient nitrogly­
cerin (85%) and regions that were un­
improved by nitroglycerin (88%).
The mechanism by which nitrogly­
cerin produces changes in left ventri­
cular wall motion are poorly under­
stood.23-27 In a recent review Warren 
and Francis28 concluded that nitrogly­
cerin’s ability to improve cardiac per­
formance is due to its effect on loading
FIG. 4— Outcome following aortocoro­
nary bypass of 36 chord segments that 
showed improvement following sublingual 
administration of nitroglycerin.
conditions rather than to an enhance­
ment of the inotropic state. Although 
nitroglycerin dilates normal coronary 
arteries, it is not believed to have 
much effect on the maximally dilated 
vessels of a patient with coronary artery 
disease. However, the nitroglycerin-in­
duced reduction in left ventricular 
volume lowers wall tension and may 
bring about a redistribution of blood 
flow to the endocardium, which would 
explain the improvement in wall mo­
tion seen in our patients after the ad­
ministration of nitroglycerin.
In evaluating left ventricular per­
formance after aortocoronary bypass 
surgery, several problems must be 
recognized. For example, some in­
vestigators have suggested that when 
restudy is carried out within a few 
weeks of surgery, there may appear to 
be an improvement in left ventricular 
function. This is not real, but is due to 
the increased adrenergic activity seen at 
that time.29 However, Helfant and co­
workers9 found no difference in the 
ventriCulographic correlation as a func­
tion of elapsed time following bypass, 
which suggests that the time of restudy 
is not a significant factor.
Other problems in evaluating post­
operative left ventricular function re­
late to the limitations of monoplane 
ventriculography and to analysis of 
the region supplied by the circumflex 
coronary artery.30 This region might in 
some instances be supplied by the right 
coronary artery. Fortunately, in most 
of our patients both the circumflex 
and right coronary arteries were dis­
eased and received grafts. Thus, our re­
sults were little affected by the diffi­
culty of deciding whether this area was 
supplied by the circumflex or by the 
right coronary artery.
Since previous studies have shown 
that qualitative estimates are too im­
precise in comparing changes be­
tween preoperative and postoperative 
studies8-31,32 we limited the ventriculo- 
graphic analysis to quantitative tech­
niques. However, the analysis of chord 
shortening, as in the present study, has 
inherent weaknesses that must be re­
cognized. Change in a single hemiaxis 
may be the effect of shortening of the 
surrounding myocardium.8 Likewise, 
motion of a hemiaxial chord may spuri­
ously affect the motion of its opposite 
member. Several recently published 
studies have suggested more sophis­
ticated methods for ventricular analy­
sis using either a greater number of 
chords or changes of regional areas 
under the diastolic-systolic tracings.8'31,32 
However, the use of only six hemiaxial 
chords gives the methodology more 
practical application. Although the 
criteria of Helfant and colleagues9 and 
Banka and associates14 for classification
of normal and abnormal chords are an 
arbitrary division of physiologic change, 
they permit selection of segments with 
reduced motion that are approximately 
1 Vi standard deviations below the nor­
mal.3” Thus, although arbitrary, these 
criteria remain useful and easily ap­
plicable.
Our results confirm the value of 
routine use of angiography after the 
administration of nitroglycerin as an 
aid in selecting ventricular segments 
that may improve following bypass 
surgery. The results obtained must be 
considered as only a part of the total 
available information when weighing 
the merits of aortocoronary bypass for 
a given case. Our results suggest that 
approximately two thirds of the chords 
that show improved contractility after 
the patient has received nitroglycerin 
will benefit by aortocoronary bypass 
grafting.
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SESAP II Question
416. A 65-year-old patient with coronary artery disease who has previously had a myocardial infarction and is 
receiving digitalis has an elective cholecystectomy. On the day after operation the electrocardiogram shown 
above is obtained. Management of this patient should include
(1) measurement of arterial blood gas tensions
(2) omission of the next dose of digitalis
(3) measurement of serum potassium concentration
(4) intravenous administration of 100 mg of lidocaine (Xylocaine) in 50 ml of 5 per cent dextrose 
in water by slow drip
For the incomplete statement above, one or more of the completions is correct. Your answer should be
A if only 1, 2, and 3 are correct,
B if only 1 and 3 are correct,
C if only 2 and 4 are correct,
D if only 4 is correct,
E  if all are correct.
For the critique of Item 416 see page 151 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: Surgical Education 
and Self-assessment Program No. 2. For enrolment in the Surgical Education and Self-assessment Program No. 
2 please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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an urgent problem 
postoperative anaerobic
A
in gynecological in abdominal
infections infections
. .clindamycin is an important antibiotic in the 
therapy of such [gynecological] infections.”
Swenson, R.M., et at. (1974). Obstet. & Gynecol., 44:699.
This study suggests ‘ ‘ ...clindamycin is an excellent 
and relatively safe antibiotic for treatment of 
[abdominal] infection caused by anaerobes when 
combined with surgery (when indicated) or other 
antibiotics active against aerobic gram-negative 
bacilli, if present.”
Levison, M.E.,etal.(Mar., 1974).
Antimicrob. Agents &Chemother., p.276-280.
an accepted solution
Dalacin C  Phosphate S.S.
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nfections
a
in pulmonary 
anaerobic infections
Indications: Dalacin C Phosphate (clindam ycin phosphate in jection  N.F.) Dalacin C Phosphate Sterile So lu tion  is  indicated fo r the treat 
ment of in fections where the oral route is not indicated or feasible.
C lindam ycin phosphate is indicated in the treatment of serious in fections due to sensitive anaerobic bacteria, such as Bacteroides 
species, peptostreptococcus, anaerobic streptococci, C los trid ium  species and m icro-aerophilic  strep tococci.
C lindamycin phosphate is also indicated in serious in fec tio ns  due to sensitive G ram -positive organism s staphylococci (including pen ic il 
linase-producing staphylococci), strep tococci and pneum ococci when the patient is in to le rant of, or the organism  resistant to, o ther 
appropriate antib iotics.
Contraindications: The use of Dalacin C Phosphate is contra ind icated in patients previously found to be hypersensitive to  th is  com pound, 
the parent compound, clindam ycin, or clindam ycin palm ita te. Although cross-sensitisation w ith  Lincocin (lincom ycin) has not been 
demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have dem onstrated lincom ycin  sensitivity. Until 
further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (infants below 30 days ofage), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhoea have been reported during or a fte r therapy w ith  Dalacin C Phosphate. This 
diarrhoea has been occasionally associated with blood and m ucus in the s tools and has at tim es resulted in acute co lit is . When endoscopy 
has been performed, some of these cases have shown pseudomembrane form ation.
If s ign ifican t diarrhoea occurs during therapy, this drug shou ld be discontinued or, if necessary, continued on ly  w ith  close observation. 
S ignificant diarrhoea occurring up to several weeks post-therapy should be managed as if antib io tic-associated.
If co lit is  is suspected, endoscopy is recommended. M ild cases showing m in im al m ucosal changes may respond to  sim ple drug d is ­
continuance. Moderate to severe cases, including those show ing ulceration or pseudom embrane form ation, shou ld be managed w ith  flu id , 
e lectrolyte, and protein supplem entation as indicated. C o rtico id  retention enemas and system ic co rtico ids  may be o f help in persistent 
cases. Anticholinerg ics and antiperis ta ltic  agents may worsen the condition. O ther causes of co lit is  should be considered.
Precautions: Dalacin C Phosphate, like any drug, should be prescribed w ith caution in atopic individuals.
The use of an tib io tics occasionally results in over-growth of nonsusceptib le o rgan ism s- particu larly  yeasts. Should superin fections occur, 
appropriate measures should be taken as dictated by the c lin ica l situation.
Since abnorm alities of liver function tests  have been noted occasionally in anim als and man, period ic liver func tion  tests  should be per­
formed during prolonged therapy. Blood counts should a lso  be m onitored during extended therapy.
As w ith  all antib iotics, perform culture and sensitivity s tud ies in conjunction w ith  drug therapy.
C lindam ycin phosphate may be used in*anuretic patien ts and patients w ith impaired liver function . The serum ha lf-life  of c lindam ycin  
phosphate in patients w ith markedly reduced renal func tion  is greater than that o f the ha lf-life  of the com pound in normal patients. The 
dose of clindam ycin phosphate should, therefore, be appropria te ly decreased. Haem odialysis and peritoneal d ia lys is  are not e ffective  
means of removing the compound from the blood. Periodic serum levels o f clindam ycin should be determ ined in patien ts w ith  severe renal 
insufficiency.
Adverse Reactions: Local.
(a) Intram uscular In jections: Of 404 patients treated w ith  clindam ycin  phosphate in tram uscularly (w ith a so lu tion  conta in ing  150 m g/m l), 
six (1.5%) demonstrated local reactions as follows: Two com pla ined of pain at the in jection  site, tw o dem onstrated induration at the in jec ­
tion site and two developed sterile abscesses.
(b) Intravenous Infusion: Of 192 patients treated w ith  c lindam ycin  phosphate by in travenous in fusion, 14 (7.3%) dem onstrated local 
reactions. Eleven patients developed superficia l th rom bophleb itis  and one patient developed both superfic ia l and deep throm bophleb itis . 
The m ajority of these cases developed in conjunction w ith  the use of indwelling IV catheters and it is d iff ic u lt to  know how much the drug 
contributed to the irritation. Two patients developed localised erythema, swelling and pain at the s ite  of the in fus ion.
Systemic Side Effects: Twenty-eight pa tien ts of 596 treated w ith  clindam ycin phosphate by e ithe r the in tram uscula r or in travenous routes 
developed systemic side effects as fo llow s:
Number o f Patients
R ash..............................................................................................................7
U rtica ria ........................................................................................................1
P ru rit is ..........................................................................................................1
Fever, Leucocytosis...................................................................................1
Nausea, w ith  or without vom iting ........................................................... 1
Diarrhoea (See also under “ Warnings” ) ................................................4
Num ber o f Patients
Hypotension................................................................................................  1
H ypertens ion .................................................................................................1
Shortness of B rea th ..................................................................................  1
S uperin fec tion*.............................................................................................4
Cardiac arrest* ..........................................................................................  1
Bad or b itte r taste in m o u th .......................................................................5
rClindamycin has been reported to be the most 
ictivje antimicrobial agent tested in vitro against 
naerobic bacteria; [in the pulmonary tract] 
concentrations of 3.1 /rg/ml or less inhibited 96% 
if strains tested...”
ass, R.J., et al. (1973). Annals Intern. Med., 78:853.
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** Due to underlying m yocarditis in th is patient.
Clinical and Laboratory Findings: Patients treated during c lin ica l tria ls of clindam ycin phosphate were fo llow ed w ith  c lin ica l laboratory 
tests, including complete haematology, urinalysis and liver and kidney function  tests. Some o f these tests were abnormal in itia lly  and 
returned to normal during therapy w ith clindam ycin phosphate, while others were norm al in itia lly  and became abnorm al during therapy. 
Overall evaluation o f c lin ica l laboratory values in these patien ts  does not indicate that c lindam ycin  phosphate therapy has a tox ic  e ffec t on 
the haematopoietic, hepatic or renal systems. Transient elevations o f serum transam inases have occurred in som e patients, but o ther liver 
function tests (alkaline phosphatase, serum  bilirubin) have not shown any tendency to increase and there have been no c lin ica l s igns of 
drug-induced hepatic toxicity.
Symptoms and Treatment of Oversoage: No cases of overdosage have been reported. No spec ific  antidote is known. Doses as high as 
1200 mg every six hours (4800 m g/day) by infusion for five days have been given w ithou t adverse e ffect.
DOSAGE AND ADMINISTRATION 
Adults
In tram uscular In jection: 600 m g/day in tw o  equal doses.
Moderately severe in fections: 600 to  1200 m g/day in tw o or three equal doses.
Severe in fections: 1200 to 2400 m g/day in two, three or four equal doses. In tram uscular in jections of more than 600 mg in to a sing le  s ite  
are not recommended.
Intravenous Adm inistration: Dalacin C Phosphate m ust be d ilu ted prior to IV adm in is tra tion  to  a d ilu tion  of 300 mg in 50 ml of d iluen t 
(6 m g/m l) or more, and infused in not less than 10 m inutes. Adm in istra tion  of m ore than 1200 mg in a single one-hour in fusion is not recom ­
mended. Dalacin C Phosphate should not be injected in travenously undiluted as a bolus.
M oderately severe in fections: 900 to  1800 m g/day by con tinuous drip or in two or three equal doses, each in fused over 20 m inutes or longer. 
Severe in fections: 1800 to 2700 m g/day by continuous drip  o r in three or four equal doses, each in fused over 20 m inutes or longer. In life- 
threatening in fections, doses of 2700 to  4800 mg/day by con tinuous drip or in three or four equal doses each in fused over 20 m inutes or 
longer may be given.
Children: (Over one month of age)
Intram uscular In jection: 10 to 15 m g /kg /d a y  in two, three or four equal doses.
Moderately severe in fections: 15 to 20 m g /kg /day  in three o r four equal doses.
Severe infections: 20 to 30 m g /kg /day  in three or four equal doses.
Intravenous Administration:
Moderately severe in fections: 15 to 25 m g /kg /day  by con tinuous drip or in three or four equal doses, each in fused over 20 m inutes or 
longer. In severe in fections, it is recommended that ch ildren be given not less than 300 m g /d ay regardless of body weight. (D ilute Dalacin C 
Phosphate Sterile Solution in the same manner as for adults.)
AVAILABILITY:
Dalacin C Phosphate Sterile Solution - Each ml contains c lindam ycin  phosphate equivalent to  clindam ycin  base 150 mg in 2 ml am poules. 
Product Monograph available upon request.
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Aortocoronary Bypass Surgery in Women
W .R . E ric  Ja m ie s o n ,
From 1970 to 1977, of 603 consecutive 
patients who had coronary artery bypass 
grafting for coronary artery disease 79 
(13.1%) were women. Because the 
results of aortocoronary bypass 
grafting are reportedly less favourable 
in women than in men, 79 men were 
randomly chosen from the total series 
and the results of bypass compared 
with those of the women.
The mean age of the two groups was 
similar. Diabetes mellitus was present 
much more frequently among the 
women (12.7% versus 2.5%) but 
previous myocardial infarction was less 
frequent (30.4% versus 48.1%) and 
consequently myocardial function was 
better than in the group of men. 
Single-vessel disease was more 
common in the women (21.5% versus 
11.4%) and the graft versus disease 
ratio (number of vessels grafted to 
number with significant stenosis) was 
lower (1:1.33 versus 1:1.28). Women 
were found to have a higher percentage 
of vessels that could not be grafted 
because of their smaller calibre and 
the presence of diffuse disease. The 
hospital mortality for the women was 
5.1% and for the men was 1.1% (the 
hospital mortality for the entire series 
of 603 patients was 1.7%). Perioperative 
myocardial infarction occurred with 
increased frequency in the female 
patients (12.7% versus 2.5%). The 
long-term actuarial survival at 8 years 
was 90% for the women and 78% 
for the men.
The authors conclude that although 
myocardial revascularization is tech­
nically more difficult in women the 
results are satisfactory and women 
should not be denied the benefits 
of the procedure.
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Entre 1970 et 1977, des 603 patients 
qui ont successivement subi un pontage 
aortocoronarien pour une maladie 
coronarienne, 79 (13.1%) etaient des 
femmes. Comme les resultats du 
pontage aortocoronarien semblent moins 
favorables chez I'homme que chez la 
femme, 79 hommes de cette meme serie 
ont ete choisis au hasard et les resultats 
du pontage ont ete compares a ceux 
des femmes.
L’age moyen etait semblable chez 
les deux groupes. Le diabete sucre 
etait beaucoup plus frequent parmi 
les femmes (12.7% contre 2.5%) mais 
I'infarctus du myocarde etait moins 
frequent (30.4% contre 48.1%) et, en 
consequence, la fonction myocardique 
etait meilleure que chez le groupe 
d'hommes. Les atteintes d'un seul 
vaisseau etaient beaucoup plus fre- 
quentes chez les femmes (21.5% contre 
11.4%) et le rapport des greffons par 
maladie (nombre de vaisseaux greffes 
vs nombre de stenoses significatives) 
etait plus bas (1:1.33 contre 1:1.28). On 
a retrouve chez les femmes un plus fort 
pourcentage de vaisseaux ne se pretant 
pas au pontage a cause de leur petit 
calibre et de la presence d'une maladie 
diffuse. La mortalite hospitaliere a ete 
de 5.1% pour les femmes et de 
1.1% pour les hommes (pour I'ensemble 
des 603 patients, la mortalite hospita­
liere a ete de 1.7%). La frequence de 
I'infarctus du myocarde dans la periode 
perioperatoire a ete plus elevee chez 
les femmes (12.7% contre 2.5%).
La survie actuarielle a long terme, 
apres 8 ans, a ete de 90% chez les 
femmes et de 78% chez les hommes.
Les auteurs concluent que, bien 
que la revascularisation myocardique 
soit techniquement plus difficile chez 
la femme, les resultats sont satisfai- 
sants et on ne devrait pas refuser aux 
femmes les benefices de cette 
intervention.
Myocardial revascularization is becom­
ing increasingly important as a means 
of treating medically refractory coro­
nary artery disease, but many are of 
the opinion that women obtain less 
favourable results than men. Women 
have been reported to have a higher 
operative mortality and decreased 
functional improvement.1"3 The study
reported here documents a personal 
series over an 8-year period and con­
firms these previously documented ob­
servations.
Patients and Study Method
From Jan. 1, 1970 to Dec. 31, 1977, 
603 consecutive patients had coronary 
artery bypass grafting for coronary ar­
tery disease. There were 524 men and 
79 women. The hospital mortality for 
the men was 1.1% (6 patients) and for 
women 5.1% (4 patients), giving an 
overall hospital mortality of 1.7% (10 
patients).
A group of 79 men were selected at 
random so that they could be com­
pared with the group of 79 women 
who formed the basis of the study.
The mean age of the women was 
54.1 years (range 39 to 71 years), and 
was comparable to that of the men, 
53.9 years (range 33 to 74 years). The 
average follow-up for the group of 
women was 36 months (range 9 to 101 
months), and for the men, 39 months 
(range 12 to 100 months). The records 
of all patients were reviewed and fol­
low-up data were obtained from chart 
review and patient and physician 
contact.
Results
Women had a significantly lower 
frequency of previous myocardial in­
farction than men, but hypertension 
was more common in women and there 
was a significantly higher incidence of 
diabetes mellitus in women (Table I).
The menopausal history of the 
women appeared to bear no definite 
relation to the severity of the coronary 
disease or to the results of the myo­
cardial revascularization. Premeno­
pausal women made up 21.5% of the 
total.
The distribution of coronary disease 
in the two groups was obtained from 
evaluation of the coronary angiograms. 
There was a higher percentage of 
women with/ single-vessel disease but 
a higher percentage of men with 
double-vessel disease. The frequency 
with which three or four vessels were 
affected was essentially the same for 
both groups (Table II).
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Table 1— Preoperative Findings
Finding Women, % Men, % P value
Previous acute myocardial
infarction 30.4 48.1 < 0 .0 5
Hypertension 24.1 17.7 > 0 .0 5
Diabetes mellitus 12.7 2.5 < 0 .5 0
Table I I— Distribution of Coronary Disease
No. of diseased vessels Women, % Men, % P value
1 21.5 11.4 > 0 .0 5
2 31.6 41.8 > 0 .0 5
3 38.0 34.2 NS
4 8.9 12.6 NS
Total 100.0 100.0
NS =  not significant.
Comparison of the operative proce­
dures in the two groups (Table III) 
disclosed that an equal proportion of 
men and women underwent single­
vessel bypass, more women than men 
had two vessels bypassed while three 
vessels were bypassed in twice as many 
men. Four-vessel aortocoronary bypass 
was performed only in men.
An analysis of this data revealed 
that women had a higher percentage of 
vessels which could not be grafted be­
cause of their small size or the degree 
of diffuse disease. The use of endart­
erectomy can also explain the discre­
pancy between the distribution of dis­
eased vessels and operative procedures, 
for the frequency of endarterectomy in
Table I I I—Operative Procedures
No. of vessels
bypassed Women, % Men, %
1 41.8 39.2
2 45.6 34.2
3 12.6 24.1
4 0 2.5
Total 100.0 100.0
women was 2.9% and in men was 
2.0% of all diseased vessels.
Coronary artery size was determined 
at the time of operation with calibrated 
intraluminal probes. The grafted coro­
nary arteries of the women were 
significantly smaller than those of the 
men (Table IV).
Women received fewer grafts than 
men (average 1.76 versus 1.94 grafts 
per patient) (Table IV). The average 
number of grafts per patient increased 
over the years, especially after the tech­
nique of hypothermic chemical cardio­
plegia was instituted to improve myo­
Table V— Operative Complications
Complication Women Men
Perioperative acute
myocardial infarction 8 2
Postoperative
hemorrhage 2 5
Major arrhythmias 6 8
Pulmonary 9 6
Cerebrovascular accident 3 2
Others 7 10
Total 35 33
Table IV— Number of Grafts and Coronary A rtery Size
Women* Men)
No. grafts No. grafts
Artery placed Size, mm placed Size, mm P value
Right coronary 41 2.51 47 2.69 > 0 .0 5
Anterior descending 60 2.14 63 2.56 <0 .01
Diagonal 9 2.25 12 2.29
Circumflex coronary 21 2.31 24 2.48 < 0 .0 5
Obtuse marginal 8 2.38 7 2.29
*No. grafts/patient =  1.76. 
|N o . grafts/patient =  1.94.
cardial preservation. This technique 
also improved the ease of operation.
The total number of postoperative 
complications was essentially the same 
in the two groups (Table V). Eight 
(12.7%) women had perioperative 
myocardial infarction compared with 
only two (2.5%) men (P >  0.05). The 
occurrence of myocardial infarction 
perioperatively was determined by elec­
trocardiographic and cardiac enzyme 
analysis. The frequency of postoper­
ative hemorrhage, major arrhythmias 
and pulmonary complications, cerebro­
vascular accidents and other complica­
tions was not appreciably different in 
the two groups.
As previously stated the hospital 
mortality in women was 5.1 % (four 
patients); for men it was 1.3% (one 
patient). The causes of death in wom­
en were acute myocardial infarction 
(two patients, one with a markedly 
elevated concentration of cold agglu­
tinins), cerebrovascular accident (one 
patient) and air embolism from an 
intraoperative accident (one patient). 
One man died of an acute myocardial 
infarction.
During the follow-up period seven 
patients died, three women and four 
men. Two women died of acute myo­
cardial infarction and one of an un­
known cause. Two men died of acute 
myocardial infarction, one of carcino­
matosis and one of an unknown cause.
Six women and three men required 
reoperation for graft occlusion or 
progression of disease in another vessel, 
or both. Graft occlusion was docu­
mented in seven women and three 
men. (Postoperative angiography was 
performed only in problem cases.) One 
man required reoperation for ventri­
cular aneurysm.
The use of medications postoper- 
atively was documented in both groups. 
Twice as many women as men were 
given digitalis or diuretics, or both 
(35.4% versus 17.7%, P <  0.05). 
Greater use was also made in women 
of //-blocking agents and coronary dila­
tors (32.9% versus 27.8%, P >  0.05).
FIG. 1—Actuarial survival curves de­
monstrating survival rates of men and 
women subjected to aortocoronary bypass 
surgery.
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Many patients required medication in 
both categories.
Actuarial analysis revealed that at 
the end of the 8-year study period, 
90% of women were alive compared 
with 78% of men (Fig. 1).
The New York Heart Association 
functional classification was used to 
classify the patients preoperatively and 
at the time of follow-up (Fig. 2). Of 
the 79 women 77 (97.5%) were class 
III or IV before surgery, and 64 
(85.3%) of 75 were in either class 
I or class II in the postoperative pe­
riod. In comparison, 69 (87.3%) of 
79 men were in class III or class IV 
preoperatively and 73 (93.6%) of 78 
were in class I or class II after surgery.
At the time of follow-up the patients 
were requested to evaluate their clinical 
status as substantially improved, im­
proved, the same or worse (Table VI). 
Of the women, 89.3% thought they 
were much improved or improved com­
pared with 91.9% of men, but a much 
greater percentage of men believed 
they were substantially improved 
(71.6% versus 50.8%, P < 0 .01);
10.7% of women and 8.1% of men 
categorized themselves as the same or 
worse.
Discussion
During the last 4 years several re­
ports have noted the inferior results of 
coronary artery bypass grafting in 
women.1-5 They have shown that 
women have a higher operative mortal­
ity, a higher rate of perioperative myo­
cardial infarction, less clinical improve­
ment and markedly lower graft patency 
rates than men.
Our evaluation of aortocoronary by­
pass surgery has revealed that a minor­
ity of our patients are women (13.1%) 
and other series have reported similar 
percentages, ranging from 11.0% to 
15.6%.1-4
J The frequency of diabetes mellitus 
was the only contributing factor that 
was appreciably increased in our group 
of women (12.7% versus 2.5%). This
Preoperative Postoperative  
FIG. 2— Preoperative and postoperative 
functional classification (New York Heart 
Association) of 72 surviving women and 
74 surviving men who underwent aorto­
coronary bypass surgery.
finding has been reported previously in 
two series.4’6
The ratio of the number of vessels 
grafted to the number of vessels that 
had significant stenosis in each patient 
(“graft versus disease” ratio) was lower 
in women than in men (1:1.33 versus 
1:1.28). This increased percentage of 
nongraftable vessels in women was due 
to the smaller calibre of the vessels 
and to the more frequent occurrence of 
diffuse disease within each vessel, as 
has been reported previously.1,4 This 
trend is apparent even though at the 
time of surgery women had fewer dis­
eased vessels per patient and a higher 
incidence of single-vessel disease 
than did men (21.5% versus 11.4%).
The finding that the calibre of the 
coronary vessels is substantially smaller 
in women than in men has been re­
ported by Tyras and associates1 and 
Spray and Roberts.7 Spray and Roberts, 
who evaluated autopsy material, con­
cluded that less atherosclerotic plaque 
is necessary to cause obstruction to 
flow in the smaller calibre vessels.
Women suffer from angina at an 
earlier stage in their disease because 
of the smaller calibre of their vessels 
and subsequently have better preserva­
tion of ventricular function and a 
lower frequency of previous myocar­
dial infarction.1,3,4 Our study also cor­
roborates the lower incidence of pre­
vious myocardial infarction in women 
than in men (30.4% versus 48.1%).
The hospital mortality for women 
(5.1%) in this series was higher than 
in the men (1.1%). Other series have 
reported a hospital mortality ranging 
from 3.3% to 9.2% for women, com­
pared with 1.4% to 4.8% for men.1-4 
Women also suffered perioperative 
myocardial infarction with greater fre­
quency than did men (12.7% versus 
2.5%). This finding has been docu­
mented in one other series.3
The cumulative survival rate in our 
patients at 8 years is gratifying, 90% 
for women and 78% for men. The 
lower frequency of previous myocar­
dial infarction and their superior 
ventricular function may explain the 
higher survival rate in our group of 
women compared with the men.
The results of surgery were some­
T a b le  V I— F o llo w -U p  S ta tu s  as A ssessed by
th e P a t ie n ts
S ta tu s W o m en , % M e n , %
M uch  im p ro ved 50 .8 71.6
Im proved 38.5 20.3
Sam e 4 .6 4.1
W orse 6.1 4.0
T o ta l 100.0 100.0
what less gratifying in the group of 
women in that a greater proportion 
have required reoperation due to graft 
occlusion which caused disabling an­
gina. Since postoperative coronary an­
giography was performed only for 
severe symptoms or other specific in­
dications, the overall graft patency for 
both groups is unknown.
The overall long-term clinical im­
provement in our patients has been 
encouraging. A smaller percentage of 
women, however, considered them­
selves to be in the “much improved” 
category (50.8% versus 71.6%). An­
other series has reported that a smaller 
percentage of women a re . completely 
free of angina after bypass surgery and 
that myocardial revascularization is in­
ferior in women.3
We are of the opinion that coronary 
revascularization is technically more 
difficult in women because of the 
smaller, thin-walled vessels and the in­
ferior quality of peripheral veins used 
for grafting.
In summary, women have accept­
able operative mortality and excellent 
long-term survival rate with reason­
able symptomatic improvement follow­
ing aortocoronary bypass grafting. 
Women do have smaller coronary ar­
teries and tend to have lower graft 
patency rates. Myocardial revascular­
ization does provide acceptable results 
in women and should not be denied 
them.
We thank Gizela Chizik for her efforts 
in the follow-up of our patients, and 
Gayle Henderson and Diane Steel for 
their help in the preparation of the 
manuscript.
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Results of Aortocoronary Bypass Surgery in Patients
with Unstable Angina
Brian M. Chesnie, md, A llan G. A delman, md, frcp[c], B rian C. D ouglas, md, 
Sheldon A. Magder, md , frcp[c], V ictor F. Huckell, md, frcp[c] 
and B ernard S. Goldman, md, frcs[c], facs
Over an 18-month period at the Toronto 
General Hospital 92 patients in whom 
unstable angina was diagnosed 
underwent aortocoronary bypass surgery. 
Forty-one had triple-, 31 had double- 
and 20 had single-vessel disease. 
Sixteen patients had stenosis of the left 
main coronary artery. Thirty patients 
had a single vessel bypassed, 48 had 
two and 14 had three vessels bypassed. 
The left anterior descending coronary 
artery was grafted in 80 of the 92 
patients and 15 patients had endarterec­
tomy. Significant left ventricular 
dysfunction (ejection fraction of less 
than 0.4) was present in 28 patients. 
Fifty-six patients had prophylactic intra­
aortic balloon pump support. Six patients 
(6.5%) died at operation and there 
were five (5.4%) documented (new 
Q waves) perioperative infarctions.
Of the 86 surviving patients, 82 
were followed up clinically for 22 
to 40 months. Forty (49%) were 
asymptomatic (class I, New York Heart 
Association classification) and 29 (35%) 
were in class II; 11 (13%) were in 
classes III and IV and there were two 
(2.4%) late deaths. Of the two late 
deaths, one resulted from a motor 
vehicle accident. This follow-up 
study indicates that the operative and 
late mortality is relatively low for 
patients with unstable angina who 
undergo aortocoronary bypass grafting 
and that the majority of surviving 
patients experience symptomatic 
improvement.
Au Toronto General Hospital, au cours 
d'une periode de 18 mois, 92 patients 
chez qui on avait diagnostique une
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angine instable ont subi un pontage 
aortocoronarien. Quarante-et-un patients 
avaient une atteinte de trois vaisseaux, 
31 de deux et 20 de un vaisseau. Sur 
30 patients, on a fait le pontage d'un 
seul vaisseau, sur 48 on en a fait deux 
et sur 14 un triple pontage. L’artere 
coronaire descendante anterieure gauche 
a ete pontee chez 80 des 92 patients et 
15 patients ont subi une endarterectomie. 
Un dysfonctionnement ventriculaire 
gauche significatif (avec une fraction 
d'ejection de moins de 0.4) etait 
present chez 28 patients. Cinquante-six 
patients, ont eu une assistance 
circulatoire par ballonnet intra-aortique 
a titre prohylactique. Six patients 
(6.5%) sont decedes durant ('inter­
vention et on a pu demontrer cinq 
(5.4%) infarctus perioperatoires 
(nouvelles ondes Q).
Des 86 survivants, 82 ont fait 
I’objet de controles ulterieurs pendant 
22 a 40 mois. Quarante (49%) etaient 
asymptomatiques (classe I selon la 
classification de la New York Heart 
Association) et 29 (35%) appartenaient 
a la classe II; 11 (13%) etaient dans 
les classes III et IV et deux (2.4%) 
deces tardifs ont ete enregistres.
Un de ces deces tardifs a ete 
le resultat d'un accident de la cir­
culation. Cette etude de post-cure 
indique que la mortalite operatoire et 
tardive est relativement faible chez 
les patients souffrant d’angine instable 
qui subissent un pontage aortocoro­
narien, et que la majorite des patients 
qui survivent presentent une ame­
lioration symptomatique.
Unstable angina is diagnosed when a 
patient experiences an accelerating pat­
tern of pain that is often unrelated to 
exertion or is refractory to medical 
management. Such patients admitted 
to coronary care units often experience 
prolonged episodes of pain even at 
rest. Serial electrocardiograms and en­
zyme studies, however, fail to show 
evidence of myocardial necrosis, al­
though evidence of ischemic changes 
may appear on the electrocardiogram 
during attacks of pain. The manage­
ment of unstable angina remains con­
troversial. We undertook a follow-up 
study to assess the symptoms and rate 
of survival in patients with previous 
unstable angina who had undergone 
aortocoronary bypass surgery.
Patients and Methods
The data were reviewed from the 
records of 92 patients (82 men and 10 
women) who underwent aortocoronary 
bypass surgery for treatment of un­
stable angina at the Toronto General 
Hospital between Nov. 1, 1974 and Apr. 30, 1976. With respect to age most 
patients were in their late 40s or early 
50s; the average age was 51.7 years. 
The women in the group tended to be 
older than the men (mean age 58.6 
versus 50.4 years). Fifty-one had had 
symptoms of coronary artery disease 
for more than 1 year and 78 had had 
angina for longer than 3 months. The 
diagnosis of unstable angina was made 
by the attending and catheterizing phy­
sicians (prior to angiography) because 
the patient was having recurrent at­
tacks or a crescendo pattern of chest 
pain despite in-hospital treatment with 
bed rest, propranolol and nitrates. In 
66 patients there was documented 
evidence of ischemic changes on the 
electrocardiogram during attacks of 
pain. Many of the patients had been re­
ferred from other medical centres be­
cause their pain could not be con­
trolled with medical treatment in a 
coronary intensive care unit; all were 
considered potential candidates for 
revascularization surgery before cathe­
terization was carried out.
Angiography was performed in mul­
tiple views using Judkins’ technique.1 
All the patients had lesions that were 
amenable to bypass grafting. An intra­
aortic balloon pump (IABP) was in­
serted before surgery2 in those patients 
considered to be at increased risk be­
cause of the coronary anatomy or a 
poor hemodynamic state; 56 had IABP 
support (group 1) and 36 did not (group 
2).Patients were followed up between 
Oct. 1, 1977 and Apr. 30, 1978 either 
directly or through their primary phy-
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sician. They were asked to complete a 
simple questionnaire relating to symp­
toms based on the New York Heart 
Association classification.
Results
The angiographic profile of the pa­
tients is set forth in Table I; 41 had 
triple-vessel, 31 double-vessel and 20 
had single-vessel disease. A greater 
proportion of group 1 patients had 
triple- and double-vessel disease than 
those in group 2. Eighty-three patients 
had disease of the left anterior des­
cending coronary artery. Sixteen pa­
tients had stenosis of the left main 
coronary artery; the one patient with 
left main coronary artery stenosis who 
did not have IABP support died at sur­
gery. Twelve of the 22 patients with 
grade 3 ventricles (i.e., dysfunction in 
three segments of the ventricle and an 
ejection fraction less than 0.4) and all 
six patients with grade 4 ventricles 
(i.e., dysfunction in all four segments 
and an ejection fraction less than 0.2) 
had IABP support. Fifteen of the 36 
group 2 patients had normal ventricles. 
Thus, group 1 patients (with IABP 
support) tended to be those with mul­
tiple-vessel disease, stenosis of the left 
main artery and poor left ventricular 
function, in addition to unstable myo­
cardial ischemic pain.
Thirty patients had grafts placed in 
a single vessel, 48 in two vessels and 
14 in three vessels (Table II). Fifteen 
patients had an associated endarterec­
tomy. A much higher proportion (al­
most 80%) of the IABP patients had 
multiple bypasses, whereas half of 
those operated on without IABP sup­
port had single bypasses. Grafts were
placed in the left anterior descending 
artery in 80 of the 92 patients.
Morbidity and Mortality (Table III)
Five perioperative infarctions were 
noted as evidenced by new Q waves 
on a postoperative electrocardiogram, 
three patients in group 1 and two in 
group 2, giving an overall infarction 
rate of 5.4%. There were six perioper­
ative deaths, three in each group, for a 
surgical mortality of 6.5%. The mor­
tality was slightly, but not significantly, 
lower in group 1 (5.4% versus 8.3%) 
even though these patients tended to 
have multiple-vessel disease, more sev­
ere left ventricular dysfunction and to 
have received multiple bypass grafts. 
Group 1 also included all but one of 
the patients with left main artery ste­
nosis. The average postoperative hospi­
tal stay was slightly longer in group 1 
than in group 2 patients (18 days versus 
14 days).
Insertion of the balloon resulted in 
some morbidity: aortic dissection in 
two cases, femoral embolism in two, 
transient ischemia in one and peroneal 
nerve palsy in one case.
Long-Term Follow-Up
Of the 86 patients surviving post- 
operatively, 82 were followed up from 
22 to 40 months (mean 31 months). 
There was symptomatic improvement in 
74 (Fig. 1). Forty patients were com­
pletely asymptomatic (class I New York 
Heart Association classification). Twen­
ty-nine patients experienced some 
symptoms on more than normal activity 
(class II). This was defined as walking 
more than two city blocks or climbing
Table I—Angiographic Profile in 92 Patients Who Underwent 
Aortocoronary Bypass Grafting
No. of diseased vessels
Stenosis of left Ejection fraction
Group* 1 2 3 main coronary artery <0.4
1 (n =  56) 7 20 29 15 10
2 (n =  36) 13 11 12 1 18
Total 20 31 41 16 28
‘ Group 1 patients received intra-aortic balloon pump support, group 2 patients did not.
Table I I— Types of Surgery Performed in 92 
Patients
No. of vessels grafted Endar- 
---------------------------------------  terec-
Group 1 2 3 tomy
1 (n =  56) 12 32 12 12
2 (n =  36) 18 16 2 3
Total 30 48 14 15
Table I I I—Surgical M ortality and Morbidity 
in 92 Patients Who Underwent Aortocoronary 
Bypass Grafting
No. of
infarctions No. of deaths 
Group (and % ) (and % )
1 (n =  56) 3 (5.4) 3 (5.4)
2 (n =  36) 2 (5.5) 3 (8.3)
two flights of stairs. Of these 29 pa­
tients, 15 had angina, 12 had angina 
and dyspnea and 2 had dyspnea alone. 
One of the patients with dyspnea alone 
also had emphysema. Five patients ex­
perienced symptoms when walking less 
than two city blocks or climbing less 
than two flights of stairs (class III); 
one had angina, one had dyspnea and 
three had both symptoms. All six pa­
tients in class IV had angina at rest.
There were only two late deaths. 
One patient who was bedridden post- 
operatively died 6 months after surgery 
of congestive heart failure. He had 
triple-vessel disease and had required 
IABP support for severe' left ventri­
cular dysfunction. The other patient 
died in a motor vehicle accident. Over­
all, 82% of the patients who were oper­
ated on and followed up for close to 
3 years maintained their clinical im­
provement.
Table IV demonstrates that of the 
40 patients in class I, 17 had one, 20 
had two and 3 had three vessels by­
passed. Of the 17 patients who had one 
vessel bypassed, 14 had single-vessel 
disease and 3 had double-vessel disease. 
Of the 20 who had two vessels by­
passed, 16 had double-vessel and 4 had 
triple-vessel disease. Of the 29 in class 
II, 8 had one, 14 had two and 7 had 
three vessels bypassed. Of 11 in classes 
III and IV, two had one, six had two 
and three had three vessels bypassed. 
The long-term results, therefore, did 
not seem to depend on the number of 
vessels bypassed, but there did appear 
to be greater symptomatic improve­
ment when the number of vessels by-
NYHC PRE OP FOLLOW-UP
DIED
FIG. 1—Results of aortocoronary by­
pass grafting in 82 surviving patients who 
had unstable angina. Follow-up was from 
22 to 40 months (mean 31 months). NYHC 
=  New York Heart Association clas­
sification.
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Table IV— Long-Term Results Correlated w ith the Number of Bypasses 
and the Use of the In tra -aortic  Balloon Pump (IA B P)
No. of vessels bypassed
New York Heart Association 
classification
Nn nf
(and % ) No. of patients 
receiving IABP  
support (and % )patients 1 2 3
Class 1 40 17 (43) 20 (50) 3 (7.5) 21 (53)
Class II 29 8 (28) 14 (48) 7 (2 4 ) 16 (55)
Classes I I I  and IV 11 2 (1 8 ) 6 (5 5 ) 3 (2 7 ) 6 (5 5 )
> *■
* t
> *
t
> *  
v
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passed matched the number of vessels 
that were critically diseased. Also, in 
each class there was a similar propor­
tion (about 55%) of patients who re­
ceived intra-aortic balloon pump sup­
port.
Discussion
Up to 20% of the patients admitted 
to coronary intensive care units3 who 
undergo angiography4 have unstable 
angina. The 92 patients in this series 
were those studied angiographically who 
then underwent coronary bypass sur­
gery for coronary artery disease during 
an 18-month period at the Toronto 
General Hospital.
The majority of patients in this series 
had multiple-vessel disease; the left 
anterior descending coronary artery was 
almost always affected (90% of cases). 
Scanlon and colleagues5 and Weintraub 
and associates6 noted a similar pattern 
in their studies, with 50 of 69 and 15 
of 16 patients, respectively, having in­
volvement of the left anterior des­
cending coronary artery.
Stenosis of the left main coronary 
artery, which occurred in 17% of our 
patients and never as an isolated le­
sion, has been reported in 2.5% to 
5.9% of patients undergoing angio­
graphy7,8 and in about 15% of patients 
with unstable angina.9'10 Recent studies 
have also emphasized that stenosis of 
the left main artery is usually associated 
with involvement of other vessels.7,8,11,12
At the Toronto General Hospital, 
most patients with unstable angina who 
underwent angiography and who were 
considered candidates for surgery were 
operated on within 1 week of investig­
ation. In these patients, surgery was 
associated with a relatively low mor­
tality (6.5%) and a low frequency of 
perioperative infarction (5.4%). The 
perioperative morbidity and mortality 
compared favourably with those of 
other surgical13'15 and most medical 
series4,6,16 for this time period. Golding 
and coworkers17 recently reported a 
4% mortality and a perioperative in­
farction rate of 17% at the Cleveland 
Clinic. Also, almost all surgical 
studies13'15 indicate that surgery offers 
more immediate and effective relief of
angina in these patients than does 
medical therapy.
Intra-aortic balloon pump assistance 
has been used in unstable angina both 
to relieve pain and as an adjunct 
to revascularization surgery.5,7,18 Al­
though patients in this study were not 
randomized, the mortality in those at 
greater risk (i.e., with multiple-vessel 
disease, stenosis of the left main coro­
nary artery and poor left ventricular 
function) was slightly, but not signif­
icantly, lower when the IABP was 
used (group 1, 5.4% versus group 
2, 8.3%). A relatively high operative 
mortality has been reported in patients 
with left main artery stenosis19-22 but 
the rate has improved with better 
awareness of the hazards of induction 
of anesthesia in these patients. In our 
study, 15 of 16 patients with stenosis 
of the left main artery who had IABP 
support survived surgery; the 1 patient 
who did not have IABP assistance died 
at operation. It was concluded23 that 
use of the IABP may be of value in 
patients with left main artery stenosis, 
poor left ventricular function and mul­
tiple-vessel disease, but recent literature 
has suggested that further investigation 
is warranted.24,25 Currently, the IABP 
is being used less at the Toronto 
General Hospital and in most other 
centres, because better anesthetic and 
myocardial preservation techniques 
have been developed.
Of the 82 patients followed up from 
22 to 40 months, 69 (84%) were 
clinically improved (from preoperative 
class IV to postoperative classes I and 
II) after surgery. Moreover, there was 
an extremely low late mortality (2.4%) 
and one of the two patients who died 
late died of incidental causes. These 
findings are comparable to those of 
other centres.26'28 Golding and associ­
ates17 had four late deaths and three 
cases of late infarction out of a total 
of 100 patients. Of their survivors 78% 
were asymptomatic.
The frequency with which patients 
obtain symptomatic relief and the 
duration of relief is thought to depend 
not only on the number of grafts in­
serted and their patency but also on 
the degree of revascularization,29 
which is the number of critically dis­
eased vessels a surgical team is able to 
bypass. For example, if two vessels are 
diseased and only one can be bypassed, 
the other being too diseased distally 
for grafting, then symptoms may not 
be completely relieved. The Cleveland 
Clinic reported that 86.6% of patients 
who had complete revascularization 
were in class I (New York Heart As­
sociation classification) postoperatively 
compared with only 55.7% of patients 
who had incomplete revascularization.30 
In our study 84% (58 of 69) of patients 
who were in classes I or II postoper­
atively had complete revascularization.
Summary
Our study was based on the records 
of 92 patients with unstable angina who 
underwent angiography and coronary 
bypass surgery. The patients were 
followed up for a mean of 31 months. 
The diagnosis had been based on an 
accelerating pattern of pain often un­
related to exertion and refractory to 
intensive medical management. The 
study indicated that these patients can 
be operated on with the expectation 
of a relatively low operative mortality 
(6.5%) and infarction rate (5.4%). The 
late mortality was extremely low 
(2.4%); one of the two patients died 
of incidental causes. Furthermore, the 
majority of patients were clinically im­
proved and maintained this improve­
ment over a follow-up period which 
averaged close to 3 years.
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Precautions
(sodium nitroprusside)
for controlled hypotension during anesthesia 
Rx Summary
S -------------------------------------------------------------------------------------
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
> * in water without preservatives. Not for direct injection.
’ '  Indications
i  ‘Nipride’ is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed 
appropriate. Benefit-risk ratio should be carefully considered on an 
individual basis.
*■ Contraindications
Adequate facilities, equipment and personnel should be available 
for frequent and vigilant monitoring of blood pressure. When the infu­
sion is slowed or stopped, blood pressure usually begins to rise imme­
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly 
patients, since they may be more sensitive to the hypotensive effects 
of the drug.
If, in the clinical situation, stress induced by pain or manipulation 
is reduced or eliminated during 'Nipride' infusion, the patient could 
experience a greater than expected reduction in blood pressure 
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the 
infusion bottle should be wrapped with aluminum foil or other opaque 
material. Solutions of ‘Nipride’ should not be kept or used longer 
than four hours. ‘Nipride’ in aqueous solution yields the nitroprusside 
ion, which reacts with even minute quantities of a wide variety of 
organic and inorganic substances to form usually highly coloured 
reaction products (blue, green or dark red). If this occurs, the infusion 
should be replaced as quickly as possible.
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In the treatment of compensatory hypertension, e.g. arteriovenous 
shunt or coarctation of the aorta. It is also contraindicated in physically 
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia 
or hypovolemia or in those with known inadequate cerebral circulation. 
In patients with liver disease, severe renal disease, Leber’s optic 
atrophy and disease states associated with vitamin B12 deficiency.
Warnings
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection. Infusion rates 
greater than 8 /ig/kg/ minute are virtually never required. If at this 
rate an adequate reduction in blood pressure is not obtained within 
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium 
nitroprusside administration. One factor is common to all known 
cases, namely that large amounts of nitroprusside were infused at 
high rates. Since detoxification relies upon enzymatic action, the 
rare possibility of deficient or atypical enzymes occurring in humans 
should always be considered. Patients most apt to run into difficul­
ties are those who are resistant to the hypotensive effect or those 
in whom maintenance at the selected blood pressure level is difficult 
or impossible.
Constant attention to the patient’s dose-response characteristics 
is mandatory. If infusion rates are in excess of 8 /ig/kg/minute deter­
mine the nature of the response (effective constant response at 
higher dose; tachyphytactic; resistant -  none or less than expected). 
As soon as either tachyphylaxis or resistance is determined the infu­
sion of ‘Nipride’ should be discontinued immediately. In abnormal 
responders it has been noted that metabolic acidosis may occur 
at higher doses.
Caution should be exercised in using ‘Nipride’ in patients with hypo­
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to 
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g/100 ml, it is 
probably safe to continue with the infusion. Peritoneal dialysis can 
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect 
of sodium nitroprusside than are normotensive subjects. Patients 
receiving concomitant antihypertensive medications (especially 
hydralazine or hexamethonium) are more sensitive to the hypotensive 
effect of sodium nitroprusside and the dosage of ‘Nipride’ should 
be adjusted downward accordingly.
The following Warnings apply to the use of ‘Nipride’ for controlled 
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially 
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin­
ished. If possible, preexisting anemia and hypovolemia should be 
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation 
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen 
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten­
sive patients infused with sodium nitroprusside. Induction of delib­
erate hypotension in healthy young individuals may prove to be 
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the 
purpose of controlled hypotension during anesthesia a rebound 
hypertension has been observed on rare occasions.
Usage in pregnancy
The safety of ‘Nipride’ in women who are or who may become preg­
nant has not been established; hence, it should be given only when 
the potential benefits have been weighed against possible hazard 
to mother and fetus.
Usage in children
The safety of ‘Nipride’ in children has not been established. Clinical 
experience is limited.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache, 
restlessness, agitation, muscle twitching, retrosternal discomfort and 
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo­
minal pain, confusion and somnolence have been noted with too 
rapid reduction in blood pressure. These symptoms rapidly disap­
peared with slowing of the rate of infusion or temporary discontinua­
tion of infusion and did not reappear with continued slower rate 
of administration.
Irritation of the injection site may occur. Methemoglobinemia and 
one case of hypothyroidism following prolonged therapy have been 
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing 
deliberate hypotensive surgery must be restricted to carefully 
selected cases. There is a possibility of an abnormal response 
occurring in normotensive patients. In this event, the infusion of 
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘Nipride’ vial should be dissolved in 3 ml 
of sterile dextrose in water without preservatives. No other diluent 
should be used. Depending on the desired concentration, all of the 
prepared stock solution should be diluted in 500 or 1000 ml of 5 per­
cent sterile dextrose in water and promptly wrapped in aluminum 
foil or other opaque material. Both stock solution and infusion solu­
tion should be freshly prepared and any unused portion discarded. 
The freshly prepared solution for infusion has a very faint brownish 
tint. If it is highly coloured, it should be discarded. (See Precautions). 
The solution should not be kept or used longer than four hours from 
initial reconstitution. The infusion fluid used for the administration 
of 'Nipride' should not be employed as a vehicle for simultaneous 
administration of any other drug.
‘Nipride’ dosage varies considerably from patient to patient, hence 
the need for individual titration. The infusion should be started at 
the lower dosage range, 0.5 /ig/kg/m inute and increased by 
0.2 ftg/kg/m inute every 5 minutes until the desired reduction in 
blood pressure is obtained. The blood pressure usually starts to drop 
immediately or at least within a few minutes. Continuous monitoring 
of the blood pressure is necessary. Blood pressure should not be 
allowed to drop at too rapid a rate and systolic pressure should not 
be lowered below 60 mm Hg.
Infusion rates greater than 8 ftg/kg/m inute should rarely be used.
The maximum recommended dose is 800 /tg/minute.
‘Nipride’ should be administered by an infusion pump, micro-drip 
regulator or any similar device that will allow precise measurement 
of the flow rate. Avoid extravasation. The rate should be adjusted 
to maintain the desired hypotensive effect, as determined by frequent 
blood pressure determinations.
For the use of 'Nipride' in the treatment of hypertensive crises please 
refer to the Product Monograph.
Supply
’Nipride’ is supplied in 5 ml amber-coloured vials containing the 
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent 
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
*  Reg. Trade Mark for sodium nitroprusside ‘Roche’
® Reg. Trade Mark
Hoffmann-La Roche Limited 
Vaudreuil, Quebec 
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Fate of the Graft and Native Vessel following Endarterectomy 
of the Left Anterior Descending Coronary Artery
B.C. M o r t o n , m d , c m , f r c p [c ], D.S. B ea n la n d s , m d , f r c p [c ], R.J. C h a m b e r s , m d , f r c p [c],P. B edard , m d , f r c s [c ] and W.J. K e o n , m d , f r c s [c ]
In 16 patients who underwent 
endarterectomy of the left anterior 
descending (LAD) coronary artery com­
bined with saphenous vein bypass 
grafting between Aug. 1, 1976 and 
July 31, 1978, the results of 
preoperative and postoperative angio­
graphy were comparable. Most 
patients had obstruction or severe 
stenosis of the proximal LAD coronary 
artery together with a poor runoff as
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demonstrated angiographically.
Eighteen vein grafts were placed 
in the LAD artery and 15 (83%) 
were satisfactorily patent. Six of 18 
grafted arterial segments became 
occluded distal to the site of graft 
insertion, but in most cases there 
was sufficient proximal runoff to 
maintain graft patency. In this study 
intraoperative measurements of graft 
flow were predictive of graft or distal 
vessel patency, or both. Careful 
postoperative assessment of the results 
of this technique seems warranted.
Chez 16 patients qui ont subi une 
endarterectomie de I’artere coronaire 
descendante anterieure gauche (ADG) 
associee a un pontage de la veine 
saphene, entre le 1" aout 1976 et le 
31 juillet 1978, les resultats de
I'angiographie preoperatoire et post- 
operatoire etaient comparables. La 
plupart des patients avaient une obs­
truction ou une stenose grave de 
I’ADG proximale ainsi qu’un mauvais 
ecoulement comme le demontrait 
I’angiographie. Dix-huit pontages de 
I’ADG ont ete realises et 15 (83%) 
ont evolue de facon satisfaisante.
Six des 18 segments arteriels greffes se 
sont obstrues dans la partie distale 
du point d’insertion du greffon mais, 
dans la plupart des cas, I'ecoulement 
proximal etait suffisant pour maintenir 
le fonctionnement de la greffe. Selon 
la presente etude, les mesures du 
debit dans le greffon au moment de 
I'operation ont permis de predire 
I'etat de fonctionnement du greffon 
ou du vaisseau distal. Une evaluation 
postoperatoire serieuse des resultats 
de cette technique semble justifiee.
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Endarterectomy of the right coronary 
artery is often carried out to allow 
saphenous vein bypass grafting of a 
diffusely diseased vessel. However, be­
cause of the technical difficulty attri­
butable to the anatomy of the vessel, 
this procedure is less often performed 
on the left coronary artery.1,2 For this 
reason we report a study of the angio­
graphic changes in arterial anatomy in 
16 patients following endarterectomy of 
the left anterior descending (LAD) 
coronary artery, performed at the 
University of Ottawa cardiac unit. All 
surgical procedures were performed 
by two of us (W.J.K. and P.B.).
Patients and Methods
Between Aug. 1, 1976 and July 31, 
1978, 53 patients underwent manual 
endarterectomy of the LAD coronary 
artery at the University of Ottawa 
cardiac unit as part of their revas­
cularization surgery. Only 16 of the 
patients were chosen for this study 
because they had been subjected to 
angiography both preoperatively and 
postoperatively in our unit. The other 
patients were excluded because they 
had undergone preoperative angio­
graphy elsewhere, or because the post­
operative study had taken place at 
another Ottawa hospital or had been 
omitted. Patients having a complicated 
operative or postoperative course 
were more likely to have been sub­
jected to angiography postoperatively, 
so the results we obtained should be 
viewed in this perspective. All patients 
had opacification of the coronary ar­
teries and vein grafts in multiple, in­
cluding angulated, projections. A Sie­
mens Cardoskop U angiographic unit 
(Siemens, Erlangen, Germany) and 
Agfa Gevaert 35-mm film were used 
for the angiographic studies. There were 
13 men and 3 women. Their ages 
ranged from 39 to 62 years (mean 52 
years). For 15 patients it was the first 
and for 1 it was the second coronary 
artery operation. Angiography was per­
formed 2 to 24 weeks (mean 9 weeks) 
after the operation.
These 16 patients received a total 
of 55 vein grafts (3.4 per patient), 
a figure comparable to that for other
patients undergoing similar surgery in 
our unit. Eighteen grafts were inserted 
in the LAD artery, 14 patients re­
ceived one graft and 2 received two 
grafts. In six instances diagonal 
branches were grafted, with separate 
veins in five instances and with side- 
to-side anastomosis of the same vein 
in one. In all cases endarterectomy was 
employed for a distal vessel which the 
surgeon considered otherwise unsuitable 
for grafting.
The preoperative and postoperative 
angiograms were reviewed by a radio­
logist and at least one cardiologist. The 
severity of lesions was judged by the 
reduction in luminal diameter of the 
artery.
Results
Preoperative Anatomy of the LAD
Artery
The proximal part of the LAD artery 
was totally occluded in 7 of the 16 
patients; the distal artery was filled 
by collateral vessels. In six cases there 
was 80% to 95% stenosis of the prox­
imal portion of the artery and in three 
cases the narrowing was 50% to 70%.
Adequacy of the distal portion of 
the vessel was defined as less than 50% 
stenosis of the distal two thirds of the 
LAD artery while a vessel with a poor 
distal runoff was one in which mul­
tiple focal or diffuse narrowings of 
50% or greater were present. Five pa­
tients were judged to have an adequate 
distal runoff and 10 a poor runoff. In 
one case the vessel beyond the site of 
obstruction was not adequately visual­
ized.
Postoperative Anatomy of the LAD
Artery and Vein Graft
Of the 18 vein grafts placed in the 
LAD artery, 15 (83% ) were satis­
factorily patent at follow-up. One 
patient whose graft was occluded un­
derwent reoperation and the postoper­
ative angiogram demonstrated that 
the second graft was patent.
The postoperative anatomy of the 
LAD artery was analysed in terms of 
the 18 grafted segments (Table I).
Of the 15 LAD artery segments served 
by a patent graft, 8 had a  good distal 
runoff and 3 a poor runoff, as defined 
previously. In the remaining four seg­
ments a new occlusion distal to the 
site of graft insertion was observed. 
We defined this occlusion as a new 
interruption of the native artery with 
intra- or intercoronary filling of the 
vessel beyond the site of occlusion. In 
these cases continued patency of the 
graft was probably attributable to ade­
quate runoff into septal and diagonal 
branches of the LAD artery.
Of the three LAD artery segments 
associated with an occluded graft, one 
was judged to have a poor runoff and 
two a new distal occlusion. In this 
group complete nonvisualization of an 
arterial segment formerly filled by 
collateral vessels was considered as 
evidence of new distal occlusion.
Comparison of Preoperative and
Postoperative Anatomy
Comparison of the anatomy of the 
LAD artery before and after surgery 
was made in each patient. As can be 
seen from Fig. 1, patients with an 
adequate runoff preoperatively were 
more likely to have an adequate runoff 
at the postoperative study. However, a 
similar proportion of patients with ade­
quate and with poor distal runoff 
following surgery sustained a new oc­
clusion of the artery, distal to the site 
of grafting.
Intraoperative Graft Flows
In all patients except one vein graft 
flows were measured by an electro­
magnetic flowmeter shortly after car­
diopulmonary bypass was discontinued. 
The 11 arterial segments shown to 
have a patent graft and distal vessel 
postoperatively had blood flows rang­
ing from 25 to 190 mL/min (mean 
80 m L/m in). The seven arterial seg­
ments demonstrating graft or distal
vessel occlusion, or both, had flows 
between 10 and 75 mL (mean 42 m L / 
min). The difference in mean flow be­
tween these two groups is statistically 
significant (P <  0.05) as determined 
by Student’s r-test.
PREOPERATIVE POSTOPERATIVE
STATUS STATUS
( n o .  o f  p a t i e n t s )  ( n o .  o f  g r a f t s )
FIG. 1— Comparison of preoperative 
and postoperative status of distal vessel 
following endarterectomy of left an­
terior descending coronary artery. Sixteen 
patients had 18 grafts inserted.
T a b le  1 - S t a t u s  o f V e in  G ra fts  an d  A r te ry  fo llo w in g  E n d a rte re c to m y  
o f L e ft  A n te r io r  D e s ce n d in g  C o ro n a ry  A r te ry
G ra fte d D is ta l
seg m en t Good P oor occlusion
(N = 18) ru n o ff ru n o ff o f a r te ry
P a te n t (n  =  15) 8 3 4
O ccluded  (n  =  3 ) * 0 1 2
* 0 n e  p a t ie n t  u n d e rw e n t a second g ra ft in g  p ro c e d u re . T h e  p o s to p e ra tiv e  a n g io g ra m  th e n  sh o w ed  
a p a te n t g ra ft .
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Consequences of LAD Artery
Endarterectomy on Myocardium
In three patients intraoperative myo­
cardial infarction was diagnosed by the 
presence o f new Q waves and appro­
priate new abnormal motion o f the 
ventricular wall. One infarct involved 
the inferior wall and was not related 
to the LA D  system. One was antero­
lateral and was related to an occluded 
graft placed in a diagonal branch of 
the LAD artery. The third infarct was 
anterior and related to a new occlusion 
o f the LA D  artery distal to the site 
o f grafting.
Anterior wall motion was assessed 
subjectively in 11 cases in which pre- 
and postoperative ventriculograms were 
obtained. In one case wall motion 
was considered to be substantially im­
proved, in 7 it was unchanged and in 
3 it was worse.
Discussion
If atherosclerosis were limited to the 
proximal portions o f the coronary ar­
teries, endarterectomy would not be 
necessary. However, when there is 
angiographic evidence o f a diffusely 
atheromatous vessel the surgeon can 
either do nothing or perform endarte­
rectomy in an effort to achieve a better 
runoff. Sometimes, the diffuse nature 
o f coronary disease may not be rec­
ognized angiographically due to under­
perfusion from collateral vessels or the 
lack o f a normal lumen for compari­
son.3 In that case, the surgeon is faced 
with the same choice at operation 
when the true nature o f the disease 
becomes apparent.
Previous studies from this unit1 and 
from others4,5 have shown a graft paten­
cy rate o f 78%  to 87% when grafting 
is combined with left coronary artery 
endarterectomy. However, changes in 
the recipient arterial tree after endart­
erectomy are potentially as important 
to the success of revascularization as is 
patency o f the vein graft. For this rea­
son we have paid particular attention to 
changes in the anatomy o f the LAD 
artery following such surgery.
Occlusion of the distal artery beyond 
the site o f graft placement was noted 
in 6 o f the 18 endarterectomized seg­
ments studied. In many cases the site 
o f occlusion corresponded to the point 
at which the surgeon believed his en­
darterectomy ended; but, in almost all 
the cases a sufficiently long segment 
o f artery remained patent to allow good 
perfusion o f several large septal and 
diagonal branches. The likelihood o f 
such distal occlusion seems to be related 
as much to the surgeon’s success in 
removing the atheromatous core as to 
the preoperative angiographic assess­
ment of the disease. Those arteries 
that angiographically appeared to have 
the poorest distal runoff preoperatively 
generally did not show substantial im­
provement after surgery. In this study 
graft flows at the time o f operation 
seemed to be predictive o f the integ­
rity o f the vein graft and arterial seg­
ment postoperatively.
Myocardial infarction complicating 
coronary bypass surgery has been re­
ported to be more frequent in patients 
undergoing endarterectomy.6 Such in­
farction may also be related to the 
postoperative changes in the distal 
arterial tree.
We conclude that endarterectomy of 
diffusely diseased LAD  coronary arteries 
permits successful bypass grafting in a 
high percentage o f cases. However, the 
improvement in myocardial perfusion 
is often limited by residual atheros­
clerosis. Arteries with a poor angiogra­
phic runoff or an atheromatous core 
that defies complete removal, as pred­
icted by lower graft flows intraoper- 
atively, are more likely to be subject 
to graft occlusion or distal vessel oc­
clusion postoperatively. One must 
balance this against improvement of 
flow through important septal and di­
agonal branches when without endar­
terectomy the vessel would be inoper­
able. Careful angiographic appraisal of 
the results o f this technique is war­
ranted to allow refinement o f its use.
We thank Mrs. Janis Lukey for her help 
in the preparation of this manuscript.
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Aortocoronary Bypass for Critical Stenosis of the Left
Main Coronary Artery
H. D a j e e , m d , D.A. M u r p h y , m d , f r c s [c ], E.A. M o f f i t t , m d , f r c p [c ],
C.E. K in l e y , m d , f r c s [c ], J.A. P a r r o t t , m d  a n d  B.M. C h a n d l e r , m d , f r c p [c ]
Over a 2-year period 33 patients with 
symptomatic stenosis (greater than 
75% ) of the left main coronary artery 
underwent aortocoronary bypass. 
Intra-aortic balloon counterpulsation 
was used preoperatively in only two 
patients as a therapeutic measure for 
medically unstable angina. There were 
no operative deaths. Follow-up study 
3 to 27 months (mean 13.3 months) 
after operation revealed one death. 
Twenty-two patients were free of pain. 
The authors conclude that aortocoronary 
bypass surgery for severe stenosis of 
the left main coronary artery can be 
safely accomplished, without prophy­
lactic use of intra-aortic balloon 
counterpulsation in the majority of 
cases, with an acceptable operative 
mortality and morbidity.
En 2 ans, 33 patients souffrant d’une 
stenose symptomatique (de plus de 
75% ) de la principale coronaire gauche 
ont subi un pontage aortocoronarien.
La contre-pulsation diastolique par 
ballonnet intra-aortique a ete employee 
avant I’operation comme mesure thera- 
peutique pour une angine medicalement 
instable, chez seulement deux 
patients. II n’y a eu aucun deces 
operatoire. Une etude de post-cure 
effectuee de 3 a 27 mois apres 
I'operation (13.3 par mois en moyenne), 
a revele un deces. Vingt-deux patients 
n'avaient aucune douleur. Les 
auteurs concluent que le pontage 
aortocoronarien pour une stenose 
grave de la principale coronaire gauche 
peut etre realise de fagon sure, sans 
■’utilisation prophylactique de la 
contre-pulsation diastolique par 
ballonnet intra-aortique dans la 
majorite des cas, tout en conservant
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une morbidity et une mortality 
operatoires acceptables.
Stenosis of the left main coronary ar­
tery of greater than 75% is now con­
sidered an absolute and urgent indica­
tion for aortocoronary bypass surgery.1,2 
Early reports indicated a mortality of 
1.4% for catheterization alone and up 
to 39% 3-5 for the surgical procedure. 
Improved catheterization techniques 
have now eliminated this risk (unpub­
lished data). Several surgeons4,6,7 have 
advocated the routine preoperative and
T a b le  1— C lin ic a l  P r o f i le  o f  t h e  33 P a t ie n ts
A g e  ra n g e  ( m e a n ) ,y r  
S e x
3 9 - 6 9 ( 5 5 )
iVlale 27
F e m a le 6
D u r a t io n  o f  s y m p to m s  
C la s s  o f a n g in a  ( N e w  Y o rk  
H e a r t  A s s o c ia t io n  c la s s i f i ­
c a t io n ) ,  n o . o f  p a t ie n ts  
I I  (p a in  o n  m o d e r a te
2 w k  to  10 y r
e x e r t io n ) 2
I I I  (p a in  o n  m ild  e x e r t io n ) 10
IV  (p a in  a t  r e s t )
N o . o f  p a t ie n ts  w it h :  
P r e v io u s  h is to r y  o f  m y o -
21
c a r d ia l  in fa r c t io n 23
D y s p n e a 16
E n la rg e d  h e a r t 14
C o n g e s t iv e  h e a r t  f a i l u r e 6
M i t r a l  in c o m p e te n c e 8
A o r t ic  in c o m p e te n c e 2
A o r t ic  s te n o s is 2
D ia b e te s 4
H y p e r lip id e m ia 3
H y p e r te n s io n 6
intraoperative use of intra-aortic bal­
loon counterpulsation in the treatment 
of this condition and attribute their 
lower mortality to such treatment. In 
this paper we present 33 patients with 
critical stenosis of the left main coro­
nary artery who underwent aorto­
coronary bypass and suggest that, with 
good anesthesia and myocardial pro­
tection, routine use of left ventricular 
assistance devices is not necessary.
Patients and Methods
Between Jan. 1, 1976 and Dec. 31, 
1977, 33 patients with 75% or greater 
stenosis of the left main coronary artery 
underwent coronary bypass surgery. 
Patients with left ventricular aneurysms 
and valvular lesions were included in 
the study. Clinical details of the group 
are outlined in Table I. All patients 
underwent prior cardiac catheterization 
(Table II) and electrocardiographic 
evaluation. Exercise tests were per­
formed on 10 patients and echocardio­
grams were obtained in 3 patients with 
aortic valvular disease.
Methods of Anesthesia
Patients received heavy premedica­
tion with an opiate (e.g., morphine 10 
to 15 mg) and a sedative (e.g., sodium 
pentobarbital 100 mg), 1 hour before 
surgery. After several minutes of oxy­
genation, anesthesia was induced slowly 
with thiopental (200 to 300 mg intra­
venously). Pancuronium bromide (0.1
T a b le  I I — D a ta  O b ta in e d  f ro m  P r e o p e r a t iv e  C a rd ia c  C a th e te r iz a t io n
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1 0 0 % 3
L e f t  a n t e r io r  d e s c e n d in g  c o r o n a r y  a r t e r y ) 25
C ir c u m f le x  a r t e r y  o r  m a r g in a l  b ra n c h e s )  > 5 0 % 26
R ig h t  c o r o n a r y  a r t e r y ) 27
L e f t  v e n t r ic u la r  fu n c t io n
C a rd ia c  in d e x ,  L /m in  ■ m 2
> 2 . 5 16
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mg/kg body weight intravenously) was 
given. Before endotracheal intubation, 
anesthesia was deepened by administer­
ing halothane or enflurane. Anesthesia 
usually was maintained with nitrous 
oxide/oxygen (50:50) supplemented 
with halothane, enflurane or an intra­
venous opiate. If the arterial oxygen 
pressure fell below 100 mm Hg when 
nitrous oxide was given, nitrous oxide 
was removed from the sequence. When 
the surgeon and pump technician 
were ready to begin perfusion phenyle­
phrine (0.5 to 1.0 mg) was given intra­
venously. As the arterial pressure 
started to rise, perfusion was begun; 
thus, initial severe hypotension was 
avoided.
Surgical Technique
The surgical technique was similar 
to that routinely used for aortocoronary 
bypass at our institution. One surgeon 
prepared the chest for bypass while 
the second surgeon prepared the vein. 
The aortic root was cannulated and 1 
unit of blood was added to the priming 
solution. Hypothermia to 30°C at 
blood flows of 2.4 to 2.6/m2 was begun 
and total bypass was instituted using 
caval snares. The left side of the heart 
was vented, either through the right 
superior pulmonary vein or through 
the aortic root (Milwaukee Heart Cen­
ter technique [personal communication, 
1978]). The aorta was cross-clamped 
and approximately 1000 mL of modi­
fied Queen’s solution* was infused un­
der pressure into the aortic root. The 
effluent was either aspirated from the 
right atrium by means of the wall suc­
tion or allowed to return through the 
vent suction apparatus. The appropriate 
distal grafts were inserted usually with 
one aortic cross-clamping; however, 
additional cryopreservative was added 
whenever there was evidence of myo­
cardial electrical activity. The aortic 
grafts were then placed as the patient 
was being rewarmed and with the heart 
beating.
Results
No mortality was associated with 
cardiac catheterization. Chest pain oc­
curred in six patients but was relieved 
when nitroglycerin was given. In one 
patient left hemiparesis developed im­
mediately after catheterization but im­
proved over the next 24 hours. Vein 
bypass grafts were inserted in all cases 
(Table III); 32 patients received sa­
*Ringer’s solution, 800 mL; low-molecular- 
weight dextran in 10% dextrose, 200 mL; 
potassium chloride, 16 mmol (original 
solution contained 8 mmol); heparin, 
2000 units; insulin, 2 units; Solu-Cortef® 
(Upjohn), 10 mg; and sodium bicarbonate, 
20 mmol.
phenous vein graft and 1 cephalic vein 
graft. Preoperative intra-aortic balloon 
pumping was required in only two 
patients with marked unstable angina. 
There were no operative deaths. Early 
cardiac failure was present in seven 
patients; it resolved within 1 week of 
surgery in all seven. Cardiac arrhyth­
mias, none of which were serious, were 
treated medically. Postpericardiotomy 
syndrome in three patients was treated 
with acetylsalicylic acid and steroids. 
Postoperative infarction developed in 
three (9%) patients. Reoperation was 
required in three patients for a kinked 
graft, for postoperative bleeding and 
for sternal dehiscence, respectively.
Postoperative follow-up at 3 to 27 
months (mean 13.3 months) in the 33 
patients discovered one death. This pa­
tient had cecal volvulus 2 weeks after 
aortocoronary bypass surgery and pan­
creatitis following laparotomy. Analysis 
of the class of angina (New York Heart 
Association classification) showed that 
24 patients were pain free, 7 had class 
II and 1 had class IV angina. Cardiac 
catheterization within 6 weeks of oper­
ation in 20 of the patients showed im­
provement in left ventricular wall mo­
tion in 9 and deterioration in 1 patient. 
The graft patency rate was 88% in 
18 patients. Hemodynamic measure­
ments such as ejection fraction (P >  
0.10), left ventricular end-diastolic 
pressure (P >  0.20) and cardiac index 
(P >  0. 20) were not significantly dif­
ferent from the preoperative measure­
ments in these 18 patients.
Discussion
It is estimated that 80 000 to 100 000 
operations for coronary artery re­
vascularization were done in 1977.8 
The incidence of stenosis of the left 
main coronary artery is reported to be 
approximately 8% to 13%.1,4 If one 
accepts the hypothesis that all patients 
should have preoperative intra-aortic 
balloon counterpulsation, then 8000 to 
10 000 patients would be subjected to 
this additional procedure. Beckman and 
associates9 reported a complication rate 
of 13.5% as a result of intra-aortic bal­
loon counterpulsation, the commonest 
complications being limb ischemia, aor­
Table III—Surgical Procedures
Procedure No. of patients
Vein grafting
1 graft inserted 1
2 grafts 10
3 grafts 12
4 grafts 9
5 grafts 1
Aneurysmectomy 2
Aortic valve replacement 3
tic dissection and sepsis. Considering 
the cost of the procedure and the small 
risk involved, both figures would never­
theless be significant if all patients were 
to receive this treatment. Advances in 
techniques of inducing anesthesia, im­
proved methods for myocardial preser­
vation and safe cardiovascular monitor­
ing, both intra- and postoperatively, 
have now relegated intra-aortic balloon 
counterpulsation from routine to select­
ive use.
Critically ill, even moribund, cardiac 
patients can be anesthetized and kept 
alive until the beginning of whole body 
perfusion, if sound principles and care­
ful practices are employed.10
Central to the success of anesthesia 
are (a) maintaining the circulation and 
myocardial oxygenation and (b) match­
ing myocardial oxygen consumption 
(MVOa) to oxygen supply by controlled 
depression of the myocardium with 
anesthetics.11
Limiting MVCE begins by giving 
heavy premedication to avoid an in­
crease in the concentration of endo­
genous catecholamine because of ap­
prehension. In the induction room, the 
arterial line is inserted and electrocar­
diographic leads are attached before 
anesthesia induction begins. Essential 
also is an accurate indication of left 
ventricular filling pressure (wedge 
pressure) by means of a Swan-Ganz 
catheter. This is placed by way of the 
right internal jugular vein after anes­
thesia is induced.
To induce anesthesia safely it is ne­
cessary to preoxygenate the patient and 
to depress the myocardium minimally 
and slowly with thiopental, diazepam 
or morphine. We prefer thiopental. 
During the 3 minutes in which pancu­
ronium bromide is administered to 
produce paralysis, the state of anes­
thesia must be deepened, otherwise en­
dotracheal intubation produces an im­
mediate severe increase in blood pres­
sure and pulse rate. With care, both 
severe hypotension from too much 
anesthetic and severe hypertension from 
too little, can be avoided. If each 
patient is considered individually a fine 
balance can be maintained. Hypoten­
sion on starting perfusion must be 
avoided. The best way to prevent this 
is to give a precisely timed dose of a 
pure peripheral vasoconstrictor (phe­
nylephrine) immediately before start­
ing perfusion. Increase of patient blood 
volume from the oxygenator, or at 
least no decrease, is also helpful.
All patients remain on their previous 
propranolol medication until 8 hours 
before operation. Bradycardia is almost 
always present and usually responds to 
intravenous administration of atropine 
(up to 1.5 mg). Marked depression of
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contractility is often apparent and oc­
casionally calcium chloride (100- to 
200-mg doses) or ephedrine (5- to 10- 
mg doses) are necessary to maintain 
blood pressure. The stimulation from 
making the incision, especially from 
sternotomy, is a potent force in in­
creasing the blood pressure.
The only modification of our myo­
cardial preservation technique has been 
the addition of a further 8 m m ol/L of 
potassium chloride to the original 
Queen’s solution.12 Although this solu­
tion has been in use at our institution 
since 1974, it was found that, despite 
aortic cross-clamping, the heart would 
continue to beat and electric fibrillation 
was often necessary to get enough per­
fusate into the coronary vessels to 
cause arrest. This modification has the 
advantage of providing additional po­
tassium and also of causing immediate 
diastolic arrest.
Although our series is small, it is 
typical of larger series and the results 
indicate that intra-aortic balloon coun­
terpulsation does not need to be used 
routinely for patients with severe ste­
nosis of the left main coronary artery 
who undergo aortocoronary bypas$ 
grafting.
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ORIGINAL CONTRIBUTIONS
Chain-Saw Facial Injuries
Bruce M. R igg, md, frcs, fracs, frcs[c], facs
Accidents caused by kickback from 
chain saws produce facial injuries with 
consistent features. These features 
include oblique, destructive, ragged 
lacerations of the left side of 
the face. Although eyelid damage may 
be severe, damage to the globe itself 
is minimal.
An analysis of 10 such accidents 
revealed this consistent pattern.
Of this group, eight injuries were 
left-sided and six involved mainly the 
eyelid and adjacent structures.
Only one patient was left with per­
manent damage to the globe and with 
slightly impaired (20/60) vision. The 
upper lid was always more severely 
damaged than the lower. The 
author discusses the merits and 
disadvantages of protective devices for 
both operator and machine.
Les accidents causes par le recul 
brusque d'une trongonneuse produisent 
des blessures faciales dont les carac- 
teristiques sont constantes, incluant des 
lacerations obliques, la destruction et 
le dechiquetage du cote gauche de 
la figure. Bien que la paupiere soit 
gravement touchee, les dommages au 
globe oculaire sont minimes.
L’analyse de 10 accidents de ce genre 
a mis en evidence ce type constant de 
blessures. Parmi ce groupe, huit 
blessures affectaient le cote gauche, et 
six impliquaient principalement les 
paupieres et les structures adjacentes. 
Un seul patient a subi des dommages 
permanents du globe oculaire avec une 
legere perte (20/60) de vision. La 
paupiere superieure etait toujours plus 
gravement endommagee que la paupiere 
inferieure. Enfin, I’auteur discute des 
merites et des desavantages des 
dispositifs de securite pour I’operateur 
comme pour la machine.
From the department of surgery, 
Peterborough Civic Hospital, Peter­
borough, Out.
Reprint requests to: Dr. B.M. Rigg,
Ste. 370, Institute of Aesthetic Plastic 
Surgery, 3316 Piedmont Rd. NE, 
Atlanta, GA 30305, USA
Each power tool or piece of powered 
equipment tends to produce a parti­
cular type of injury. For example, power 
lawn mowers are responsible for foot 
lacerations and toe amputations; 
planers are associated with fingertip 
and pulp amputations; power saws 
cause digit amputations and injection 
injuries from high pressure guns ac­
count for digit necrosis.
It has been observed that there is 
a peculiar type of facial injury asso­
ciated with the use of chain saws, 
namely an oblique destructive lacera­
tion across the left side of the face 
produced by kickback of the saw. The 
range of the kickback is considerable. 
While being used at ground level the 
machine can be propelled backwards 
by its own force and driven into the 
face producing a fairly standard type 
of injury. Because these severe in­
juries tend to have many features in 
common, analysis of such injuries, a 
study of their mechanism and a con­
sideration of possible preventive and 
protective measures were undertaken.
Mechanism of Injury
Chain-saw kickbacks are responsible 
for more than 20% of on-site logging 
accidents.
The chain saw is a hand-held power 
saw with a power source supplied by 
an internal combustion engine at the 
heel of the machine. All chain saws 
are designed for right-handed use so
FIG. 1—Close up view of chain with 
teeth; direction of movement is from left 
to right
that the left hand acts as a central 
stabilizing force while the right hand 
is the guiding force at the heel of 
the machine. The projecting blade sup­
ports a continuous metal chain with 
attached teeth which are exposed 
throughout the greater part of their 
run. The teeth move in a  direction 
away from the operator (Fig. 1) on the 
upper edge of the blade, then down 
around the distal tip and return 
towards the operator along the lower 
edge of the blade arm which is used 
as the cutting edge in most operations. 
The operator usually works with the 
tip of the blade directed downwards. 
Hence, it may happen that the tip 
makes contact with a hard object, 
such as frozen ground, ice, a rock, a 
branch or a knot in the wood (Fig. 2), 
which acts as a counter point for 
forced rotation and elevation of the 
entire blade on the pivot of the left 
hand. The whole machine kicks back, 
is thrust upwards and rotates towards 
the operator, striking the face (Fig. 3).
The position of the two hands tends 
to angulate the saw during its eleva-
FIG. 2—Toe of unguarded saw makes 
contact, producing anticlockwise rotation 
and elevation of saw.
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tion so that the blade makes contact 
obliquely with the left side of the face, 
very commonly along a line running 
across the left eye and brow, supra­
orbital rim and maxilla (Fig. 4). The 
upward movement of the teeth carried 
by the chain produces a ripping effect 
with destruction of an 8- to 10-mm 
width of tissue through the upper lip, 
cheek and eyelid. The free edge of the 
upper eyelid is very readily caught by 
the upward moving chain and there-
FIG. 3— Resultant contact with cheek 
and face. Note upward direction of saw 
as blade is driven into face.
fore often receives a more severe in­
jury than the lower eyelid. The globe is 
infrequently damaged, and, if it is, the 
injury is usually relatively minor when 
compared with the extensive destruc­
tion of other soft tissue. Superficial 
fractures of the bones of the maxilla 
and the supraorbital rim are common.
Case Presentations
We have had experience of 10 cases 
of facial injury inflicted by a chain 
saw (Table I, Fig. 5). There was no 
seasonal variation, for these injuries 
were scattered throughout the year. 
Two occurred in observers who were 
standing close to the operator when a 
kickback took place. In eight of the
FIG. 4— Front view, showing typical 
oblique disposition of blade resulting from 
rotational kickback and angulation pro­
duced by hand position on machine.
cases the injury was on the left side. 
Six injuries were chiefly to the cheek 
and eyelid area and all caused exten­
sive soft tissue damage.
In the five patients with massive eye­
lid damage and destruction the damage 
to the globe was minimal. One patient 
at long-term follow-up had a corneal 
scar and 20/ 60 vision but no other 
damage of note. Another had a mild 
hyphema which cleared without inci­
dent leaving no permanent damage. In 
two patients there was no damage to 
the globe at all, and the other patient 
received a compound subluxation of 
the lachrymal gland only. It is remark­
able to observe the extensive destruc­
tion of the eyelid in the absence of 
any consequential globe damage.
The facial fractures usually involved 
the anterior wall of the maxilla (four 
patients). In the case of deeper wounds, 
peripheral branches of the facial nerve 
were transected (three patients); all 
showed spontaneous subtotal recovery 
within 12 months. There was one tran­
section of the parotid duct on the right 
side.
Discussion
In rural areas chain saws are used 
extensively and it is not unusual for 
relatively young adults (two of these 
patients were 12 years old) to use such 
tools.
The similarity of the facial injuries 
is noteworthy. The most interesting 
feature is the severe eyelid damage as-
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Table I— Chain-Saw Facial In juries
Patient no.
Information 1 2 3 4 5 6 7 8 9 10
Age, yr 62 58 12 12 47 64 4 46 50 50
M F M M M M M M M M
Lacerated side L L L L L L R L R L
Site of damage
Brow + + — — + + —* +  + — +
Nose — — — — + — + — —
Upper lid + + + + + + + — — — — —
Lower lid + + + + + — + — — —
Cheek + + + + + — + — + —
Upper lip + + + + — — + — — —
Lower lip + + — + — _ _
Chin — + — + — — — — — —
Neck — + — — — — — — ++ —
Globe Corneal scar 
20/60 vision
Hyphema
Supraorbital fractures + — — + —
Maxilla and intraorbital rim
fractures + — + + — — - 1-
Damage to facial nerve-
peripheral branches — — + + — — — — ~ r —
Miscellaneous comments Passive
observer
kickback
Lachrymal gland 
damaged, post­
operative ect­
ropion repair
Passive
observer
kickback
Lacerated 
transected  
parotid duct
- f  =  mild or moderate; + +  =  severe; — =  none.
sociated with minimal global damage. 
Possible explanations for the absence of 
any direct global damage are: (a) the 
bony orbit provides mechanical pro­
tection; (b) the smooth surface of the 
globe lacks any projection which the 
teeth of the chain may bite or on which 
they can catch; (c) the extraorbital fat 
has a “floating” effect, permitting the 
globe to recoil from the damaging force 
just as an apple in water recedes on the 
application of the slightest pressure. 
The upper lid is subject to more severe 
lacerations than the lower lid probably 
because the upward movement of the 
chain teeth catches the free lower edge 
of the upper eyelid and produces a
ripping, eversion effect.
The prevention of these injuries may 
be considered under the headings, 
operator protection and machine modi­
fications.
Protective protruding head gear, 
with a face mask extension, would 
provide a mechanical guard against 
more direct contact.
The machine can be equipped with 
toe protection which will eliminate the 
tip contact. However, this limits its 
operation and, as the toe protection is 
a removable device, more often than 
not the machine is usually operated 
without this attachment and thus is 
free to kick back. The use of a spring-
loaded guard for the upper edge would 
also provide a mechanical protection 
should kickback occur. However, on 
occasion this edge is required for oper­
ation and a guard would limit its use­
fulness. Finally, there is the automatic 
chain break. This automatically oper­
ates by contact from the back of the 
left hand when the machine rotates up­
wards during the kickback. Regulations 
are being introduced to make this 
modification mandatory and these can 
be expected to become more generally 
applied. The chain break at least pro­
vides an automatic lock to the move­
ment of the chain, even though the 
saw may still strike the face.
C ritique o f item  416 (S E S A P  II)
Abnormality in cardiac rhythm after an elective operation is a common problem. The electrocardiogram clearly 
shows frequent premature ventricular contractions (PVCs) which occur in runs. There is one particular time where 
there are three consecutive PVCs. This is a hazardous situation which could result from a number of different 
problems. It could result because the patient has hypoxemia as well as hypoxia of the myocardium. There­
fore, measurement of arterial blood gas tensions should be done to determine if the patient is receiving oxygen. 
Since the patient has been receiving digitalis, and since digitalis toxicity can produce ventricular irritability and 
more frequent PVCs, the next dose of digitalis should be omitted. Third, this type of problem can result from 
a low serum potassium, particularly if a patient is receiving digitalis. Therefore, it is important that the con­
centration of serum potassium be measured, and, if it is low, supplemental potassium be given.
Finally, some immediate treatment is best because frequent PVCs, in runs, could lead to ventricular 
tachycardia, decreased cardiac output, and even to a ventricular fibrillation. The administration of lidocaine 
by slow intravenous drip is the best treatment for ventricular irritability. Therefore, all of the procedures 
or measurements suggested are appropriate in response to this patient’s needs.
E
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Experience with Polytetrafluoroethylene Grafts in Patients
on Long-Term Hemodialysis
C.F.D. Ackman, md, frcs[c], facs,* S. O’R egan, mb, FRCp[c],f M.J. Herba, md, frcp[c],$
M.P. Laplante, md, frcs[c],* P. Lemaitre, md, cm |  and M. Kaye, mb, frcp[c], FACPf
Expanded polytetrafluoroethylene 
(PTFE) is a new material now being 
used to create subcutaneous arterio­
venous anastomoses for vascular access 
in hemodialysis. The authors have been 
impressed with the versatility of 
grafts made from this material and, 
where failure occurs, the ease with 
which surgical revision can be carried 
out. Two cases are described to 
illustrate the adaptability of this 
material to reconstruction. The authors’ 
initial impression based on 22 months' 
experience is that PTFE grafts have 
appreciably modified the management, 
with respect to vascular access, of 
many patients on long-term hemo­
dialysis.
Le polytetrafluoroethylene (PTFE) dilate 
est un nouveau materiel qui est 
maintenant utilise pour creer des 
anastomoses arterioveineuses sous- 
cutanees servant d’acces vasculaire 
pour I’hemodialyse. Nous avons ete 
impressionnes par la versatility des 
greffons faits de ce materiel et, dans 
les cas d'echec, de la facilite avec 
laquelle une revision chirurgicale peut 
etre realisee. Deux cas illustrant 
comment ce materiel se prete a la 
reconstruction sont decrits. Apres 22 
mois d'experience, notre premiere 
impression est que les greffons de 
PTFE ont modifie de facon appreciable, 
en ce qui a trait a I’acces vasculaire, 
le traitement de plusieurs patients 
sous hemodialyse a long terme.
The weakest element in the manage­
ment of patients on long-term hemo­
dialysis is vascular access. Use of the 
Brescia-Cimino subcutaneous fistula 
has been the most reliable method.1
*Department of urology, The Montreal 
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t Division of nephrology, The Montreal 
General Hospital
XDepartment of radiology, The Montreal 
General Hospital
Reprint requests to: Dr. M. Kaye, 
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However, this technique is not applica­
ble in many new cases and its avail­
ability has been exhausted in most pa­
tients who have been on hemodialysis 
for extended periods. The search con­
tinues for a maintenance-free subcu­
taneous angioaccess technique for ap­
plication to these patients. Bovine 
carotid heterografts appeared promis­
ing but soon demonstrated a high fre­
quency of thrombosis, aneurysm and 
inability to withstand infection;2-4 only 
2 of 19 such grafts introduced by the 
authors were functioning successfully 
at 12 months. Venous autografts, when 
these have been possible, have also been 
disappointing.
We have used grafts fashioned 
from expanded polytetrafluoroethylene 
(PTFE) (IMPRA™, IM PRA Inc., 
Phoenix, AZ) for the creation of sub­
cutaneous forearm fistulas in 42 pa­
tients not considered suitable for the 
creation of a Brescia-Cimino fistula. 
Three loop grafts have also been em­
ployed for prolonged chemotherapy in 
nonuremic patients lacking adequate 
veins. As with other auto- and allo­
grafts, vascular complications have en­
sued (Table I). Aggressive angiographic 
analysis and hemodynamic flow stud­
ies,5 used to delineate these problems, 
have led us to appreciate the high sur­
vival rate of these inert implants and 
the ability to repair and otherwise serv­
ice them. We describe the procedures 
performed on two patients in whom an 
abnormal hemodynamic state made the 
graft unsuitable for hemodialysis, but 
in whom reconstructive surgery allowed 
graft salvage.
Case Reports
Case 1.—A 66-year-old man who had
been maintained on hemodialysis for 3 
years had a PTFE loop graft inserted in 
his left forearm, above- the site of a 
previous shunt. Postoperatively the suture 
line of the venous anastomosis became 
infected but the infection resolved when 
antibiotics were given. Shortly thereafter 
a pulsatile mass was noted at the anas­
tomosis. Angiography, performed as previ­
ously described,3 demonstrated the pres­
ence of a false aneurysm. This was re­
paired by closing the leak at the anasto­
mosis with a PTFE patch graft. Six 
weeks later the patient presented with a 
pulsating mass (diameter 2 cm) at the 
site of the arterial anastomosis. A false 
aneurysm at the arterial anastomosis and 
marked stenosis of the venous anasto­
mosis were demonstrated by antegrade 
and retrograde angiography (Fig. 1). 
These mechanical complications prevented 
the use of the graft for hemodialysis. Be­
cause there were no satisfactory forearm 
veins for construction of another arterio­
venous fistula, reconstructive surgery on 
the graft was again performed.
Under general anesthesia the arterial 
anastomosis was explored and organizing 
thrombus removed. A Dacron patch (0.5 
X 1.5 cm) was sutured to the margins 
of the defect in the anastomosis. The 
absence of severe fibrosis facilitated this 
procedure. Because of the previous re­
pair of the false aneurysm at the venous 
anastomosis, it was not possible to re­
lieve the stenosis. Consequently an inci­
sion was made distal and proximal to the 
anastomosis and a length of PTFE (0.5 
cm x  6.0 cm) was inserted between the 
graft proximal to the obstruction and 
the cephalic vein on the lateral side of 
the elbow. Anastomoses were performed 
with 7-0 Tevdek sutures (Fig. 2).
Case 2.—This patient had been on 
dialysis for 18 months, with a forearm 
bovine loop fistula for access before 
aneurysmal disintegration developed at 
several sites. A PTFE graft was then in-
T a b le  1— R e s u lts  o f  P la c e m e n t  o f  P o ly t e t r a f lu o r o e t h y le n e  G ra fts  
f o r  V a s c u la r  A c c e s s  in  P a t ie n t s  on  H e m o d ia ly s is
G r a f t  ty p e
N o . o f  
p a t ie n ts
N o . o f  
g r a f ts
N o . o f  
f a i lu r e s
N o .
r e v is e d
N o .
fu n c t io n in g  
(a n d  % )
S t r a ig h t 15 15 10 0 5 (3 3 )
L o o p 27 29 3 5 24  (8 3 )
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troduced in the same arm, 2.5 cm outside 
the bovine graft loop. Both functioned for
2 months; then the defective bovine graft 
was successfully removed and dialysis 
transferred to the PTFE graft.
Seven months later the patient, who 
was living in another province, and was 
maintained on home hemodialysis noticed 
the absence of pulsation in his forearm 
PTFE straight graft. Because of the dis­
tance of his home from the hemodialysis 
centre and because it happened on a Fri­
day, he did not report to the centre until 
the following Monday. On arrival there 
was no flow in the graft and clot could 
be aspirated from the lumen. At opera­
tion all thrombus was removed from the 
graft and flow through it resumed. Be­
cause of extremely high intragraft pres­
sures, graft angiography was carried out 
and demonstrated stenosis at the graft’s 
venous anastomosis. Surgical repair was 
performed utilizing a venotomy both 
proximal and distal to the anastomosis. 
A diamond-shaped PTFE graft was 
fashioned and sutured into place.
The patient was instructed to return 
in 3 months for graft evaluation. How­
ever, 2 weeks before his planned return 
he noticed clotting in the graft. On exam­
ination, the arterial end was pulsating but 
the remainder was obstructed by clot. 
A new venous limb 20 cm in length was 
inserted between the PTFE in the lower 
forearm and the cephalic vein in the 
upper arm. Subsequently dialysis was 
successful and angiograms were obtained. 
These demonstrated a narrow arterial 
anastomosis which probably contributed 
to graft failure on both occasions (Fig.
3 a and b). A new arterial limb was in­
serted between the brachial artery, at the 
site of attachment of a previous bovine 
graft and the end of the venous limb in 
the forearm. Dialysis was carried out 
without difficulty after 48 hours and re­
peat angiography 1 week later showed ex­
cellent results (Fig. 3c).
Fig. la  Fig. lb
FIG. 1— Case 1. (a) Formation of false 
aneurysm at arterial graft anastomosis, 
(b) Repair of aneurysm with Dacron 
patch.
Six months later, angiography carried 
out because of poor flow revealed arterial 
stenosis and several kinks in the graft. 
This time it was decided to replace the 
graft completely using the same arterial 
site but a venous site higher in the arm. 
With a fasciotome, the old graft was 
easily cored out and the same channel used 
for the new one. This patient now has 
had a total of three loops in the same 
forearm over a period of 3 Vi years with­
out sacrifice of any major vessels.
Discussion
Several straight grafts from the 
radial artery to the antecubital fossa 
have been introduced. These have not 
proved satisfactory, probably owing 
to a combination of inadequate radial 
artery flow and excessive turbulence 
associated with the abrupt directional 
change at the arterial anastomosis.
Our experience with PTFE grafts 
to date indicates that they provide ex­
cellent vascular access for patients who 
have lost superficial forearm veins or 
arteries, or whose venous drainage sys­
tem is unsuitable for construction of a 
Brescia-Cimino fistula. Unlike bovine 
grafts, PTFE grafts provoke minimal 
tissue reaction and allow extensive re­
constructive surgery as described above. 
Moreover, removal of a graft not 
amenable to reconstruction is a simple 
matter. The only major evidence of 
host response to foreign material has 
been the occasional presence of for­
eign body giant cells in the adventitia;6 
the general response consists of forma­
tion of a neointima, media and ad­
ventitia. The ease with which new 
PTFE tubing can be anastomosed to 
previously grafted material may be due 
to the presence of this neointima and 
media.
Fig. 2a Fig. 2b
FIG. 2— Case 1. (a) Severe stenosis at 
venous anastomosis, (b) Reconstruction 
of stenosed area using polytetrafluoroethy- 
lene (PTFE) bypass graft (arrows).
Polytetrafluoroethylene has provided 
vascular access in two patients who 
would otherwise have required external 
shunts. It has lent itself to reconstruc­
tion of an intricate nature that has per­
mitted salvage of the graft which other­
wise would have been lost.
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Polytetrafluoroethylene Grafts for Vascular Access
for Hyperalimentation
P.D. Fry, md, frcs[c] and D.B. A llardyce, md, frcs[c]
A polytetrafluoroethylene (PTFE) graft 
from the brachial artery to the axillary 
vein may provide a safe and trouble-free 
means of vascular access in selected 
patients requiring long-term intravenous 
feeding in the hospital setting. This 
route for the administration of solutions 
supplying total parenteral nutrition 
(TPN) should be considered in persons 
whose requirement for parenteral 
feeding is likely to extend over many 
months and in whom there are other 
sources of bacteremia which can imitate 
or be confused with infection of a 
conventional central venous feeding 
line. In a 52-year-old man an 8-mm 
PTFE graft was anastomosed end-to-side 
to the brachial artery and the axillary 
vein and brought through a sub­
cutaneous tunnel on the medial aspect 
of the upper arm. Access to it was 
obtained by intermittent puncture with 
a no. 21 butterfly needle. Hyperosmolar 
TPN solutions flowed easily by gravity 
drip into the shunt. The graft seemed 
resistant to infection. This form of 
vascular access appears to exclude 
parenteral feeding lines, solutions and 
catheters as sources of sepsis.
Une greffe de polytetrafluoroethylene 
(PTFE) entre I'artere brachiale et la 
veine axillaire peut offrir un moyen 
sur et sans ennui d'acces vasculaire 
chez certains patients necessitant 
une alimentation intraveineuse a long 
terme dans un milieu hospitalier. On 
devrait envisager cette voie d'admi- 
nistration pour ies solutions destinees 
a I’alimentation parenteraie complete
From the department of surgery, Uni­
versity of British Columbia, Vancouver, BC
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(APC) chez Ies personnes dont Ies 
besoins en alimentation parenteraie 
sont susceptibles de se prolonger 
pendant plusieurs mois, et chez qui 
il existe d'autres sources de bacteremie 
capables d'imiter ou d'etre confondues 
avec I'infection d'un circuit central 
conventionnel d'alimentation veineuse. 
Chez un homme de 52 ans, une greffe 
de PTFE de 8 mm a subi une anastomose 
termino-lateraie entre I'artere brachiale 
et la veine axillaire, et ramene par un 
sillon sous-cutane jusqu'a la partie 
mediane du haut du bras. Son acces a 
ete obtenu par ponction intermittente a 
I’aide d'une aiguille a ailettes de calibre 
21. Les solutions hyperosmolaires 
d'APC circulaient facilement par ecou- 
lement par gravite dans la derivation.
La greffe semblait resistante a I’infec- 
tion. Cette forme d’acces vasculaire 
semble exclure les tubulures d'alimen­
tation parenteraie, les solutions et les 
catheters des sources d'infection.
Parenteral nutrition can usually be 
provided by centrally placed catheters 
inserted percutaneously either by the 
subclavian or internal jugular route. 
This form of vascular access has proved 
entirely satisfactory in many centres 
and can be used over a long time with 
an acceptable rate of sepsis resulting 
from catheterization. In some individ­
uals, however, namely those with 
severe intraperitoneal sepsis and wound 
infections, the clinical course may be 
complicated by intermittent septicemia 
and continuous evidence of severe bac­
terial toxicity. If there are repeated 
peaks of fever, with or without positive 
blood cultures, it may be extremely dif­
ficult to exclude sepsis from the cathe­
ter as the cause. The catheter may 
therefore have to be removed and re­
inserted at frequent intervals. For 
these reasons it may be desirable to
create an arteriovenous shunt in the 
upper extremity to allow long-term 
total parenteral nutrition. Such a 
shunt may be readily created by the 
insertion of a polytetrafluoroethyl­
ene (PTFE) graft in the forearm or 
upper arm. The parenteral fluids can 
then be administered by gravity drip 
through a no. 21 butterfly needle that 
enters the graft. This shunt is avail­
able for use within a few hours after 
its introduction and forms a relatively 
hazard-free and convenient means of 
venous access that remains usable for 
a long period.
The following case report illustrates 
the clinical circumstances in which this 
method of furnishing vascular access is 
extremely valuable.
Case Report
A 52-year-old man was transferred to 
the Vancouver General Hospital because 
of complications of previous colonic sur­
gery. Six months earlier a Hartmann’s 
resection had been performed for com­
plications of sigmoid diverticulitis. Six 
weeks prior to transfer an attempt had 
been made to restore colonic continuity. 
Subsequently a leak developed at the 
colonic anastomosis and later acute acal- 
culous cholecystitis developed. Following 
exteriorization of the anastomosis, small- 
bowel fistulas formed, abdominal sepsis 
was persistent and eventually a gastric 
ulcer perforated.
On admission he had severe intra­
peritoneal and wound sepsis and con­
tinuous drainage of intestinal content from 
his incision and from drains placed at his 
previous procedures. At operation a large 
collection of bile was drained from the 
right upper quadrant of the abdomen and 
multiple loculations of intestinal content 
and pus were found in both paracolic 
gutters. The bowel was involved in a dense 
fibroblastic reaction. Resection of the 
small-bowel fistulas was not possible.
The patient received total parenteral
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nutrition (TPN) through centrally placed 
jugular and subclavian catheters. Contin­
uous lavage of the peritoneal cavity with 
normal saline was carried out. He was 
given antibiotics and respiratory support. 
He continued to show evidence of severe 
sepsis. Over a 7-week period his leukocyte 
count ranged from 11 to 25 x  109/L. His 
peripheral smear consistently demonstrated 
marked elevation of band cell counts and 
the presence of metamyelocytes and 
myelocytes; toxic vacuolation and granu­
lation were consistently seen. The num­
ber of mature polymorphonuclear leu­
kocytes seldom exceeded 20% of the total 
count. Bacterial cultures taken from the 
peritoneal cavity at the initial operation 
yielded Escherichia coli and Bacteroides 
sp. Cultures of sputum and tracheal as­
pirate were overgrown with coliform or­
ganisms. Candida albicans was cultured 
from his oral cavity, urine and wound 
drainage. After 2 weeks in hospital Pseu­
domonas aeruginosa became the dominant 
organism in both sputum and drainage 
from the abdominal incision.
The patient had continuous pyrexia 
(temperature 38°C to 40°C, pulse rate 140 
to 160 beats/min). During this period 
organisms failed to grow in blood cultures 
but enterococci were cultured from a TPN 
line removed 15 days after admission. 
Antibiotics given were tobramycin and 
gentamicin. On the 36th hospital day 
Klebsiella and Pseudomonas sp. grew in 
cultures of blood from the left internal 
jugular TPN line. The same organisms 
were grown repeatedly from the drainage 
from the abdominal wound. Cultures of 
aspirates and drainage from the right 
upper quadrant, now known to originate in 
the biliary tree, also grew Pseudomonas 
and two strains of E. coli. Because of 
the repeated confirmation of septicemia 
and the uncertainty as to whether the
central lines were serving as a nidus 
ensuring its continuation, an alternative 
form of vascular access was devised.
Technique
On the patient's 47th hospital day, 
under general anesthesia administered 
through the tracheostomy, a PTFE (Gortex, 
Gore and Associates, Flagstaff, AZ) 
graft was inserted in the right upper arm. 
Through an incision in the axilla the axil­
lary vein was identified and the brachial 
artery was exposed' in the antecubital 
fossa- Bleeding from both vessels was con­
trolled proximally and distally. A sub­
cutaneous tunnel was created between the 
two incisions and dilated with Pratt dila­
tors. An 8-mm PTFE graft was drawn 
through the tunnel and anastomosed to the 
brachial artery and to the axillary vein 
using 6-0 Prolene running sutures (Fig. 
1). At the conclusion of the operation 
good flow through the graft was dem­
onstrated and a bruit was audible through­
out its course. The incisions healed 
normally. Some edema and induration of 
the skin over the medial aspect of the 
upper arm was evident for approximately 
1 week, but a week after the procedure 
the shunt was used for parenteral nutrition 
for the first time.
Protocol for TPN
For access to the shunt a no. 21 but­
terfly needle was used (Fig. 2). The TPN 
solutions ran easily against the arterial 
pressure within the shunt without the 
need for constant infusion pumps. As with 
other parenteral nutrition lines, the in­
fusion tubing and needle were changed 
every second day. Care was taken each 
time the needle was removed or inserted 
at another site to be certain that hemosta­
FIG. 1—Placement of 8-mm polytetrafluoroethylene (PTFE) graft in upper right 
arm, originating from brachial artery at elbow and anastomosed end-to-side to axillary 
vein. Insets show end-to-side anastomosis of graft to artery and graft to vein, respectively, 
using 6-0 Prolene suture. (Reprinted from Allardyce DB: Symposium on nutritional 
requirements of the surgical patient. 3. Total parenteral nutrition. Can J Surg 20:
495, 1978.)
sis was obtained at the puncture site. At 
no time did a hematoma develop in 
relation to the shunt. Perhaps because 
of the Venturi effect of the shunting 
arterial blood, problems with arterial 
backflow up the infusion lines were 
rare. Puncture of the graft was easily per­
formed by regular duty nurses and was 
well tolerated by the patient. The graft 
easily received a hyperosmolar TPN 
solution composed of 1100 mL of 10% 
Travasol® (Baxter Travenol Laboratories 
of Canada Ltd., Malton, Ont.), 400 mL of 
50% dextrose and 1500 mL of Intra­
lipid 10% (Pharmacia [Canada] Ltd., 
Dorval, PQ) on a daily basis. There was 
no discomfort or irritation at the infu­
sion site.
From approximately the 45th hospital 
day manifestations of systemic sepsis 
slowly relented. Contraction and rapid 
growth of granulation tissue in the abdo­
minal incision were evident. Continued 
drainage of intestinal content from the 
small-bowel fistula prevented resumption 
of oral intake and it was necessary to 
continue parenteral feeding. On day 68 
resection of three segments of small 
bowel was carried out and the continuity 
of the sigmoid colon established; the 
colonic anastomosis was protected by a 
right transverse loop colostomy. Following 
this procedure parenteral nutrition was 
resumed. On day 88 all TPN was dis­
continued and the patient was allowed oral 
intake for the first time. From the nutri­
tional standpoint, enteral intake appeared 
satisfactory, but drainage of intestinal con­
tent from the transverse loop colostomy 
proved difficult to control and excoria­
tion of the skin and ulceration around the 
stoma developed. Total parenteral nutri­
tion was resumed through the PTFE 
graft on day 110 in order to improve the 
condition of the skin around the stoma 
before closing the transverse loop col-
FIG. 2— Graft can be readily seen and 
palpated on medial aspect of upper arm 
of patient. To start total parenteral nutri­
tion, skin is prepared and butterfly needle 
is introduced and taped in position. Solu­
tions will flow readily into shunt without 
backflow or clotting, and continuous in­
fusion pumps are not required.
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ostomy; this was delayed until day 180. A leak occurred from the colonic anasto­mosis through the colostomy incision and parenteral feeding was necessary until day 216, by which time all drainage of intestinal content had ceased and all abdominal incisions and drain sites were dry. Parenteral feeding was gradually withdrawn and the patient slowly resumed an adequate oral intake. The shunt was left in place. A period of intensive phy­siotherapy was required to improve the patient’s strength and ability to walk be­fore he could be discharged from hospital on day 258. He had received TPN for 194 days and on 147 days it was supplied through the PTFE graft.
Discussion
A  PTFE graft placed in the right 
upper arm served as a trouble-free and 
infection-resistant form of vascular ac­
cess for an extended period in a critic­
ally ill patient who required prolonged 
total gastrointestinal rest. This means 
of vascular access deserves serious con­
sideration in any person in whom the 
course of parenteral nutrition is ex­
pected to be unusually prolonged. In­
dications for placing such a shunt would 
be strengthened by the presence of 
multiple sites of sepsis and by occur­
rence of septicemia having its source 
from the same foci of infection.1 Un­
der these conditions a centrally placed 
conventional type of catheter would 
raise constant concern that the septi­
cemia might be arising from the par­
enteral feeding line. The creation of 
the shunt alleviates these concerns and 
allows continuous uninterrupted and 
hazard-free parenteral nutrition. In our 
experience with renal patients under­
going vascular access procedures the 
PTFE graft appeared resistant to local 
and systemic infection. This opinion 
is also reflected in the literature1 and 
in the study of Fry, Naiman and Dene- 
gri (unpublished data). The graft in our 
patient did not show any tendency to 
bleed following intermittent puncture 
with a butterfly needle. It was ready 
for use within a few days of its place­
ment in the arm. The changes of the 
needle puncture site in the graft caused 
no significant discomfort. The low 
resistance shunt, although it had a 
high flow judging from the vigorous 
bruit, produced no signs of congestive 
heart failure. The patient’s pulse rate 
settled to between 75 and 80 beats/ 
min with a normal pulse pressure once 
the manifestations of sepsis had dis­
appeared.
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Anterior Intranasal Carcinoma
N orman J. Shiffman, md, frcp[c]*
In a series of nine consecutive cases 
of anterior intranasal carcinoma seen 
between 1965 and 1975, a single 
treatment failed to control the disease 
in four. This failure rate is much higher 
than that reported for squamous cell 
carcinomas of the skin in general and 
appears to indicate that tumours at this 
site require aggressive therapy.
Dans quatre d'une serie de neuf cas 
consecutifs de carcinome intranasal 
anterieur vus entre 1965 et 1975, le 
contrdle de ia maladie n’a pu etre obtenu 
avec un seul traitement. Ce taux 
d'echec est beaucoup plus eleve que 
celui qui a ete signale pour I’epithe- 
lioma spinocellulaire de la peau en 
general et semble indiquer que les 
tumeurs de cette localisation necessitent 
un traitement agressif.
From the department of dermatology, 
Ottawa Civic Hospital, Ottawa, Ont.
*Former resident in dermatology, 
Ottawa Civic Hospital
Reprint requests to: Dr. N.J. Shiffman, 
2927 Lawrence Ave. E, Scarborough, 
Ont. M1P 2T3
The nasal vestibule may be defined as 
a recess immediately within the aper­
ture of the nostril, bounded by the 
medial and lateral crura of the alar 
cartilages, extending to the apex of the 
nose and bounded medially by the 
anterior nasal septum. The walls of this 
recess are covered by hair-bearing skin, 
not by mucous membrane.
Although uncommon, squamous cell 
carcinomas represent the most common 
primary tumour of this region. They 
may arise from the walls of the 
vestibule or the floor of the nasal 
cavity. Often it is impossible to ascer­
tain where such tumours have origin­
ated, since by the time they receive 
clinical attention they involve more 
than one area. Therefore the term 
“anterior intranasal carcinoma” has 
been coined to designate squamous cell 
carcinomas that develop in this region.
Because of their unique location 
these tumours present problems in 
diagnosis and treatment. Whereas the 
frequency of metastases from squam­
ous cell carcinomas of the skin is 
generally only 2% to 5% ,1-3 anterior 
intranasal carcinomas have a less 
favourable prognosis.
We report nine consecutive cases of 
squamous cell carcinoma of the nasal 
vestibule, confirmed by biopsy, that 
were seen between Jan. 1, 1965 and 
Dec. 31, 1975 at the Ottawa Civic 
Hospital division of the Ottawa clinic 
of the Ontario Cancer Foundation. 
This is a general referral and multi­
disciplinary clinic, the staff of which 
includes a radiotherapist, a dermatol­
ogist, a plastic surgeon and a pathol­
ogist. Each patient was managed and 
followed up under the direction of the 
clinic.
The clinical data are set forth in 
Table I. In none of the cases was there 
evidence of either regional lymph-node 
or distant metastases at the time of 
initial treatment. Mostly the tumours 
were relatively small (six were less than 
2 cm in greatest diameter) and had 
been present for relatively short pe­
riods. Nevertheless in four of the nine 
cases a single treatment failed to con­
trol the disease. Three failures were 
represented by local recurrence and one 
by metastatic lymphatic spread. No pa­
tient has yet died as a direct result of 
this tumour, although two succumbed 
to other malignant processes.
T a b le  1 - -D e t a i ls  o f N in e  C a s e s  o f  A n te r io r  In t r a n a s a l  C a rc in o m a
D u ra t io n  of
C a se A ge , S ize ,  sym p tom s,
C o m m e n tno. y r Se x S ite cm  m o M o d e  o f  t re a tm e n t F o l lo w -u p
i 80 M F lo o r  o f  r ig h t  n o s t r i l  w ith 1 14 E x c is io n 27 m o M e ta s t a s e s  to r ig h t  s u b m a n d ib u la r  n o d e s
e x te n s io n  to  n a sa l  se p tu m a fte r  2 m o, r ig h t  r a d ic a l n e c k  d is s e c t io n .  
D ie d  o f  lu n g  c a rc in o m a
2 74 F R ig h t  a n te r io r  n a sa l  se p tu m 1 12 E x c is io n 11 y r L a rg e  lo ca l r e c u r re n c e  a f t e r  9 y r .  T re a te d  by
ra d io th e ra p y .  F re e  o f  d i s e a s e  f o r 2  y r
3 78 M R ig h t  n a sa l v e s t ib u le ,  e x te n d -
in g  to  f lo o r  o f  n o s t r i l  a n d  
se p tu m 1 12 E x c is io n 17 m o F re e  o f  d is e a s e
4 53 M B o th  v e s t ib u le s  a n d  e ro d in g  
th r o u g h  se p tu m 2.5 5 E x c is io n 5 ’/? y r F re e  o f  d is e a s e
5 57 F R ig h t  n a sa l v e s t ib u le 3 6 E x c is io n  an d  ra d io - 5'A V L o c a l r e c u r re n c e  a f t e r  1 m o  d e s t r o y in g
th e ra p y r ig h t  a la r  c a r t ila g e .  M u l t ip le  r e c u r re n c e s  
d e sp ite  f u r t h e r  s u r g e r y  a n d  ra d io th e ra p y .
D is e a s e  f in a l ly  c o n t r o l le d  b y  e x c is io n  o f 
e n t ire  n o se .  D e v e lo p e d  m u lt ip le  p r im a r y  
m a lig n a n t  le s io n s  a n d  d ie d  o f  c a n c e r  o f  
co lo n
6 76 M R ig h t  a n te r io r  se p tu m 1.3 ? E x c is io n 10 m o R e c u r r e n c e  lo c a l ly ,  e x t e n d in g o u t s id e  n o s e  to
u p p e r  lip. R a d io t h e ra p y .  F r e e  o f  d is e a s e  
fo r  3 m o
7 58 F Le ft  v e s t ib u le  a n d  e x te n d in g 2 30 E x c is io n  o f  e n t ire 32 m o F re e  o f  d is e a s e
th ro u g h  se p tu m n o se
F re e  o f  d is e a s e8 62 F L e ft  n a sa l s e p tu m  e ro d in g 1 24 R a d io th e ra p y 33 m o
th ro u g h  se p tu m  in to  r ig h t  
n o s t r i l
F re e  o f  d is e a s e9 77 M Le ft  a n te r io r  se p tu m  and  e x - 1.5 3 E x c is io n 15  m o
te n d in g  a ro u n d  co lu m e lla  
in to  r ig h t  n o s t r i l
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In 1966 Deutsch4 reviewed the liter­
ature and reported on 27 cases of 
squamous cell carcinoma of the nasal 
septum reported up to that time. There 
were metastases in about one third of 
these cases. Deutsch concluded that 
one should take an aggressive surgical 
approach in the treatment of these 
tumours, using supplemental radio­
therapy if necessary for their control. 
Five patients with squamous cell car­
cinoma of the nasal vestibule were re­
ported by DesPrez and Kiehn,5 of 
which one had regional metastases. 
Yarington, Jaquiss and Sprinkle6 agreed 
that this dangerous carcinoma requires 
wide excision. One of their five pa­
tients with carcinoma of the nasal 
septum died of widespread metastatic 
disease within 6 months of presenta­
tion.6
A three-stage treatment regimen con­
sisting of irradiation, followed by ex­
cision and finally by reconstruction 
was advocated by Lyons.7 All four of 
his patients were free of disease at 
follow-up from 8 months to 6 years 
following this aggressive form of 
therapy.
More recently Goepfert and col­
leagues,8 in 1974, reported on 26 cases 
of squamous carcinoma of the nasal 
vestibule. Although only one patient 
had lymph-node involvement at the 
time of initial treatment, metastatic 
disease developed in 16. Results of 
surgical and radiation therapy were 
equally disappointing.
The results of our series appear to 
substantiate the comments of others.
Anterior intranasal carcinoma is indeed 
a dangerous form of squamous cell 
carcinoma and requires early diagnosis 
and aggressive therapy for its control. 
Due to the paucity of cases it is not 
possible to determine with certainty 
whether surgery, radiotherapy or a com­
bination of the two is the treatment of 
choice.
I thank Drs. R. Jackson and J. Fielding, 
without whose enthusiasm and guidance 
this study would not have been possible.
References
1. Williamson GS, Jackson R: Treat­
ment of squamous cell carcinoma of 
the skin by electrodesiccation and 
curettage. Can Med Assoc J 90: 408, 
1964
2. Lund HZ: How often does squamous 
cell carcinoma of the skin metastasize? 
Arch Dermatol 92: 635, 1965
3. Epstein E, Epstein NN, Bragg K, 
et al: Metastases from squamous cell 
carcinomas of the skin. Arch Dermatol 
97: 245, 1968
4. D eutsch HJ: Carcinoma of the nasal 
septum. Report of a case and review 
of the literature. Ann Otol 75: 1049, 
1966
5. D esPrez JD, Kiehn CL: Carcinoma 
of the nasal vestibule. Am J Surg 114: 
587, 1967
6. Y arington CT, Jaquiss GW, Sprinkle 
PM: Carcinoma of the nose and nasal 
septum: treatment and reconstruction. 
Trans Am Acad Ophthalmol Oto­
laryngol 73: 1178, 1969
7. Lyons GD: Squamous cell carcinoma 
of the nasal septum. Arch Otolaryngol 
89: 585, 1969
8. Goepfert H, Guillamondequi OM, 
Jesse RH, et al: Squamous cell car­
cinoma of nasal vestibule. Arch Oto­
laryngol 100: 8, 1974
BOOK REVIEWS
a t l a s  o f  r a d i c a l  p e l v ic  s u r ­
g e r y . 2nd ed. James H. Nelson, Jr. 
365 pp. Illust. Appleton-Century-Crofts, 
New York, 1977. $36.50. ISBN 0-8385- 
0123-0.
In this new edition of his book, Professor 
Nelson offers to the practising gynecolo­
gist and the trainee a comprehensive 
presentation of radical pelvic surgery. The 
atlas is an overview of the subject and 
includes such topics as preoperative 
assessment, the diagnosis of malignant 
pelvic disease and selection of the correct 
mode of therapy.
The section on postoperative care is 
comprehensive; the author pays particular 
attention to the preventive aspects of 
postoperative care. From a practical view­
point, the chapter on bowel and urinary 
tract diversions is particularly useful.
The section dealing with actual pelvic 
surgery is concise and easy to follow. The 
illustrations by Frank Robertson are ex­
cellent; his drawings of the anatomy are 
without equal. Nelson has included an 
illustration of every type of procedure in 
radical pelvic surgery, including modified 
radical hysterectomy, radical vulvectomy 
and exenteration. In addition, he provides 
a large section dealing with bowel and 
urinary tract problems associated with 
radical pelvic surgery.
Nelson has a very personal and 
practical view of this subject. For persons 
with a more academic interest and for
continued on page 166
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Pyogenic Infections of the Adult Spine
Peter A. Gutmanis, md and Cecil H. Rorabeck, md, frcs[c]
A retrospective analysis of 61 patients 
forms the basis for this paper's 
comment on three major types of 
pyogenic spinal disease. The first group 
consists of 22 patients with vertebral 
osteomyelitis and intervertebral discitis. 
The second group comprises 22 patients 
in whom the diagnosis of pyogenic 
spinal disease was made only after 
failure of discectomy. In retrospect 
they were shown to have atypical 
degenerative disc disease and were 
similar to the first group. The third 
group of 17 patients, while demonstrating 
some similarities to the second group, 
represents true postdiscectomy wound 
infection. An understanding of the 
clinical presentation and pathophy­
siology of pyogenic disease of the 
spine allows it to be distinguished 
preoperatively from degenerative disc 
disease which superficially it resembles. 
Further, true postdiscectomy wound 
infection can be distinguished from 
pyogenic spinal disease misdiagnosed 
preoperatively. The differences in the 
results of treatment of these three 
groups warrant such distinctions.
Une analyse retrospective de 61 
patients est a I'origine des presents 
commentaires sur les trois principaux 
types de maladies pyogenes de la 
moelle. Le premier groupe comprend 
22 patients ayant une osteomyelite 
vertebrale et une discite intervertebrale. 
Le second groupe comprend 22 patients 
chez qui le diagnostic de maladie 
pyogene de la moelle a pu etre pose 
apres I'echec d'une discectomie. 
Retrospectivement, on a decouvert, chez 
eux une discopathie degenerative 
atypique semblable a celle du premier 
groupe. Le troisieme groupe de 17 
patients, meme s'il offrait quelques 
similarites avec le second groupe, 
presente de veritables cas d'infection
From the department of surgery, 
division of orthopedic surgery,
University Hospital, London, Ont.
Presented at the 47th annual meeting of 
the Royal College of Physicians and 
Surgeons of Canada, Vancouver, BC, 
Jan. 26, 1978
Reprint requests to: Dr. P.A. Gutmanis, 
Department of surgery, Brome-Missisquoi- 
Perkins Hospital, 950 rue Principal, 
Cowansville, PQ J2K 1K3
de plaie post-discectomie. Line 
connaissance de I’aspect clinique et 
de la pathophysiologie de la maladie 
pyogene de la moelle permet de la 
distinguer, avant I'operation, d'une 
discopathie degenerative a laquelle elle 
ressemble a premiere vue. De plus, 
une veritable infection de plaie post- 
discectomie peut etre distinguee d'une 
maladie pyogene de la moelle dont le 
diagnostic aurait echappe a I'examen 
preoperatoire. Les differents resultats 
obtenus dans le traitement de ces 
trois groupes justifient de telles 
distinctions.
Back pain is a common complaint, but 
its causes are often difficult to dis­
cover. In 1937 Barr1 concluded: “There 
seems to be no doubt that a clinical 
entity [the ruptured intervertebral disc] 
with a proved pathologic etiology, is 
being removed from the vague classifi­
cation of lumbosacral and sacroiliac 
strains.” Ten years later he wrote: 
“One must consider and rule out, in 
each suspected case of ruptured inter­
vertebral disc, a long list of diagnostic 
possibilities, including infectious pro­
cesses . . .”.2 Isolated cases of pyogenic 
infection of the spine had been de­
scribed previously.3*4 By 1936 Kulowski5 
had noted that such infection had be­
come more common than tuberculous 
spondylitis. He had also observed that 
suppuration could arise in either the 
vertebral body or intervertebral disc. 
More recently, others6'12 have described 
various aspects of pyogenic spinal dis­
ease.
The purpose of this paper is to 
elucidate a neglected and misunder­
stood cause of back pain, pyogenic dis­
ease of the adult spine. A study was 
undertaken against a background of 
limited understanding of the clinical
presentation, pathophysiology and re­
sults of treatment of this disease.
Patients and Methods
Sixty-one patients (40 men and 21 
women), seen over a 5-year period 
(1971 to 1976) form the basis of this 
review. In each patient infection of the 
spine or the soft tissues surrounding it, 
or both, had been diagnosed. The 
average age of these patients was 46.9 
years. All relevant charts, laboratory 
data and roentgenograms were exam­
ined. Forty-five patients were examined 
personally by the senior author (chart 
review only was carried out in 15 
and 1 had died). The average duration 
of follow-up was 3.5 years. In addition, 
specimens obtained from the spines of 
54 patients were subjected to repeat 
histopathologic examination by a pa­
thologist who had no prior knowledge 
of the history or radiologic findings.
On the basis of this review, these 
61 patients were classified into three 
groups (Table I). The age and sex dis­
tribution in each group were similar.
Results
Group 1
In the 22 patients of this group a 
spinal infection was diagnosed before 
any treatment was instituted. Two 
varieties of untreated pyogenic disease 
of the spine, vertebral osteomyelitis 
and intervertebral discitis, were noted 
and were distinguished by their clinical 
and radiologic presentations.
Vertebral osteomyelitis.—Nine pa­
tients with vertebral osteomyelitis pre­
sented with a history of back pain for 
6 months or less. Six patients had a 
prodromal febrile illness. Roentgeno-
Table 1—Classification of Pyogenic Disease of the Spine
Group (and no. 
of patients) Classification
Radiologic criteria 
(and no. of patients)
1 (22) Diagnosed as spinal infection 
before spinal surgery
Changes of vertebral osteomyelitis |j) 
Changes of intervertebral discitis (13).
2 (22) Diagnosed as spinal infection 
after spinal surgery
Changes of vertebral osteomyelitis g ) 
Changes of intervertebral discitis (70)
3(17) Diagnosed as wound infection 
after spinal surgery
No radiologic changes
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grams of the spine obtained within 6 
months of the onset of back pain de­
monstrated destructive lesions in the 
anterior corner of a vertebral body. 
Fig. 1 shows the radiologic progression 
of such a lesion. The erythrocyte sedi­
mentation rate in these patients aver­
aged 51 mm/h.
Intervertebral discitis.—Thirteen pa­
tients had intervertebral discitis. Back 
pain was the presenting complaint 
in all patients and was of many
FIG. 1— (a) Lateral roentgenogram of 
6 weeks after onset of symptoms. Lesion 
Primarily involved vertebra can usually be 
stage (b) when early bony ankylosis occurs.
months’ duration in the older members 
of the group. The younger members 
had a shorter history of back pain, 
usually following a minor back injury. 
Roentgenography at the time of diag­
nosis revealed destructive lesions of 
two continuous vertebral end-plates in 
all patients. Fig. 2 shows the roentgen- 
ographic progression of such a lesion. 
The erythrocyte sedimentation rate 
averaged 21 mm/h in these patients.
All patients in group 1 complained
osteomyelitic lesion of L4 obtained about 
is usually diagnosed only as it enlarges, 
identified without difficulty except at end
Fig. 2a Fig. 2b
FIG. 2— (a) Lateral roentgenogram of discitic lesion at L5-S1, taken many months 
after onset of symptoms, showing disc space narrowing and erosion of two affected 
vertebral end-plates bordering disc, (b) In end stage of discitis bony ankylosis 
often occurs.
of constant, well-localized back pain 
which was not relieved by rest. Twelve 
had symptoms of nerve root irritation. 
Seven had motor, sensory or reflex 
neurologic deficit in the distribution of 
a spinal nerve root. Only one patient 
had long tract signs. In nine patients 
an erroneous diagnosis of cholecystitis 
or other visceral disease was made 
initially. Two patients had cholecys­
tectomy which did not relieve the pain. 
Subsequently all nine patients had 
radiologic changes typical of discitis. 
A bacteriologic condition was diagnosed 
in 11 patients; in 7 bacteria were 
harvested directly from the spine, either 
by needle or open biopsy, and in the 
other 4 bacteria were cultured from the 
blood alone. Staphylococcus aureus 
was cultured from the biopsy specimen 
in six patients, anaerobic streptococcus 
in two and Escherichia coli, pneumo­
coccus and Staphylococcus albus in one 
each. Cultures were negative for 
tubercle bacilli in all patients. Only 
one patient had a positive reaction to 
the tuberculin skin test. Histopathologic 
analysis of material obtained by needle 
or open biopsy showed moderate vas­
cularity and moderate or severe acute 
and chronic inflammation (Fig. 3). The 
dead and reactive bone and cartilage 
seen in these specimens were similar to 
those found in osteomyelitic specimens 
and septic arthritis of long bones and 
their joints. The treatment in these pa­
tients varied considerably. In three 
operative drainage and fusion of the 
involved spine were carried out, anti­
biotics were given and 4 to 8 weeks of 
bed rest were followed by a 2- to 6- 
month (average 4.3 months) period of 
bracing. At the other extreme, three 
elderly patients had no treatment other 
than bed rest at home. All patients but 
one, who died of pulmonary embolism, 
did well. At follow-up 8 of 21 had re­
turned to their former occupations.
Group 2
Twenty-two patients were considered 
to have spinal infection after discec­
tomy. Back pain was the presenting 
complaint in all. It was constant and 
was not relieved by bed rest. Sixteen 
patients complained of lower extremity 
pain. Eleven had objective evidence of 
nerve root tension and four had a new 
neurologic deficit. Nineteen patients 
underwent myelography prior to the 
discectomy. In only two patients did 
the myelographic findings agree with 
the neurologic signs. Ten patients were 
subjected to discography which was 
not helpful in making a diagnosis. The 
preoperative erythrocyte sedimentation 
rate was elevated in most patients, 
averaging 15 mm/h. A retrospective 
review of the preoperative roentgeno­
grams demonstrated early destructive
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FIG. 3— Histopathology of lesion in group 1 patient showing moderate vascularity 
of lesion and inflammation.
Fig. 4a
4
S1
Fig. 4b
Fig. 4c
FIG . 4— (a) Preoperative discogram of group 2 patient shows L5-SI disc degener­
ation and also early lysis of L5-S1 vertebral end-plate, (b) Six weeks after L5-S1 
discectomy end-plate erosion at operated level is noted, (c) Ten weeks postoperatively 
symmetrical lysis of adjacent end-plates of L5-S1 is obvious, (d) By 11 months, clinical 
relief of pain was coincident with early bony ankylosis of L5-JS1.
changes in the spines of 16 patients. 
These were the changes of discitis in 14 
and of vertebral osteomyelitis in 2 
(Fig. 4). A review of the operative 
notes in these 22 patients disclosed 
only three discs that were described as 
sequestrated; the remaining 19 were 
described as “bulging”, “boggy” or “ap­
parently normal” discs.
Postoperatively all patients experi­
enced increasing back pain associated 
with an elevation of the oral temper­
ature (range 38°C to 39.5°C). Three 
patients had an increase in their neuro­
logic deficit. In 14 pus began to drain 
from the incisions. The onset of these 
signs and symptoms was noted on an 
average 4 days after operation. Staphyl­
ococcus aureus was the organism most 
frequently cultured. Eight patients did 
not drain pus. They were classified as 
having postoperative wound infections 
on the basis of an increased oral tem­
perature and wound induration. De­
structive changes at the operated level 
were obvious radiologically in all pa­
tients within 3 months of discectomy. 
In 20 patients the radiologic changes 
of discitis evolved and in 2 those of 
osteomyelitis. Histologic review of the 
operative specimens showed mild focal 
vascularity and mild chronic inflam­
mation in more than two thirds of 
these 22 patients (Fig. 5). Once a 
diagnosis of pyogenic infection of the 
spine had been made, 11 patients were 
treated by approximately 6 weeks of 
bed rest and antibiotics. Of the remain­
ing 11, 3 elderly patients confined 
themselves to bed on their own initia­
tive; 5 patients had further surgery 
consisting of debridement of a persist­
ently draining wound and 3 patients 
who did not drain pus after the original 
discectomy were subjected to a total 
of five further laminectomies or discec­
tomies. Thus all patients eventually had 
relief of their back pain and all had 
bed rest. Relief of pain was roughly 
coincident with spontaneous fusion of 
the affected spinal level. None of 
these patients, however, returned to his 
former occupation.
Group 3
Postdiscectomy wound infection de­
veloped in the 17 patients in this group. 
Episodic back pain was the presenting 
complaint in all. Sixteen patients com­
plained of lower extremity pain. On 
examination, only five had objective 
signs of nerve root tension and seven 
had a neurologic deficit. Thirteen pa­
tients were subjected to myelography. 
In only three patients did the myielo- 
graphic findings agree with the neuro­
logic deficit. In three patients disco- 
grams were obtained which were not 
helpful in making a diagnosis. The sedi­
mentation rate was mildly elevated (14
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to 38 mm Hg, average 23.9 mm Hg) 
preoperatively in 7 of 11 patients in 
whom the test was done. The operative 
findings supported the diagnosis of disc 
rupture in only six patients. An average 
of 6 days postoperatively, all 17 pa­
tients began draining pus from their in­
cisions. Staphylococcus aureus was 
again the organism most frequently cul­
tured. Unlike the group 2 patients none 
of these 17 patients had an increase in 
back pain or neurologic deficit. Destruc­
tive radiologic changes at the operated 
level were not present and did not de­
velop later. Histologic review of the 
operative specimens showed mild focal 
vascularity and mild focal chronic in­
flammation in less than one third. The 
remaining specimens were typical of 
disc degeneration. Treatment consisted 
of antibiotics and a short period of bed 
rest in all but three patients whose 
wounds required surgical debridement. 
Only two patients had a chronic drain­
ing sinus. Fifteen of 17 patients returned 
to their preoperative employment.
Discussion
Pyogenic disease of the spine may 
present in several ways. It may present 
as infection of either the vertebral body 
or the intervertebral disc with no pre­
vious back surgery. It may be mistaken 
for a herniated intervertebral disc and 
the disc operated on unsuccessfully. In 
addition, it may present as a postdis­
cectomy wound infection, uncom­
plicated by recurrence of back pain.
Group 1
Two varieties of pyogenic spinal dis­
ease are described in group 1: vertebral 
osteomyelitis and intervertebral discitis.
Vertebral osteomyelitis was more readi­
ly diagnosed than discitis. This was 
probably owing to the more dramatic 
clinical presentation of vertebral osteo­
myelitis. It may also have been due to 
the popular understanding of its patho­
physiology. An infectious agent de­
posited in the sluggish end-circulation 
in the anterior corner of a vertebral 
body accounts for the typical location 
of an osteomyelitic lesion.13 Primary 
pyogenic discitis, on the other hand, 
was initially misdiagnosed in 9 of 13 
patients in group 1, probably because 
of the relative clinical indolence of 
discitis. Furthermore, the existence of 
primary pyogenic discitis has been re­
cognized by only a few authors.5*6 
Since the adult disc is generally con­
sidered to be avascular14 an explana­
tion of the pathophysiology of primary 
hematogenous suppurative discitis has 
been lacking. Recently, microangio- 
graphic studies have shown vasculature 
in certain adult discs.15 Schmorl and 
Junghanns16 and Brown, Hansen and 
Yorra17 have shown that an axially 
compressed disc complex invariably 
fails at the vertebral end-plate, which, 
in a younger person, usually suffers 
only a microfracture. Recently, Pritz- 
ker18 observed that failure of the 
nucleus pulposus in disc degeneration 
is invariably preceded by failure, or 
microfracture of the end-plate. Heal­
ing of such microfractures is the pro­
cess that brings vasculature to the 
physiologically avascular disc. Conse­
quently we postulate that the inter­
vertebral disc cannot become primarily 
hematogenously infected unless the 
end-plate has previously been disrupted, 
either traumatically or by a degener­
ative process. An infectious agent
deposited in this disc space neovas­
culature could account for the typical 
appearance of a discitic lesion. All 13 
patients in group 1 who had discitis 
had past histories compatible with disc 
degeneration or traumatic end-plate 
microfracture.
Group 2
The syndrome of postdiscectomy re­
currence of back pain accompanied by 
destructive spinal lesions demonstrated 
radiologically at the operated level has 
been observed in the past.8,9 The patho­
genesis of this syndrome has not been 
elucidated previously. The signs and 
symptoms of patients in group 2 were 
atypical of disc rupture. Their constant 
back pain, elevated preoperative sedi­
mentation rates and their less than 
optimal indications for discectomy 
were overlooked. The preoperative 
roentgenographic spinal changes (Fig. 
4) of pyogenic discitis, when present, 
were dismissed as “degenerative”. 
These changes, however, evolved into 
recognizable pyogenic spinal lesions in 
a shorter period than would have been 
possible had infection been implanted 
only at the time of surgery. Further­
more, the histologic review of the 
operative specimens demonstrated disc 
vasculature and chronic inflammation 
which are not compatible with simple 
disc degeneration (Fig. 5). All these 
findings suggest the probability that 
discectomy merely exacerbated a pre­
existing pyogenic lesion. Only when 
treated with bed rest did these patients, 
like those in group 1, obtain relief of 
their back pain.
Group 3
Group 3 patients were similar to 
those of group 2 with two notable ex­
ceptions. Roentgenographic changes of 
pyogenic disease of the spine were not 
present before or after discectomy in 
the patients of group 3. Although a 
wound infection developed postoperat­
ively, these patients had no exacerba­
tion of their back pain postoperatively. 
In view of these two observations, the 
disease process in group 3 patients 
probably represents true postdiscectomy 
wound infection. On the other hand, 
some patients did have elevated sedi­
mentation rates preoperatively, and his­
tologic review of their discectomy ma­
terial revealed vascularity and chronic 
inflammation in some instances. It is 
conceivable that some of these patients 
had a very indolent, unrecognized 
discitis preoperatively.
Conclusions
Pyogenic disease of the spine should 
be included in the differential diagnosis 
of back pain in adults. The disease may
FIG. 5— Histopathology of lesion in group 2 patient. Note similarity to histo­
pathologic specimen of patient in group 1 (Fig. 3). One of several vessels in midst 
of chronic inflammation is indicated by arrow.
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be present in one of two forms: verte­
bral osteomyelitis or intervertebral 
discitis. These two disease variants may 
be distinguished by their clinical and 
radiologic presentations.
Intervertebral discitis can be mis­
diagnosed as either a visceral disorder 
or intervertebral disc rupture, owing to 
the clinical indolence of discitis and to 
a limited understanding of its patho­
physiology. Failure to consider discitis 
in the differential diagnosis of disc 
rupture may lead to unnecessary and 
unsuccessful discectomy.
A period of approximately 6 weeks 
of bed rest is the common denominator 
in the successful treatment of the con­
dition. This is true to a lesser extent of 
pyogenic spinal disease mistakenly 
treated by discectomy than of the un­
treated disease.
When postdiscectomy wound infec­
tions develop without exacerbation of 
back pain and roentgenographic de­
structive changes at the operated level 
the patient will do well with no more 
than a short period of bed rest and 
treatment with antibiotics.
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those in training he has provided a multi­
tude of up-to-date references and sugges­
tions throughout the book for further 
reading.
In summary, the “Atlas of Radical 
Pelvic Surgery” will have a great appeal 
for the small group of gynecologists who 
perform this type of surgery, and for 
this small group the book is a must.
J.M. Beresford, md, frcs[c]
1081 Carling Ave.,
Ottawa, Ont.
MORPHOGENESIS A ND  MALFORMA­
TION OF THE GENITAL SYSTEM. 
The Third International Conference on 
Morphogenesis and Malformation. Held 
at Lake Wilderness, Washington, July 
1976. Edited by Richard J. Blandau and 
Daniel Bergsma. 161 pp. Illust. Alan 
R. Liss, Inc., New York, 1977. $18. 
ISBN 0-8451-1009-8.
This report synthesizes the available knowl­
edge of the intricacies and complexities of 
its subject. The panel of contributors com­
prises representatives from many medical 
disciplines including morphologists, phy­
siologists, reproductive biologists, repro­
ductive gynecologists and endocrinologists.
In the chapter on the genetic basis of 
human sex determination and differentia­
tion in mammalian germ cells, the topic 
of specific genetic loci for germinal and 
somatic gonadal differentiation is well 
presented. An elegant pictorial review of 
human genital morphogenesis is given. The 
morphogenic role of the human fetal testis 
and the development of the internal and 
external genitalia in both male and female 
infants is excellent.
The chapter on sex steroid production 
by the human fetus presents information
continued on page 191
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Transpleural End-to-End Repair of Esophageal Atresia 
and Tracheoesophageal Fistula
Harold O. Nason, md, frcs[c] and D. A lexander Gillis, md, frcs[c], facs
Successful surgery for esophageal 
atresia and tracheoesophageal fistula is 
a relatively recent development, and 
progress has been rapid over the 
past 10 years. Because the surgical 
technique is still controversial, the 
authors reviewed their experience 
in treating 38 infants with the 
condition. Transpleural end-to-end repair 
was carried out in all cases. In 21 
cases a two-layer repair was done and 
in 17 a one-layer repair. After 10 days, 
if no anastomotic leak was detected 
radiologically, esophagoscopy and 
dilatation at the anastomotic site were 
performed; dilatation was carried out 
routinely once or twice thereafter when 
necessary. The most common com­
plication was stricture of the anasto­
mosis (eight cases), which required 
more than the three dilatations routinely 
performed. Other complications were 
recurrent fistula (two patients) and 
anastomotic leak (two patients).
Six of the 38 infants died; all had 
other serious anomalies. The results 
overall compared favourably with those 
of other published series. The authors 
conclude that end-to-end repair using 
a transpleural approach is a safe and 
effective method for surgical repair of 
esophageal atresia and tracheoesophageal 
fistula. The approach provides excellent 
exposure so that anastomotic tension 
can be evaluated, thus allowing 
improved mobilization of the esophagus. 
Both factors contribute to a low 
frequency of anastomotic complications.
Depuis 10 ans, le traitement chirurgical 
de I’atresie congenitale de I’oeso- 
phage avec fistule tracheo-oesopha- 
gienne a connu de nouveaux develop- 
pements et des progres rapides. 
Comme cette technique est encore 
controversee, les auteurs ont passe 
en revue leur experience dans le 
traitement de 38 bebes souffrant de 
cette affection. Une reparation trans- 
pleurale bout-a-bout a ete pratiquee
From the department of surgery,Izaak Walton Killam Hospital for Children, Halifax, NS
Reprint requests to: Dr. H.O. Nason, Izaak Walton Killam Hospital for Children, 5850 University A ve., Halifax, N S B3J 3G9
dans tous les cas. Dans 21 cas, on a 
procede a une reparation de deux 
feuillets et, dans 17 cas, a celle d’un 
feuillet. Si, apres 10 jours, aucune 
fuite anastomotique n’avait ete decelee 
a la radiographie, une oesophagoscopie 
et une dilatation du point d'anastomose 
etaient pratiquees; par la suite une 
dilatation etait couramment pratiquee, 
une ou deux fois au besoin. La com­
plication la plus frequente a ete un 
retrecissement de I’anastomose 
(huit cas), lequel a necessity plus que 
les trois dilatations habituellement 
effectuees. Une recidive de la fistule 
(deux patients) et une fuite anasto­
motique (deux patients) ont aussi 
ete observees.
Six des 38 bebes sont decedes; tous 
etaient porteurs d'autres anomalies 
serieuses. Au total, ces resultats se 
comparent favorablement avec ceux 
d'autres experiences qui ont fait 
I’objet de publications. Les auteurs 
concluent que la reparation bout-a-bout 
par voie transpleurale est une methode 
chirurgicale sure et efficace pour la 
reparation de I’atresie congenitale de 
I’oesophage avec fistule tracheo- 
oesophagienne. Cette approche offre 
une excellente exposition, permet 
d’evaluer la tension anastomotique et 
une meilleure mobilisation de I’oeso- 
phage. Ces deux facteurs entrainent 
une faible frequence des complications 
anastomotiques.
Successful surgery for esophageal atre­
sia and tracheoesophageal fistula is a 
relatively recent development and pro­
gress has been rapid over the past 10 
years. Of babies born with this serious 
anomaly, 80% to 90% should now 
survive. At present most deaths occur 
in babies with other severe, usually 
cardiac, anomalies (Waterston group 
C).1 Morbidity, however, is a serious 
problem. The technique of repair re­
mains controversial2 as surgeons at­
tempt to improve results and particu­
larly to avoid postoperative leaks, re­
current fistulas and stenosis.
After reviewing our own experience 
over 5 years in treating this condition, 
we conclude that end-to-end repair 
using a transpleural approach is safe 
and effective. Our results compare 
favourably with those of others who
have employed different surgical ap­
proaches.
Clinical Details
During the 5-year period between 
Jan. 1, 1970 and Dec. 31, 1974, 38 
infants with esophageal atresia and 
tracheoesophageal fistula were admitted 
to the Izaak Walton Killam Hospital 
for Children, Halifax. In all a primary 
repair was performed using a trans­
pleural approach. The fistula was di­
vided and the trachea repaired with 
interrupted 5-0 silk sutures. In 21 
cases the end-to-end esophageal repair 
was carried out in two layers as de­
scribed by Haight.3 In the other 17 
cases a one-layer repair using inter­
rupted 5-0 silk sutures was done. Gas­
trostomy was performed on all patients 
immediately following the thoracotomy 
and in no instance were complications 
related to this procedure. To provide 
nutrition we have continued to use the 
gastrostomy instead of parenteral meth­
ods for two reasons: (a) alimental 
nutrition is superior to parenteral nu­
trition, especially in the long term; 
and (b) the gastrostomy may be used 
to produce bowel decompression which 
is advantageous during the immediate 
postoperative period.
Gastrostomy feedings were begun as 
soon as normal peristalsis resumed. On 
the 10th postoperative day, the eso­
phagus was examined roentgenologi- 
cally using barium, and if there was 
no sign of any leak, esophagoscopy 
and dilatation at the anastomotic site 
were performed some time within the 
next 48 hours. A filiform catheter was 
first passed through the anastomosis 
under direct vision and subsequently 
larger catheters were directed along the 
filiform one. Second and occasionally 
third dilatations were done at intervals 
of 7 to 10 days when necessary.
Results
There were 32 survivors. Of these 
10 were in Waterston group A (birth 
weight over 2.5 kg and w ell), 15 were 
in group B (birth weight 1.8 to 2.5 kg 
and well, or higher birth weight but 
moderate pneumonia or minor con­
genital anomaly, or both) and 7 were 
in group C (birth weight under 1.8 kg,
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or higher birth weight with severe 
pneumonia or major anomaly, or 
both). The six fatal cases (16% ), all 
Waterston group C, are briefly de­
scribed below:
Case 1.—This baby who had Di- 
George’s syndrome died of overwhel­
ming infection 64 days after operation. 
No complications of the repair were 
noted at autopsy.
Case 2.—This infant had associated 
coarctation of the aorta, ventricular 
septal defect and a hypoplastic left 
ventricle. He died of cardiac failure 
10 days after surgery. The repair was 
intact at autopsy.
Case 3.—This baby with associated 
Down’s syndrome died from unrecog­
nized duodenal atresia. Again no com­
plications of the repair were noted at 
autopsy.
Case 4.—Ventricular septal defect 
and patent ductus arteriosus were as­
sociated anomalies in this infant who 
died of cardiopulmonary disease at 21 
days. The repair was intact at autopsy.
Case 5.—This 1400-g baby had te­
tralogy of Fallot, severe renal anom­
alies and respiratory distress syndrome. 
Constant respiratory support was re­
quired. A recurrent fistula developed 
before she died.
Case 6.—This postmature infant had 
congenital absence of the right lung, 
hydrocephalus and a single hydrone- 
phrotic kidney. He died immediately 
following a ventriculoperitoneal shunt 
28 days after operation. At autopsy 
the repair was intact.
Complications
In two patients leakage occurred 
at the esophageal anastomosis. In 
the first this was discovered radio- 
logically by means of a barium swal­
low (Fig. 1) and the leak healed spon­
taneously without drainage or in­
tervention. In this baby stenosis de­
veloped later and required a total of 
eight dilatations during the first 5 
months of life; in the subsequent 5 
years he has experienced no difficulty. 
In the second case there was a gross 
disruption of the anastomosis that ne­
cessitated cervical esophagostomy and 
subsequent colon interposition. This 
child is now 5 years old, is small for 
her age and requires soft or blended 
food.
Recurrent fistulas developed in two 
patients. One infant (case 5) died and 
the other suffered from apneic spells 
that required intubation and use of a 
respirator on day 4 after operation. His 
fistula was later repaired successfully. 
This baby is the only one in this series
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with tracheal collapse as recently de­
scribed by Filler, Rossello and Lebo- 
witz.4 A tracheostomy was performed 
and he was successfully extubated at 7 
months of age. He is now well.
Stenosis is a complication more dif­
ficult to define. We believe that 
routine, early dilatations prevent severe 
organized strictures and these should 
be done under general anesthesia by 
the operating surgeon. Stenosis was 
assumed to have occurred in any of 
our patients requiring more than three 
dilatations postoperatively. By this de­
finition there were eight cases of 
stenosis. Only four of these babies re­
quired more than four dilatations, or 
dilatations at an age beyond 3 months. 
None required more than nine dilata­
tions and in all the stenosis was not
FIG. 1—Postoperative roentgenogram 
obtained after barium swallow discloses 
leak at esophageal anastomosis. Arrow 
indicates barium outside esophagus.
evident after the age of 1 year. There 
were no complications resulting from 
this procedure.
Esophageal Function
All babies had roentgenography after 
a barium swallow on the 10th post­
operative day. Abnormal peristalsis in 
the distal esophagus was noted in most 
cases although in two the peristalsis 
was described as normal. None of the 
children had problems with eating or 
swallowing related to these radio- 
logic studies.
Discussion
With modern methods of repair and, 
perhaps more important, supportive 
help, the mortality in esophageal 
atresia associated with tracheoeso­
phageal fistula seems related more to 
severe associated anomalies than to the 
method of repair. Morbidity, however, 
remains a serious problem and may be 
influenced by the methods of repair.
The most serious such complications 
are anastomotic disruption or recur­
rent fistulas. Therefore the method of 
choice must be the one associated with 
the lowest frequency of these com­
plications.
Primary repair should be done on all 
but the most seriously ill infants or 
where the gap between the esophageal 
segments is too wide for safe repair. 
Several of our babies had pneumonia 
but, as Abrahamson and Shandling5 
have indicated, pneumonia and pre­
maturity alone do not contraindicate 
the use of primary one-stage repair.
Empyema is more likely to occur 
when a large leak develops after trans­
pleural repair, but the improved ex­
posure and greater accuracy made pos­
sible by this technique justify the 
risk. Empyema was encountered in 
only one patient during our study 
and probably would have been pre­
vented had a double-layer anastomosis 
been performed. In all cases in which 
tension is present the repair should 
be done in two layers. We used 
this type of anastomosis in the more 
difficult cases and in none did a leak 
later develop. We would further claim 
that stenosis associated with the two- 
layer anastomosis is not a serious 
problem. Where there is a good length 
of esophagus and tension is not a fea­
ture, a one-layer repair results in better 
function.6 Judgement and experience 
are required in selecting the method; 
when there is doubt, two layers should 
be used.
Although the rate of stenosis follow­
ing end-to-end repair was higher than 
that reported in some series of end-to- 
side repair, none of our patients re­
quired reoperation. Early routine
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dilatation of the anastomosis helps to 
prevent serious stenotic problems.
Recurrent fistula was less frequent 
than in other series.7
Conclusion
Transpleural end-to-end repair of 
esophageal atresia is a satisfactory me­
thod of dealing with this condition, its 
results comparing favourably with 
those of the other methods described. 
It has the advantage of allowing ex­
cellent exposure, making it possible to 
evaluate anastomotic tension and per­
mitting improved mobilization of the 
esophagus. Both these features con­
tributed to the low frequency of an­
astomotic complications in our series.
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Gangliocytic Paraganglioma of the Duodenum
G.P. K O N O K , M D , M  SC, F R C S [C ], FA C S* AND G. S a N C H E Z -C a SSIS , M D f
In spite of possessing microscopic 
features of invasiveness, the clinical 
behaviour of duodenal gangliocytic para­
ganglioma is benign. The operation of 
choice for removal of the tumour is 
local excision. This conservative 
approach was used in the case of a 
70-year-old white woman who presented 
with occult gastrointestinal bleeding.
The unusual histologic features of this 
woman's tumour are discussed. Although 
the tumour appears to be aggressive 
no recurrence has been reported to date 
following adequate local excision of a 
duodenal gangliocytic paraganglioma.
En depit du fait qu'il possede les 
caracteristiques microscopiques propres 
aux tumeurs envahissantes, le com- 
portement ciinique du paragangliome 
gangliocytique duodenal s ’avere benin.
L'excision locale est I'operation de choix 
pour I'ablation de cette tumeur. Cette 
demarche conservatrice a ete utilisee 
dans le cas d'une femme de 70 ans, 
de race blanche, presentant un saigne- 
ment intestinal microscopique. Les 
aspects histologiques inhabituels de la 
tumeur retrouvee chez cette femme 
sont discutes. Bien que la tumeur semble 
etre agressive, aucune recidive n’a ete 
signalee jusqu'a maintenant, apres une 
excision locale adequate d'un para­
gangliome gangliocytique duodenal.
In this communication we review the 
North American literature dealing with 
gangliocytic paraganglioma, a rare 
polypoid tumour of the duodenum, 
and describe in detail the clinical and 
pathologic features of a case that oc­
curred in our own practice.
In 1957 Dahl, Waugh and Dahlirr1 
reported on an unusual submucosal 
duodenal tumour found incidentally 
during a laparotomy. They called it a 
ganglioneuroma but noted that in one 
small area of a microscopic section un­
usual gland-like structures were pre­
sent.
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Taylor and Helwig2 in 1962 pub­
lished a collected series of cases of 
similar polypoid lesions of the duo­
denum and called them nonchromaffin 
paragangliomas. They found typical 
ganglioneuromatous elements but, be­
cause of the presence of epithelioid 
cell nests surrounded by a rich net­
work of capillaries (a histologic feature 
usually present only in tumours of 
chemoreceptor organs), they were of 
the opinion that the term “paragangli­
oma” best described these lesions. 
Lukash, Hyams and Nielsen3 in 1966 
reported a single case of a duodenal 
tumour with similar histologic features.
In 1971 Kepes and Zacharias4 de­
scribed such tumours and proposed the 
presently accepted term, gangliocytic 
paraganglioma. Finally, in 1972 Lau- 
zon and Cadotte5 reported a new case, 
increasing to 14 the number of gan­
gliocytic paragangliomas reported in the 
North American literature. To this 
number we add a case of our own.
Case Report
A 70-year-old white woman was hos­
pitalized after a moderately severe cere­
brovascular accident. During the routine 
investigation she was found to have a 
hypochromic, microcytic anemia (hemo­
globin value 10.9 g/dL). Results of the 
guaiac test on the stools were repeatedly 
positive while the patient was on a meat- 
free diet. On sigmoidoscopic examination 
a small villous adenoma was found. A 
biopsy was done and the lesion fulgurated. 
Roentgenograms obtained after a barium 
enema were normal.
Roentgenography of the upper gastro­
intestinal tract revealed a small hiatus 
hernia and a mobile lacunar image meas­
uring 4 X 2.5 cm with an ulcer crater on 
its surface in the third portion of the 
duodenum (Fig. 1). The lesion was diag­
nosed as an ulcerated benign polypoid 
tumour of the submucosa, probably a 
leiomyoma. Cholecystography disclosed a 
solitary calculus in the gallbadder.
Following a routine cholecystectomy, a 
firm polypoid lesion was excised from the 
third portion of the duodenum. The pa­
tient’s postoperative course was uncom­
plicated, her hemoglobin stabilized at 12.9 
g/dL and now, 2Vi years later, she is in 
good health with no evidence of occult 
gastrointestinal bleeding or recurrence of 
her tumour.
On gross examination the lesion was of 
a firm, rubbery cortsistency. It was 
slightly lobulated, yellowish-brown and 
measured 3.5 X 3 X 2 cm. On its smooth 
surface there was a small ulcer crater 
filled with fresh blood clot. Its pedicle 
was covered with apparently normal duo­
denal mucosa at the line of resection 
(Fig. 2).
FIG. 1—Roentgenograms of gastrointestinal tract showing ulcerated polypoid 
lesion in third portion of duodenum.
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To demonstrate the various histologic 
features, a number of different tissue 
stains were used.
In sections stained with hematoxylin 
and eosin the tumour was composed 
largely of medium-sized oval and fusiform 
epithelioid cells arranged mainly in an 
organoid fashion (Fig. 3). Other cells 
formed interlacing ribbons with palisading 
of the nuclei in certain areas. The or­
ganoid nests of epithelioid cells did not 
show the closely associated vascular pat­
tern seen in classic endocrine tumours. In 
addition to the epithelioid cells there was 
a moderate number of large cells with 
abundant, slightly granular cytoplasm and 
a large round nucleus with a prominent 
central nucleolus. In some areas of the 
tumour these ganglion-type cells showed 
a marked tendency to cluster. In other 
areas large neuron-like cells with an oval 
cytoplasm full of basophilic granules 
were observed.
Staining by the Bodian method clearly 
showed large, pale ganglionic cells with 
well-impregnated multibranching den­
drites. Other nerve fibrils were present in 
the fibrovascular supporting stroma, pre­
sumably originating from the epithelioid 
cells (Fig. 4).
When the Fontana stain was used none 
of the tumour cells were shown to contain 
chromaffin material. Reticulum stain and 
Masson’s trichrome stain showed a rich 
network of reticulum and collagen fibres 
surrounding the islands of epithelioid cells. 
In some sections there were ischemic 
changes which in a few areas had already 
progressed to the stage of fibrosis. The 
supporting stroma was diffusely infiltrated 
with eosinophils and lymphocytes. The 
tumour was largely surrounded by a 
pseudocapsule but in some areas the 
tumour cells infiltrated the submucosa 
causing ulceration.
In places the muscularis propria had 
been split into islands by the tumour cells, 
giving the appearance of invasiveness and 
aggressive behaviour (Fig. 5).
Electron-microscopic studies were not 
done.
Discussion
Kepes and Zacharias4 were the first 
to suggest that this tumour, now called 
gangliocytic paraganglioma, occupies a 
special position among the tumours of 
neuroectodermal origin.
In the usual chemodectomas the 
ganglionic elements are extremely rare, 
and to date no ganglioneuromas have 
been reported from the area of the 
carotid bifurcation and the glomus 
jugularis where chemodectomas nor­
mally occur. On the other hand, tu­
mours of neuroblastic and gangliocytic 
origin do not contain epithelioid 
elements.
The mixture of these two elements 
was striking in our own case and we 
agree with Kepes and Zacharias4 that 
the term gangliocytic paraganglioma 
aptly describes the unusual histologic 
features of this lesion.
The gangliocytic elements of this 
tumour probably arise from Meissner’s 
myenteric plexus. The origin of the 
paraganglionic elements remains a 
mystery as they have never been iden­
tified in the normal duodenal wall. We 
may conjecture that the tumour cells 
are more closely related to ganglio- 
neuroblastic than to paraganglionic 
elements and thus the tumour could 
originate entirely from the terminal 
branches of the vagus nerve. Indeed, 
in the mouse, intravagal paragangli­
omas have been described.6 Also the 
distribution of paraganglion cells in 
the human fetus and newborn is much 
more extensive than in the adult.7 This 
may explain the occurrence of para­
gangliomas in residual cell nests, in 
areas where no constant paraganglions 
are found in the adult.
It is interesting to speculate whether
FIG. 2—Intraoperative view of ulcer­
ated pedunculated tumour delivered 
through incision in anterior duodenal wall.
FIG. 3—Organoid pattern of epithelioid 
cells forming main component of tumour 
(hematoxylin and eosin, reduced by 49% 
from X 100).
or not these tumours are secretors. 
Histologic and histochemical examina­
tions have not provided us with a 
definite answer. Kepes and Zacharias4 
did report on the ultrastructure of 
these tumours. Electron microscopy 
showed that all cells had essentially 
similar features. In the cytoplasm there 
were fibrillary structures with the ap­
pearance of neurofibrils. A notable 
finding was the presence of granules 
with a prominent dark centre and a
FIG. 4— Numerous ganglion cells with 
multibranching dendrites (Bodian stain, 
reduced by 49% from X400).
FIG. 5—Tumour cells splitting mus­
cularis propria, giving appearance of 
aggressive behaviour (hematoxylin and 
eosin, reduced by 49% from X63).
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membranous envelope. The authors 
believed that these granules were 
morphologically identical with the cate­
cholamine storage granules observed in 
paragangliomas and in some ganglio­
neuromas.3
The tumour is most commonly 
found in the second portion of the 
duodenum; two have been described as 
originating from the fourth portion 
while the one we report was removed 
from the third portion of the duo­
denum. These polypoid lesions are 
usually small, rarely causing duodenal 
obstruction. As in most of the cases 
reported the presenting symptom in 
our patient was an iron deficiency 
anemia caused by chronic blood loss
from the ulcerated surface of the 
lesion. Radiologically these tumours 
are usually diagnosed as leiomyomas 
or lipomas and only upon microscopic 
examination can the correct diagnosis 
be established.
In spite of the microscopic appear­
ance of invasion and aggressiveness, 
the tumours are benign and to  date no 
recurrence has been reported following 
adequate local excision.
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Nontraumatic Hemobilia: Disparate Episodes 
7 Years Apart in the Same Patient
R .T . L ew is , m b , m sc , frcs[c], fa c s*
A case is reported of nontraumatic 
hemobilia, which occurred twice in the 
same patient. Initially it was due to 
carcinoma of the gallbladder and 7 years 
later it was due to a ruptured intra- 
hepatic aneurysm. The management of 
these two conditions is reviewed. The 
clinical marker of nontraumatic hemobilia 
originating in the gallbladder is the 
hemocholecyst and the treatment is 
cholecystectomy. Ruptured intrahepatic 
aneurysm can be diagnosed only by 
angiography. Cholangiography is indicated 
to rule out pathologic conditions of the 
ducts. In the absence of hepatobiliary 
sepsis selective hepatic artery ligation 
is the preferred treatment, otherwise 
hepatic resection is required.
On sigrtale un cas d'hemobilie non 
traumatique survenu a deux reprises 
chez un meme patient. Initialement, 
I'hemobilie etait due a un carcinome 
de la vesicule biliaire et, 7 ans plus tard, 
elle fut causee par la rupture d’un
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anevrisme intrahepatique. L'indicateur 
clinique de I'hemobilie non traumatique 
prenant son origine dans la vesicule 
biliaire est I’hemocholecyste; on la traite 
par la cholecystectomie. Un anevrisme 
intrahepatique rupture ne peut etre 
diagnostique qu’a 1'angiographie. La 
cholangiographie est indiquee afin 
d'eliminer les pathologies des canaux.
En (’absence d’une sepsie hepatobiliaire, 
une ligature selective de I'artere 
hepatique constitue le traitement de 
choix; autrement, une resection 
hepatique s’impose.
Hepatic trauma accounts for most cases 
of hemobilia.1 Of nontraumatic c uoCS, 
vascular disorders and tumours are the 
least common. The case of a patient 
who was found to have hemobilia due 
to gallbladder carcinoma and, 7 years 
later, the same condition due to intra­
hepatic artery aneurysm is reported and 
the management of the problem is 
reviewed.
Case Report
An 82-year-old white woman was ad­
mitted to the Queen Elizabeth Hospital of 
Montreal Centre in 1969 with a history 
of crampy postprandial pain in the right 
upper abdominal quadrant of 2 years’ 
duration and a sudden severe exacerbation 
of colic on the day of admission. The 
gallbladder was palpable and tender. The 
hemoglobin concentration was 13 g/dL,
hematocrit 38% and leukocyte count 9.2 
X 109/L. At emergency abdominal ex­
ploration a tense hemocholecyst with 
hemobilia and a widely dilated common 
bile duct also containing blood were 
found. Cholecystectomy and choledocho- 
duodenostomy were performed. The tissue 
specimen showed a bleeding papillary 
carcinoma of the gallbladder invading the 
muscularis but not penetrating to the 
serosa. No gallstones were present. Tran­
sient jaundice developed postoperatively 
but the patient made a good recovery.
She was readmitted in 1976 with a 
3-year history of epigastric pain and, on 
the day before admission, coffee-grounds 
hematemesis and liquid melena. The 
hemoglobin value was 13.6 g/dL; the con­
centration of serum bilirubin was normal 
and of alkaline phosphatase 14 King- 
Armstrong units/dL. Emergency roent­
genography after a barium meal showed 
no potential source of bleeding and there 
was free reflux of barium and air into the 
biliary tree through the choledochoduo- 
denostomy. Two days after admission the 
hemoglobin value had fallen to 9.7 g/dL, 
but by the fourth day the stools were 
normal and her hemoglobin was stable.
One week after admission she vomited 
800 mL of bright red blood. Endoscopy 
performed afterwards suggested the pre­
sence of a large duodenal ulcer. However, 
at operation only a small posterior duo­
denal erosion and the intact choledocho- 
duodenal stoma were found. Vagotomy 
and pyloroplasty was performed. Further 
hemorrhage occurred on postoperative 
days 7 and 10. As the patient was now 
suffering from sepsis and pancytopenia,
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treatment with gentamicin and cloxacillin 
was started. Celiac axis arteriography re­
vealed a bleeding aneurysm of the left he­
patic artery within the substance of the 
liver. At reoperation the left hepatic artery 
was ligated and the bleeding controlled. 
Postoperatively progressive respiratory fail­
ure developed, with liver failure and 
coma. On the fourth postoperative day 
her serum bilirubin concentration was 
10.5 mg/dL (180 u.mol/L) total, 6.76 
mg/dL (116 ijjnol/L) direct; the concen­
tration of serum glutamic pyruvic trans­
aminase (SGPT) was 129 IU/L and the 
concentration of serum glutamic oxalo­
acetic transaminase (SCOT) was 124 
IU/L; 2 weeks later the serum bilirubin 
value had risen to 31.5 mg/dL (539 
p.mol/L) total and 18.3 mg/dL (313 
amol/L) direct; the concentration of al­
kaline phosphatase was 19.6 King-Arm- 
strong units/dL, of SGPT 49 IU/L, of 
SGOT 40 IU/L and of lactic dehydro­
genase 225 IU/L. Despite heroic therapy 
the patient did not recover.
At autopsy bilateral bronchopneumonia 
was present, as well as obstructive chol­
angitis and small abscesses in the left 
lateral lobe of the liver related to two 
calculi in the left intrahepatic duct. There 
was no communication between the left 
hepatic artery aneurysm and the liver 
abscesses, nor was there any blood clot 
within the abscesses.
Discussion
Hemobilia is an uncommon cause of 
upper gastrointestinal bleeding, and 
nontraumatic hemobilia is quite rare. 
On two occasions, 7 years apart, our 
patient presented with disparate and 
uncommon causes of nontraumatic 
hemobilia —  on the first occasion with 
gallbladder tumour and on the second 
with intrahepatic aneurysm. Because 
they are rare, these conditions are 
seldom considered in the differential 
diagnosis of gastrointestinal bleeding. 
One may stumble upon the diagnosis 
at operation, as we did at this patient’s 
first presentation, or be led to the 
correct diagnosis after one or more 
irrelevant operations, as in her second 
admission. But the initial presentation 
with hemocholecyst is typical of a gall­
bladder cause of hemobilia; the sub­
sequent repeated abrupt episodes of 
bleeding with disproportionately severe 
collapse strongly suggest a vascular 
cause of hemobilia. The patient had no 
obstructive jaundice then because of 
her widely patent choledochoduodeno- 
stomy, and this undoubtedly contri­
buted to the delay in diagnosis.
A hemocholecyst is defined as 
hemorrhage from the gallbladder that 
is not traumatic in origin and has not 
resulted from intraperitoneal rupture 
of the gallbladder.2 The diagnosis is 
rarely made preoperatively in the ab­
sence of gastrointestinal bleeding, but 
should be suspected when hematemesis 
or melena is accompanied by biliary
colic and a palpable tender mass in the 
right upper abdominal quadrant. A 
gallbladder distended by blood may be 
found with hemobilia from any cause 
when the gallbladder is present,3 but it 
is particularly characteristic of hemo­
bilia when the gallbladder is the source 
of bleeding. Hemocholecyst in non­
traumatic hemobilia is important be­
cause of the risk of spontaneous rup­
ture of the gallbladder, which is often 
fatal.4 Moreover, once the condition is 
recognized its many causes may be 
sought, identified and treated appro­
priately. The various causes of hemo­
cholecyst are listed in Table I.5'14 Most 
hemocholecysts are due to gallstones 
and inflammation, but vascular abnor­
malities are the second most frequent 
cause and tumours the third. Table II 
lists the reports of hemobilia due to 
malignant gallbladder tumours found 
in a review of the literature to 
date.10,15"19 The cases cited are those in 
which bleeding was accompanied by 
hematemesis or melena rather than the 
mere demonstration of occult blood in 
the stool.
Aneurysms of the hepatic artery are 
uncommon. Extrahepatic aneurysms of 
the hepatic artery occur four times as 
often as intrahepatic aneurysms and 
usually present with intraperitoneal 
rupture.20 In the past, intrahepatic 
aneurysms of the hepatic artery were 
found only at autopsy. Today the 
diagnosis of ruptured intrahepatic 
artery aneurysm can be confirmed ante 
mortem by angiography. I could find 
only six reports of intrahepatic aneu­
rysm producing hemobilia diagnosed 
by angiography before operation.21'26 
Three others were diagnosed by oper­
ative arteriography.27"29 Hence this 
paper reports the 10th such case in the 
literature, but in three of these22*28'29 
the patient presented with pain rather 
than upper gastrointestinal bleeding; 
one30 was only partially intrahepatic 
and was suspected at operation when 
a hematoma was seen in the hilum of 
the liver. Table III details the findings 
and treatment of these cases.
The etiology of hepatic artery aneu­
rysms is uncertain, but infection, local 
or systemic, seems to be the most 
frequent cause, with arteriosclerosis a 
close second. Intrahepatic aneurysms 
have been associated with a variety of 
inflammatory disorders of the liver — 
inflammation of the biliary system,21 
arteritis,22 subacute bacterial endocar­
ditis with mycotic infection14 and sys­
temic infection.1
The treatment of hemobilia due to 
hemorrhage from a gallbladder tumour 
is cholecystectomy. As in the present 
case, biliary drainage and decompres­
sion by choledochoduodenostomy may 
be added if there is marked dilatation
of the common bile duct. The specimen 
should be examined in the operating 
room to identify the cause of the hemo­
cholecyst, for the finding of carcinoma 
of the gallbladder calls for more pre­
cise staging of the disease and may 
indicate further therapy.30
Little information is available on the 
appropriate treatment of intrahepatic 
aneurysms with hemobilia, but hepatic 
artery ligation and hepatic resection 
have been employed. Nonoperative 
therapy alone has no place. It is im­
portant to note that the wide range of 
surgical procedures applied to the 
treatment of extrahepatic and hilar 
aneurysms20 — aneurysmectomy with 
or without grafting, endoaneurysmor- 
rhaphy, wrapping or wiring — cannot 
be used for intrahepatic aneurysms.
Hepatic artery ligation is quick and 
effective in the treatment of arterial 
bleeding from the liver. The rebleeding 
rate of 23% noted by McGehee and 
associates31 has not been observed by 
Mays,32 the principal proponent of this 
form of therapy. Mays, however, ad­
vocates ligation as close to the liver 
as possible to avoid a high collateral 
flow. Markowitz and Rappaport33 have 
shown that the hepatic necrosis due to 
sepsis following ligation of the hepatic 
artery in dogs, cats and rabbits is not 
found in humans, since portal bactere­
mia, which is normal in these animals, 
is absent in man. The progressive septic 
hepatic necrosis that followed hepatic 
artery ligation in our patient who had 
pre-existing bile stasis within the af-
Table I— Classification of Hemocholecysts 
by Cause
Calculous6
Vascular
Ruptured aneurysm6 
Hypertension and apoplexy7 
Embolic infarction8 
Tumorous 
Benign9 
M alignant10'11 
Ulcerative  
Peptic12 
Idiopathic6 
Drug-induced 
Steroid13 
Anticoagulant14 
Cryptogenic6
Table II— Hemocholecyst and Hemobilia due 
to Malignant Lesions of the Gallbladder
Author Year Tumour
Strauss15 1929 Carcinoma
Hudson and Johnson10 1946 Sarcoma
Morice and Bezard16 1961 Epithelioma
P etrin 17 1966 Carcinoma
Patel and Robin18 1968 Carcinoma
Faure, Maupin and 
B arbier19 1969 Carcinoma
Present report Carcinoma
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Table I I I—Ruptured Intrahepatic Aneurysms Diagnosed by Angiography
Author Year
Age,
yr Symptoms Site Etiology
Irrelevant
operations Treatment Fate
Mackay and Page27 1959 29 Rec. Gl bleeding, 
abdominal pain
Right Unknown 2 Hepatic artery 
ligation
S
Caroli, Paraf and Chevrel28 1963 50 Abdominal pain Left Congenital defect 0 Hepatic artery 
ligation
S
Cohen, Chow and Seah21 1966 19 Rec. Gl bleeding, 
abdominal pain
Right Infection 1 Hepatic wedge 
resection
S
Ranniger and associates23 1967 60 Rec. Gl bleeding Right Mycosis 3 None D
Weaver, Fleming and Barnes22 1968 58 Abdominal pain, 
anemia
Left Arteritis 0 Hepatic lobectomy D
5 mo postop
Winchester and associates29 1970 37 Abdominal pain Right ? previous operative 
accident
0 Hepatic wedge 
resection
S
Gupta and Cope24 1972 30 Rec. Gl bleeding, 
abdominal pain
Right Mycosis 0 Hepatic artery 
ligation
D
1 yr postop
Berenson and Freston25 1974 51 Rec. Gl bleeding Left Unknown 0 Hepatic artery 
ligation 
Hepatic artery 
ligation
S
Thorlakson26 1976 38 Rec. Gl bleeding, 
abdominal pain
Right Remote needle 
biopsy
1 S
Present report 82 Rec. Gl bleeding, 
abdominal pain
Left Infection 1 Hepatic artery 
ligation
D
Rec. =  recurrent, Gl =  gastrointestinal, S =  survived, D =  died.
fected hepatic lobe may, however, re­
present an interesting clinical simulation 
of the experimental findings of Mar­
kowitz and Rappaport. Table III shows 
the suspected cause and the treatment 
applied in, the cases collected from the 
literature. It is notable that the pa­
tients treated successfully by hepatic 
artery ligation had no evidence of 
sepsis at the time. The admonition of 
Caroli, Paraf and Chevrel28 that chol­
angiography be performed in all pa­
tients with hemobilia to exclude prim­
ary intraductal disease may be helpful 
in excluding hepatobiliary sepsis.
The alternative to hepatic artery 
ligation is hepatic resection. Cohen, 
Chow and Seah21 reported the case of 
a 19-year-old man with an intrahepatic 
aneurysm, which was diagnosed pre- 
operatively and treated successfully by 
partial hepatic resection. Since the 
cause of intrahepatic aneurysm is often 
an infective one, they favour hepatic 
resection over hepatic artery ligation. 
However, as major hepatic resection 
carries significant morbidity and mor­
tality, it should only be performed if 
no simpler treatment is available. It 
seems likely, therefore, that where 
there is no clinical or operative evi­
dence of hepatobiliary sepsis, hepatic 
artery ligation is safe and is the pre­
ferred procedure.
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Methylmethacrylate as an Adjunct in the Internal 
Fixation of Pathologic Fractures
Joseph Schatzker, mb, b sc(med), frcs[c]* and G.B. Ha’E ri, md |
The authors evaluated methylmetha­
crylate as an adjunct to internal fixation 
of 47 pathologic fractures of long 
bones (10 of the humerus and 37 
of the femur) in 43 patients with 
metastatic disease. In their experience 
this method proved to be vastly 
superior to other methods of internal 
fixation. All patients were relieved 
of pain and, if able to walk, could 
do so almost immediately after fixa­
tion of the fracture. In the others 
comfort was enhanced and nursing 
greatly facilitated. The surgical 
technique of internal fixation is des­
cribed in detail. Correct selection of 
the metal implant, meticulous attention 
to the biomechanical considerations 
and restoration of bone continuity by 
means of methylmethacrylate are 
most important if a gratifying result 
is to be obtained.
Les auteurs ont evalue le methylmetha­
crylate utilise comme appoint therapeu- 
tique dans la fixation interne de 47 
fractures pathologiques des os longs 
(10 de I'humerus et 37 du femur) chez 
43 patients atteints de metastases.
Selon leur experience, cette methode 
s'est averee grandement superieure aux 
autres methodes de fixation interne. 
Tous les patients ont vu leur douleur 
soulagee et, lorsqu'ils etaient en etat de 
marcher, ils pouvaient le faire presque 
immediatement apres la fixation de la 
fracture. Chez les autres, le confort 
etait augmente et les soins infirmiers 
considerablement facilites. La technique 
chirurgicale de fixation interne est 
decrite en detail. La selection judicieuse 
de I'implant metallique, I’attention 
meticuleuse portee aux considerations 
biomecaniques et I'utilisation du methyl­
methacrylate pour la restauration de
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la continuity osseuse s’averent de la 
plus grande importance si Ton veut 
obtenir des resultats satisfaisants.
The surgeon’s aim in treating a pathol­ogic fracture due to metastatic disease 
should be the prompt return of the extremity to full function. To achieve this a method of stabilization must 
be used that not only is sufficiently 
rigid to relieve all pain, but also is 
sufficiently strong to enable the bone to withstand the forces of unprotected weight bearing without breaking down. 
Such stabilization is possible if con­ventional methods of internal fixation 
are combined with the use of methyl­
methacrylate.A pathologic fracture does not lend itself well to the conventional methods of fracture care. Nonoperative treat­ment rarely succeeds; the patient often continues to have pain and the fracture fails to unite. Conventional methods of internal fixation are unsuccessful for several reasons. The tumour destroys bone with resultant bone loss. The 
lesions may be multiple. The bone often becomes osteoporotic. Fixation may be difficult to accomplish and if it is obtained it is rarely rigid and 
is usually very tenuous. Use of the extremity must be prevented while ir­radiation is carried out in the hope of suppressing the tumour sufficiently to permit reossification with union of the 
fracture. The high failure rate of this 
standard approach to the pathologic fracture, along with the failure to return the patient rapidly to full func­tion makes this method of management 
unacceptable.Scheuba1 in 1968 reported on 
the use of methylmethacrylate as an adjunct in the internal fixation of pathologic fractures. The experiences of others2-4 in recent years have con­firmed the advantage of this method over conventional internal fixation. The initial concern that nonunion would result from the presence of the cement has been shown to be unfounded. Charnley and associates,5,6 Harrington and associates2*3 and Schatzker and Lambert7 have shown that union will occur as long as the cement is not interposed between bone fragments. 
Union of pathologic fractures is of little concern, for the patients often
rapidly succumb to their disease. It is important that the fixation should last and permit function for whatever 
length of time may be required.
Patients
Forty-three patients with 44 actual and 3 impending pathologic fractures 
of long bones due to metastatic di­sease were treated at the Wellesley Hospital, Toronto, between Sept. 1, 
1968 and Aug. 31, 1976. Cases of primary bone tumour and fracture treated by arthroplasty were not in­cluded. Each patient was referred to 
us by an oncologist and radiotherapist. There were 4 men and 39 women. The women ranged in age from 42 to 83 
years (average 60 years) and the men from 64 to 82 years (average 73 years). 
Metastases from breast carcinoma were by far the commonest cause of pathologic fractures (Table I).The anatomic distribution of the fractures and the various methods of internal fixation used are listed in Table II. The humerus and femur were the only bones treated in this series.
Results
Two patients were still alive at the 
time of this review; the other 41 had died. Death occurred from 2 days to 
2 years following surgery (average sur­vival 5 months). There were no intra­
operative deaths. Two deaths occurred within the first week after operation. One was due to pulmonary embolism 
and the second to myocardial infarc­tion. The remaining 39 patients suc­cumbed from dissemination of their 
neoplastic process. Eight died within
Table 1—Primary Malignant Conditions from 
Which Pathologic Fractures Resulted
Primary disease No. of patients
Breast carcinoma 28
Lung carcinoma 5
Prostatic carcinoma 1
Renal carcinoma 2
Malignant lymphoma 2
Malignant melanoma 2
Unknown origin 3
Total 43
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Table I I— Distribution of Fractures and Methods of Fixation
Means of fixation
D istribution No. of fractures (no. of fractures)
Humerus
Diaphysis
Femur
10 A0 plate (7 ), Rush pin (3)
Base of neck 2 130° AO blade plate (1 ), Jewett nail 
plate (1 )
Intertrochanteric 11 130° AO blade plate (5), 95° A 0 con­
dylar plate (3), Jewett nail plate (3)
Subtrochanteric 7 95° AO condylar plate (3), 130° AO 
blade plate (1), Jewett nail plate (2), 
Zickle nail (1 )
Proximal and middle one thirds 10 AO intram edullary nail (10)
Distal third and supracondylar area 7 95° AO condylar plate (6), 2 straight 
AO plates (1)
AO =  Association for Osteosynthesis.
the first month and by 3 months 28 
had died.
The results were graded as poor, 
fair or good. If pain persisted at the 
same level after operation, or if the 
walking ability and limb function prior 
to fracture were not regained, the 
result was considered as poor. Reduc­
tion of pain and functional improve­
ment constituted a fair result. Complete 
relief of pain and restoration of limb 
function to what it had been before 
the fracture occurred was termed a 
good result. Of the nine actual fractures 
and one impending fracture of the 
humerus, the result was good in nine. 
In one man who previously had re­
ceived irradiation to the humerus for 
metastatic bronchogenic carcinoma, 
radial nerve palsy and loss of fixation 
developed postoperatively; 2 weeks 
following surgery his recovery was 
complicated by infection and break­
down of the wound due to Staphylococ­
cus aureus infection. The infection 
persisted despite antibiotic therapy 
until he died 2 months later. He never 
regained useful function of the limb 
so the result was rated as poor.
Two impending and 35 actual 
pathologic fractures of the femur at 
various anatomic sites were treated by 
operation. The results were rated as 
good in 30 and fair in 6. Pain was 
relieved in all patients. Of the 32 
patients who were able to walk before 
incurring their fracture, 30 walked 
postoperatively, although 15 of them 
required some walking aid such as a 
cane, crutch or walker. Difficulty in 
walking was often due to debility rather 
than to weakness of the extremity. 
Seven patients were confined to a 
wheelchair or bed; five of them were 
so confined before surgery because of 
their disease. Fixation was lost in 
only one patient, a 50-year-old woman 
with disseminated metastatic carcinoma 
of the breast who had a basal neck 
fracture. The fracture was stabilized 
with a 130° AO (Association for Oste­
osynthesis) blade plate in combination 
with methylmethacrylate cement. The 
postoperative course was smooth and 
she enjoyed early pain-free walking. At 
3 months she once again had pain 
about the hip and roentgenograms 
showed that the blade plate had 
migrated anterosuperiorly through a 
new pathologic fracture and caused 
displacement. This new pathologic 
fracture occurred as a result of local 
extension of her disease.
Technique
Our method evolved as we gained 
experience with this technique of in­
ternal fixation. Initially, after exposure 
of the pathologic fracture, we endeav­
oured to remove the tumour mass be­
fore reduction and internal fixation. 
We have learned that this is wrong; 
it is best to reduce the fracture and 
secure provisional fixation before at­
tacking the tumour mass.
Upon surgical exposure pathologic 
fractures may sometimes be associated 
with brisk bleeding from the tumour 
and such bleeding may be difficult to 
control. Therefore blood for adequate 
replacement must be available. Standard 
surgical exposures have been used 
without modification. If there has been 
segmental loss of bone, no attempt 
should be made to restore length un­
less the loss is very great. In planning 
the internal fixation one must pay 
close attention to biomechanical prin­
ciples.
Fixation must be adequate in both 
the proximal and distal fragments. A 
plate must not end abruptly at a 
metastasis or the bone will fracture 
again. The cement should not be carried 
to the end of the plate; rather the 
plate should protrude beyond the in­
tramedullary mass of cement at least 
the distance included between two or 
three screws. Two or preferably three 
screws should provide fixation through 
the cement mass on each side of the
line of fracture. If an angled blade 
plate device is used, such as the 130° 
blade plate, a condylar blade plate, a 
Jewett nail plate or the Richards screw, 
then the cement should extend not 
only down the medullary canal but also 
up into the neck and should surround 
the device on the cephalad aspect 
to prevent the device from cutting out 
of the bone.
Once the fixation device is selected 
we have found it best to secure provi­
sional fixation of the fracture by at­
tachment of the device proximally and 
distally, as in the case of a straight 
plate, with one or twd screws. With 
an oscillating saw the anterior cortex 
of the bone is then fenestrated by 
cutting a trough usually 1 cm wide 
and of sufficient length to extend over 
the tumour and adjacent normal bone 
to permit filling with cement. Through 
this fenestration the tumour is easily 
removed by suction and curettage. No 
attempt is made to extirpate the whole 
tumour mass, only what is present be­
tween the bone fragments and any 
extensions into the medulla. Often a 
cuff of tumour extends into the soft 
tissues; this is usually best left behind.
We have found that by first re­
ducing the fracture and obtaining 
provisional fixation we have been able 
to proceed with much greater accuracy 
and speed and with fewer complica­
tions. The definitive fixation can be 
more carefully planned, removal of 
the tumour is simpler and the re­
duction is much easier.
Once all the tumour is evacuated 
the remaining screw holes are drilled, 
the screw length is measured and the 
screws are inserted so as to tap the 
prepared holes. The methylmetha­
crylate powder is carefully mixed with 
barium sulfate and then with the fluid 
monomer. As soon as a homogeneous 
mass results which is still wet and 
sticky and flowing, it is rapidly in­
serted into the cavity prepared in the 
bone. Great care is taken to make 
certain that the cement is packed prox­
imally and distally into the medullary 
canal to fill the space left by the 
evacuation of the tumour. If a power 
drill is at one’s disposal, such as the 
AO air drill, the screws can be rapidly 
inserted through the wet cement into 
the pretapped holes long before the 
cement polymerizes. The polymerization 
of cement about the screws in situ 
results in the best fixation. As the 
cement sets, digital pressure is used 
to keep it in place. Once the cement 
polymerizes the screws are checked for 
tightness and fixation is then com­
plete. If a longer setting time for the 
cement is required, this can be provided 
by cooling both the powder and liquid 
in a deep-freeze for half an hour before
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surgery. This at least doubles the set­
ting time. A power drill should be 
available in case the cement should 
polymerize before the screws can be 
inserted. Cement can be power tapped, 
but only if one has a power drill 
with instant reverse, such as the small 
AO air drill. If this is not available 
the cement must be tapped by hand. 
Hand drilling, however, is extremely 
laborious and time-consuming and 
should be avoided. Although the hold­
ing power of the screws is somewhat 
reduced if the cement is drilled and
FIG. 1—Multiple metastatic deposits 
in humerus. Pathologic fracture is stab­
ilized by broad AO (Association for 
Osteosynthesis) plate in combination with 
methylmethacrylate cement.
tapped after it has polymerized, this is 
of no practical importance. No attempt 
has been made to cool even a very 
large mass of cement during its poly­
merization. Any thermal necrosis 
caused by the heat of polymerization 
may be considered as beneficial.
Modifications
Certain modifications based on re­
gional considerations are worthy of 
mention. For fractures of the humerus 
we used plating as described above in 
seven cases and found it most ef­
fective (Fig. 1). We employed Henry’s 
anterior approach8 to the humerus and
FIG. 2—Rush rod used in prophylactic 
fixation of humerus.
FIG. 3—Intertrochanteric fracture without displacement. Note screw in calcar.
anterolateral placement of the plate. 
In two cases of actual fracture and in 
one impending fracture we used Rush 
rods. They are indicated for multiple 
lesions or lesions in the mid-shaft area 
but not where there has been loss of 
segmental bone. In our opinion their 
main use is as a prophylactic measure 
(Fig. 2).
Subcapital fractures of the femur 
are best treated by endoprosthetic re­
placement. Pathologic fractures in the 
intertrochanteric area may be ade­
quately stabilized with either the 130° 
AO blade plate, a Jewett blade plate 
or a Richards screw or condylar blade 
plate. Our preference is the condylar 
blade plate (Fig. 3). It permits the 
insertion of one or two screws into 
the calcar greatly enhancing the fixa­
tion of the device in the proximal 
fragment. Great care must be taken 
to extend the cement well into the 
neck and, if possible, cephalad to the 
blade as well as down the femoral 
shaft. The reconstitution with cement 
of any defect medially and posteriorly 
is most important, as this portion of 
the femur comes under the greatest 
compressive stress when loaded axially. 
Too little cement will fail to buttress 
the implant and the bone and direct 
transmission of forces to the metal 
implant will result. This will lead to 
failure of the fixation under repeated 
loading. The cement within the me­
dullary canal should stop at least two 
screws short of the tip of the plate 
(Fig. 4) in order to prevent the sudden 
concentration of stress that occurs at 
the junction of the rigid segment bear­
ing both the plate and cement and
FIG. 4— Subtrochanteric fracture stab­
ilized by AO 95° condylar blade plate. 
Note screw through calcar enhancing 
fixation of plate in proximal fragment.
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the more viscoelastic bone without the 
implant. This necessitates use of a 
longer plate in treating pathologic 
fractures than the recommended number 
of screws to grip seven cortices in the 
femur on each side of the fracture.
For subtrochanteric fractures we 
have used either the condylar blade 
plate or the 130° AO blade plate 
(Figs. 4 and 5).
The ideal method of internal fixa­
tion for fractures at the junction of
Fig. 5a
FIG. 5— Low subtrochanteric fracture
(a) stabilized by 130° AO blade plate
(b) . Length of proximal fragment permitted 
insertion of screws above fracture. If frag­
ments short, condylar plate should be 
used (see Fig. 4).
the proximal and middle one thirds 
and in the middle one third of the 
femur is with intramedullary nails. The 
nail provides poor fixation for fractures 
in the proximal one third of the femur 
unless cement is used, when very satis­
factory fixation of the proximal frag­
ment is achieved. We used the open 
nailing technique in all cases. The 
fracture is first exposed and then a 
guide wire is inserted in an antegrade 
manner through the greater trochanter 
until it appears at the fracture site. 
After removal of the tumour the femur 
is aligned and the guide wire is passed 
into the distal fragment. Reduction is 
maintained provisionally with a plate 
and bone-holding clamps and the posi­
tion of the guide wire in the distal 
fragment is checked radiologically. 
Reaming is next performed to a size 
larger than that for nonpathologic 
fracture, the aim being usually to in­
troduce at least a 16-mm nail. Two lots 
of cement are prepared and injected as 
soon as possible by means of cement 
syringes into the proximal and distal 
fragments. To accomplish this the re­
duction has to be lost but often the 
guide wire can be left in place. Speed 
is essential. For intramedullary nailing 
we have found it most helpful to 
retard the setting of the cement by 
cooling. Once the cement is in place 
the fracture is again reduced, reduction
FIG. 6— Large AO intramedullary nail 
used to stabilize this extensive metastatic 
deposit with fracture through middle one 8. 
third of femur.
is maintained provisionally by the plate 
and the nail is then inserted. The 
cement has a great tendency to ooze 
out at the fracture site; it should be 
pushed back and held in by finger 
pressure. Although the volume of 
cement used in some of our cases was 
large (Fig. 6), the patients did not 
suffer hypotensive episodes and the 
heat generated did not appear to cause 
any ill effects.
Fractures in the supracondylar area 
of the femur are best stabilized with 
the condylar blade plate. The technique 
and considerations are identical to those 
obtaining in the subtrochanteric area.
The problem of segmental bone loss 
and discrepancy in leg length may 
theoretically be overcome by the use 
of two plates applied at right angles 
to each other together with cement. 
However, it is our opinion that it is 
better to sacrifice length for stability.
Following internal fixation and 
wound healing, most fractures are ir­
radiated to control the tumour remain­
ing in the soft tissues.
Fracture healing is affected by 
previous irradiation, by the presence 
of tumour mass and, unquestionably, 
by the large mass of cement between 
the fracture fragments. The number 
of patients who survive for any length 
of time is small. In our series there 
was a 65% mortality at 3 months 
so that healing of the fracture is of 
little importance. Like others we have 
found that the adjunctive use of methyl­
methacrylate has given us stable and 
reliable rigid fixation which has pro­
vided almost immediate return of 
function, a most desirable result in the 
terminally ill patient.
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HISTORY OF MEDICINE
Early Medicine and Surgery in New Brunswick
W .B. Stewart, md, frcp[c]
The author discusses some of the major 
events in medicine and surgery in 
New Brunswick prior to 1900. The 
influences of Indian medicine, of early 
French and Acadian surgeons, of the 
British colonial surgeons at the siege of 
Fort Beausejour, of the pre-Loyalist and 
Loyalist surgeons all led up to the 
building of marine hospitals and 
quarantine stations. The introduction 
of anesthesia with ether and chloroform 
hastened progress towards “modern 
surgery” which was carried out in the 
many general hospitals that were built 
follc./ing the opening, in 1865, of 
New Brunswick's first general hospital, 
the General Public Hospital (now the 
Saint John General Hospital).
L’auteur presente quelques-uns des eve- 
nements majeurs, en medecine et en 
chirurgie, survenus au Nouveau- 
Brunswick avant 1900. Les influences de 
la medecine indienne, des premiers 
chirurgiens francais et acadiens, des 
chirurgiens coloniaux britanniques lors 
du siege de Fort Beausejour, des chirur­
giens des epoques pre-loyaliste et 
loyaliste, toutes contribuerent a la 
construction d’hopitaux de la marine et 
de postes de quarantaine. L'introduction 
de I'anesthesie a I'ether et au chloro- 
forme a hate I’arrivee de la “chirurgie 
moderne” qui fut pratiquee dans la 
plupart des hopitaux generaux qui furent 
construits apres I'ouverture, en 1865, 
du premier hopital general du Nouveau- 
Brunswick, le General Public Hospital 
(aujourd'hui, le Saint John General 
Hospital).
When the white man came to Canada, 
about 200 000 native Indians were 
scattered over the lonely wilderness of 
mountains, valleys, forests, plains and 
rivers that have shaped Canadian his­
tory. Of these Indians some 4000 were 
nomadic Micmacs who lived along the 
coast of New Brunswick and the other
Reprint requests to: Dr. W.B. Stewart,
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Maritime provinces, and about 5000 
were Maliseets who inhabited inland 
areas near the rivers.1
The Europeans regarded the natives 
as ignorant savages. Nothing could be 
further from the truth; their treatment 
o f children was centuries ahead o f that 
o f the French and English and, as 
Champlain2 noted, they spurned cor­
poral punishment. Their medical 
methods were interesting and in some 
cases very effective. Indian methods 
and those o f the early European set­
tlers formed a primitive basis for the 
development o f medicine and surgery 
in New Brunswick.
Native Medicine
Medicine among the Indians had two 
aspects, the magical and the practical.1 
The Indians believed that unnatural 
evil influences caused many illnesses 
and that a human enemy with magical 
powers could inject an object or spirit 
into a person to cause disease. A  ma­
levolent spirit might assume the form 
o f a wild w olf or bear and attack 
its victim.
Some o f the Indians’ beliefs were 
rational. They believed dancing pre­
served health. They massaged their skin 
with seal oil to prevent mosquito bites 
and to help them withstand heat or 
cold.1 Scurvy in the winter was pre­
vented or cured by a decoction or tea 
made o f “ Annedda” , spruce or hem­
lock twigs and bark. (The natives told 
Jacques Cartier o f this remedy in 1535 
but the information did not spread 
through France and England for many 
years.1) The Indians constructed a 
sweat bath, made o f bark or skins, to 
treat a fever. Hot stones were placed 
inside the bath to make the ill person 
sweat. Attendants threw water on the 
hot stones to produce steam and a hot 
rain that fell on the patient. After the 
bath the patient plunged into a lake 
or river to cool himself.
The medicine man o f a tribe was 
second only to the chief. He wielded 
great psychologic power that might 
destroy the authority of a chief or
determine the course o f war or peace. 
He might be murdered if this magic 
failed or if he lost an important patient.
Practical measures o f treatment 
were often carried out by lesser 
shamans or herbalists and by the 
women. Dislocations were reduced by 
a strong rotary force; fractures were 
splinted. Soft tissue injuries were treated 
with bark or reeds padded with leaves, 
grass or moss and fastened by band­
ages. The Indians used flint knives to 
perform amputations o f fingers and 
toes at the joints and cauterized bleed­
ing vessels with red-hot stones. They 
closed incised wounds with sutures 
made o f the inner bark o f trees or the 
tendons o f  the deer. Sometimes they 
treated wounds by placing a slice o f 
beaver kidney over the wound that had 
previously been sucked and licked 
clean. They chewed the balsam o f fir 
and spat it on cuts, wounds, burns and 
sores. The rest o f  the gum could be 
used as a salve or heated to make a 
poultice.
The Indians had an interesting meth­
od o f managing near-drowning,1 a 
comm on occurrence as their canoes up­
set easily. The victim was taken ashore 
and hung over a tree branch with his 
head down. A  length o f animal gut 
tied at both ends and ordinarily used 
to carry cooking oil or fat was emptied. 
It was filled with tobacco smoke and 
the smoke was forced into the victim’s 
lungs. If the procedure was successful, 
the victim coughed, expelled the water 
from  the lungs and normal breathing 
was restored.1
Duties o f the Early Surgeons
French law decreed that a surgeon 
must accompany each ship that visited 
Acadia, even small fishing vessels;2 
hence many surgeons must have visited 
the area between 1604 and the time o f 
the expulsion o f the Acadians in 1755. 
W e can name very few.
About 1650 Nicolas Denys, who 
had been granted fishing rights from  
Canso Strait to the Baie de Chaleur, 
recorded the duties o f a surgeon,3
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Antiemetic Stemetil shown to haw 
beneficial effect on LOS tone
Aspiration of acid into the lungs remains a 
common cause of death associated with gen­
eral anaesthesia. The lower oesophageal 
s p h in c te r (LO S) is sa id  to be a m ajo r 
mechanism which maintains competence of the 
gastro-oesophageal junction, and several drugs 
commonly used during anaesthesia may influ­
ence LOS tone, thereby increasing or decreas­
ing the tendency to regurgitation.
Reporting in the July 1978 issue of the British 
Journal of Anaesthesia, researchers demon­
strated that Stemetil (prochlorperazine) an an­
tiem etic used commonly before and after 
surgery, significantly increases LOS tone with­
out affecting oesophageal pressure. The resul­
tant increase in Barrier Pressure (BP) de­
creases the tendency to regurgitation. The in­
vestigators measured an average increase of 
BP from 2.31 kPa to 3.36 kPa (P<0.005) in 8 
volunteers following the I.V. administration of 
12.5 mg Stemetil.'
This information further enhances Stemetil’s 
reputation as a pharmacologically complete an­
tiemetic. In addition to its effect on LOS tone, 
Stemetil’s multi-level antiemetic action promptly 
stems nausea and vomiting of central or 
peripheral origin. Its anxiolytic action2 inhibits 
cortical impulses associated with “psychological 
vomiting”. Its C.N.S. action directly blocks the 
chemoreceptor trigger zone,3 4 raising the 
threshold for impulses arriving at the medullary 
vomiting center.
Stemetil in Radiation Sickness
The results of a trial involving 45 patients who 
developed nausea and vomiting following radia­
tion therapy showed that Stemetil was effective 
in all of the patients within 1-2 days, with good to 
excellent results.
References: Brock-Utne, J. G. et al.: The action ot commonly used 
antiemetics on the lower oesophageal sphincter. British Journal of 
Anaesthesia, no. 50, 295-298, July 1978. 2. Peterfy, G. and Pinter, J.: 
Current Therap. Res., 14, (9), 590-598, September 1972, 3. Goodman, 
L. and Gilmour, A.: The Pharmacological Basis of Therapeutics, 5th Ed., 
161, 1975. 4, Today’s Drugs: British Medical Journal, 1, 481, February 
21, 1970. 5. Dutta, A. K.: Study of Prochlorperazine (Stemetil) in radia­
tion sickness, Antiseptic Vol. 73, no. 1, pp 16-18, 1976.
Stemetil was administered in a dosage of 10 mg 
b.i.d. after the onset of nausea and vomiting, 
and was continued for 5-10 days after symp­
toms ceased. The only side effect was drowsi­
ness, which might not have been drug related.5
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Stemetil
prochlorperazine
Indications: nausea and vomiting of various 
etiologies: gastrointestinal disorders, drug 
intolerance, motion and radiation sickness, 
post-operative conditions, pregnancy, vertigo 
and migraines.
Dosage: Adults, oral route - Usual effective 
dosage is 5 to 10 mg, 3 or 4 times daily; in very 
mild cases, a single dose of 5 to 10 mg is often 
adequate. 'Spansule' Capsules: one or two 
every twelve hours. This dosage may be 
increased as required by increments of 10 mg 
every 2 or 3 days until symptoms are 
control led. For maintenance therapy the dosa­
ge should be reduced to the minimum 
effective dose. Because of the lower pediatric 
dosage requirements, the 'Spansule' Capsules 
are not intended for use in children. Rectal 
route - 1 or 2 suppositories of 25 mg per day. 
Children: oral and rectal routes - up to 10 mg 
per day in divided doses according to body 
weight.
Parenteral route (not to exceed 40 mg per day) 
- In general practice: 5 to 10 mg I.M., 2 or 3 
times a day. In surgery: 5 to 10 mg I.M ., 1 to 2 
hours before anesthesia. Repeat once during 
surgery if necessary. Post-operatively, same 
dose of 5 to 10 mg I.M., repeated every 3 to 4 
hours. M ay be given I.V. during and after 
surgery in the infusion solution at a concen­
tration of 20 mg per litre. In obstetrics: 10 mg 
I.M. during first stage of labor; subsequent 10 
mg doses as needed. Post partum: the usual 
total daily dose is 15 to 30 mg orally or I.M. 
Contraind ications: Comatose or deeply 
depressed states of the CNS due to hypnotics, 
analgesics, narcotics, alcohol, etc.; hypersen­
sitivity to phenothiazines; blood dyscrasias; 
bone marrow depression; liver damage. 
W arnings and precautions: etiology of vomit­
ing should be established before using the 
drug as its antiemetic action may mask 
symptoms of intracranial pressure or intestinal 
obstruction. Patients with a history of convul­
sive disorders should be given an appropriate 
anticonvulsant while on therapy. Tardive 
dyskinesia may occur in patients on long-term 
therapy. If used with CNS depressants, the 
possibility of an additive effect should be 
considered. Use with great caution in patients 
with glaucoma or prostatic hypertrophy. The 
drug may impair the mental and/or physical 
abilities required for the performance of 
potentially hazardous tasks such as driving a 
car or operating machinery, especially during 
the first few days of therapy. Keep in mind that 
all medications should be used cautiously in 
pregnant patients, especially during the first 
trimester.
Side effects: extrapyramidal reactions, dis­
turbed temperature regulation and seizures 
have been encountered. Other side effects due 
to phenothiazine derivatives should be borne 
in mind; for complete list, see product 
monograph.
Overdosage: no specific antidote; symptoma­
tic treatment. If a pressor agent is required, 
norepinephrine may be given (not epine­
phrine as it may further depress the blood 
pressure).
Dosage forms: tablets 5, 10 and 25 mg; am­
poules 2 ml/10 mg; liquid 5 mg per teaspoon­
ful (5 ml); suppositories 5 and 10 mg. 'Span­
sule' Capsules, 10 mg.
Com plete inform ation upon request
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which have been summarized in 
English.4
The surgeon needed a large medicine 
chest and barbering tools. He could 
earn extra money by trimming beards, 
cutting hair and shaving the crew of 
the ship. At the fishing station he 
acted as the cook’s helper ready with 
a hot evening meal as the deep laden 
boats returned at dusk. He had charge 
of the apprentices and boys, with the 
power to punish misbehaviour. He 
provided garden vegetables and shot 
or trapped game and fowl for fresh 
meat. He helped to clean and fillet the 
fish and to carry them to the drying 
stages on the beach. He was a surgeon 
of the short gown to whom Ambroise 
Pare had brought respectability some 
years earlier.5 If he carried out his 
duties and cared competently for the ill 
and injured he was rewarded at the 
end of the voyage by a gift of the large 
medicine chest with its depleted store 
of drugs and dressings.
Some of the Early Acadian Surgeons
In 1713 British rule over Acadia 
began. Eventually their rule over all of 
Nova Scotia including Cape Breton 
Island, after the second capture of 
Louisburg in 1758, extended to what 
is now the border of the province of 
Quebec and the state of Maine. Sun- 
bury county of Nova Scotia became 
New Brunswick in 1784.
Little is known of many of the early 
surgeons who visited or lived in this 
area, but the contributions of some 
have been recorded.
Although surgeon Ripault of Jacques 
Cartier’s second expedition had de­
scribed the autopsy findings of scurvy 
some 70 years earlier,6 on an island in 
the Saint Croix River surgeon Guil­
laume DesChamps de Honfleur per­
formed the first autopsy in New 
Brunswick, on the body of a young 
Frenchman who died of scurvy in the 
winter of 1604.7 He noted hemor­
rhages under the skin, purpura and 
swelling of the limbs and trunk. In­
flammation and hemorrhages of the 
gums and mouth were present in all 
afflicted by scurvy.
Jacques Bourgeois Jr., son of a 
senior army officer at Port Royal, 
Acadia was born at Couperans-en-Brie 
in the Seine-Marne region of France. 
He studied medicine and surgery in 
France. He came to Port Royal where 
he married Jeanne Trahan; their seven 
girls and three boys were said to be the 
ancestors of ail Acadians named 
Bourgeois.
In 1672 Jacques Bourgeois with two 
sons and three sons-in-law founded the 
Bourgeois settlement at Beaubassin 
(Amherst, Nova Scotia). The settle­
ment prospered; on the farms there
were herds of cattle, sheep and pigs; 
sawmills and grist mills were built. In 
1686 the settlement numbered 123, 
and that year a church was erected. 
Little is known of Jacques Bourgeois’ 
medical or surgical skill but he showed 
elements of greatness as an adminis­
trator and colonist. He founded settle­
ments as far west as Petitcodiac (32 
km west of Moncton, New Brunswick). 
Bourgeois was an octogenarian when 
he died at Port Royal in 1700.8
It is recorded that in 1676 Enault 
de Barboucannes de Sameur worked as 
a surgeon for Richard Denys de Fron- 
sac. Enault was in charge of the fishing 
and trading post of Nepisiquit (Bath­
urst, New Brunswick). He practised 
surgery and supervised fishing, farming 
and fur trading in the region. He mar­
ried an Indian girl in 1679 and they 
had several children. He died violently 
during a quarrel with his Indian 
brother-in-law. After his death his wife 
and children returned to the native 
way of life and his land rights lapsed.
The missionaries cared for the 
physical as well as spiritual needs of 
the Acadians.9 Nearly all had some 
knowledge of first aid and simple 
remedies.
In his diary for the year 1755, John 
Thomas, a physician and paymaster of 
Colonel Monckton’s staff, recorded 
that he had performed successful am­
putations.10 He treated colonial soldiers 
and Acadian prisoners and civilians at 
Fort Beausejour during the short siege 
and after the fort surrendered to the 
English Colonials in 1755.
Dr. Jacob March, we are told, was 
a surgeon who accompanied a colonial 
detachment. In 1755 while his detach­
ment was burning a “Mass House” at 
Petitcodiac it was attacked by the out­
standing Acadian leader, Boishebert. 
March was killed along with 21 other 
soldiers. Seven were wounded and a 
few escaped down the Petitcodiac 
River in boats.10
About 1760 John T. Larlee came to 
what is now New Brunswick from 
Connecticut. He practised medicine 
and surgery on the Saint John River 
from Burton 160 km north to Wood- 
stock.11
T he L o y a lis t  Su rg eo n s
From the  13 colonies in 1783 and 
later came a flood of refugees from 
the revolutionary war. With the 
Loyalist regiments came surgeons and 
surgeons’ mates who added their 
meagre stock of knowledge and skill to 
those of the Indians, Acadians and 
pre-Loyalists already in the region.
Jonathan Odell was a physician and 
surgeon, poet, theologian and chaplain 
of a regiment. He had been a nego­
tiator between Benedict Arnold and the
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British headquarters during the re­
volutionary war.9 He became provincial 
secretary, registrar of records, and 
clerk of His Majesty’s Council in New 
Brunswick. He also wrote a book on 
medical remedies, which is now a 
valuable relic in the New Brunswick 
Museum at Saint John. To add lustre 
to an outstanding career, he became 
known as “The Father of the University 
of New Brunswick”.
Fredericton’s first physician and 
surgeon, Charles Earle? came with a 
small band of refugees in the fall of 
1783. He led a heroic overland march 
to Quebec City in the dead of winter. 
The band brought back supplies on 
handsleds to save the settlement. He 
and his “wife” attended all the soirees 
and society balls and entertained the 
elite of Fredericton in their home, but 
Fredericton society rocked on its foun­
dations when Earle died and his real 
wife came front the 13 colonies to 
settle his estate and deal with his 
paramour.
William Payne had bought an 
honorary MD from Marischal College12 
(later to become the highly respected 
University of Aberdeen). He was an 
able politician who became an aider- 
man of Sydney ward (Saint John), 
clerk of the legislative assembly, prin­
cipal deputy surveyor of the woods 
under Sir John Wentworth, governor 
of Nova Scotia and a commissioner 
for christianizing the Indians. He 
returned to the 13 colonies in 1787 
where he continued to draw his half­
pay officer’s pension until 1812 when 
the British ordered him to go on 
active service; this he avoided by be­
coming a citizen of the republic, to our 
south. He was a “wheeler-dealer” type 
of politician.
Samuel Moore12 was the first to per­
form an autopsy in Saint John. In the 
fall of 1784 Nancy Mosley killed her 
husband by driving a “dung-fork” into 
his skull. The autopsy report stated: 
“Sir, agreable to your request, I exam­
ined the black man’s head. I am per­
fectly satisfied he was murdered. 
After examining where the fork per­
forated the temporal bones of the 
skull, T sawed off the arch of the head 
and found the ventricles of the brain 
everywhere impacted with matter. The 
symptoms before death were also very 
obvious. AH the jury were spectators.” 
After a jury verdict of manslaughter, 
Nancy had M branded on her thumb 
and was discharged.
John Calef2 was supervisor and sur­
geon of the army staff of a garrison 
hospital at Fort Howe, Saint John, 
which was opened about 1784. Later 
he became the first doctor of Saint 
Andrews, now a summer resort on the 
Bay of Fundy. His assistant, Dr. David
Brown,'* was appointed hospital mate 
by the British government. Another 
Loyalist surgeon at the Fort Howe 
garrison hospital was Ambrose Shar- 
man;'2 he also had a private practice. 
He is reported to have drowned in the 
Saint John River in 1793.
These Loyalist surgeons are a small 
sample of the large number who prac­
tised in New Brunswick before 1800. 
Some returned to the 13 colonies as 
soon as they were allowed but many 
stayed.
Development between
1800 and 1869
In this period speed was the sine qua 
non of a good surgeon and one such 
surgeon was Samuel G. Hamilton who 
came from Ireland to Saint John in 
1823. Physically Hamilton was the big­
gest doctor in town; as a surgeon he 
had the fastest hands. Of him, as of 
some other surgeons of this era, one 
could say, “Dr. X amputated a leg in 
15 seconds and with the same swipe 
cut off his assistant’s finger and his 
own coattails.” Hamilton never ac­
quired a horse, a bank account or a 
wife, hence some of his contemporaries 
would have considered him unsuc­
cessful.
Between 1800 and 1869 the surgeons 
of New Brunswick saw two important 
developments: hospitals and general 
anesthesia. Hospitals had been known 
before in the Maritimes, as in Port 
Royal in 16052 and the garrison hos­
pital at Fort Howe,9 but during the 
first half of the 19th century their 
numbers increased greatly.
Marine Hospitals
In 1820 the New Brunswick legis­
lature passed an act9 to provide for 
sick and disabled seamen belonging to 
the province and not being paupers. 
Funds, collected by a tax of a penny 
a ton on all vessels coming to any port
in the province, were used to build 
marine hospitals at many ports. Often 
the hospital was a small house with a 
caretaker. A local doctor gave medical 
care for which the government paid 
him.
The Kent Marine Hospital at Saint 
John opened in 1822.13 It was a larger 
hospital with good medical and surgical 
supervision by Drs. Calef, Brown and 
others. The marine hospital at West­
morland Point near Dorchester, which 
opened about 1830,9 was under the 
supervision of Dr. Rufus Smith. Smith 
was born in 1767 and began to prac­
tise at a very young age in 1785. He 
owned the first two-wheeled travelling 
vehicle in Westmorland County called 
a “grasshopper shay”. From 1816 to 
1831 he was a member of the pro­
vincial legislature and acted as a 
county judge.
In 1825 in Saint Andrews a new 
marine hospital was built. Dr. Samuel 
Frye was the first surgeon in charge.9 
Dr. Samuel Tilley Gove, a cousin of 
the well-known Father of Confeder­
ation, Sir Samuel Tilley, was the second 
surgeon in charge of this hospital and 
held the post for many years.
Another marine hospital (Fig. 1) was 
built in Douglastown,9 a village mid­
way between Chatham and Newcastle, 
and it is recorded that in 1832 the 
surgeon in charge was Dr. John 
Thomson.9
In Richibucto a marine hospital was 
opened about 1849, probably under the 
supervision initially of Dr. Hugh H. 
Wilson; in 1859 Dr. Isaac Wilson 
Doherty took over. Earlier Doherty, a 
surgeon who received his training in 
New York, had done a successful stra­
bismus operation on someone named 
Mick McGuiness and had trephined 
the skull of one Amos Seurat following 
an injury. These operations took place 
about 1855 in Shediac, New Brunswick; 
hence Doherty may be considered the
FIG. 1—Marine hospital at Douglastown.
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first ophthalmic surgeon and neuro­
surgeon in the province.
The records show that Dalhousie 
had a marine hospital in 1844s and 
other active ports such as Campbellton 
and Bathurst might have had such
FIG. 2—Dr. John Vondy “The Martyr 
of Middle Island”, Chatham, New Bruns­
wick, 1847. (Reproduced by permission 
from Stewart WB.S)
hospitals but no record of them has 
been found.
Quarantine Stations
Because outbreaks of typhus fever 
and other infectious diseases were com­
mon, particularly on the ships bringing 
immigrants to the area, quarantine 
stations and hospitals had to be built.
There was a quarantine station on 
Partridge Island in Saint John har­
bour,9 and a marine hospital pest house 
was located in Carleton (West Saint 
John) from 1830 to 1847, at which 
time it was moved to Partridge Island. 
Drs. George and William Harding, 
physicians at the quarantine station, 
treated many victims of typhus fever. 
A severe outbreak of the disease oc­
curred in 1847 and during this out­
break James Patrick Collins, a 23-year- 
old doctor at the pest house, died along 
with almost 600 immigrants on Part­
ridge Island and on ships near by. An­
other physician who died of typhus 
fever that same year was John Vondy 
(Fig. 2) who was at a quarantine hos­
pital on Middle Island near Chatham.
Dr. Alexander Key, a small man
with a large temper, came to the Mira- 
michi River in 1816, where he became 
quarantine officer.9 It is reported that 
when he ordered one of the ships on 
the river to stop for a quarantine 
check and the ship did not stop, Key 
fired a musket ball into the main mast. 
The splinters flew. The ship hove to as 
the captain received the message loud 
and clear.
Gradually the marine and quarantine 
hospitals and stations closed down as 
general hospitals and public health de­
partments took over most of their 
functions.
General Hospitals
The General Public Hospital in 
Saint John was founded by Dr. William 
Bayard (Fig. 3) in 1860 and opened in 
1865. The Hotel-Dieu at Chatham 
(Fig. 4), which had only three beds, 
opened in 1869. Victoria Public Hos­
pital, Fredericton, opened in 1888 un­
der the distinguished patronage of 
Lady Tilley.9 In that year also Camp- 
bellton’s first Hotel-Dieu opened as a 
combined school and hospital.9
General Anesthesia
On Jan. 22, 1847 a few months after 
Morton demonstrated ether anesthesia 
in the famous “ether dome” of the 
Massachusetts General Hospital, Dr. 
Martin H. Peters, a New Brunswick 
surgeon, performed an operation for 
removal of a tumour from the patient’s 
arm under ether anesthesia. Dr. C.R. 
Fiske, a dental surgeon of Saint John 
administered the drug under the super­
vision of a Dr. Adams of Boston. A 
short time later Dr. William Bayard 
performed another operation using 
ether anesthetic. Presumably both these 
operations were performed at the doc­
tor’s office as no general hospital 
opened until 1865.
Soon after ether came chloroform 
anesthesia and a few years later 
Lister’s antiseptic surgery allowed sur­
geons to do abdominal surgery and to 
reduce the mortality and morbidity in 
amputations and other forms of sur­
gery. Dr. Henry A. Lunam, who had 
amputated several frost-bitten toes in 
1888, used general anesthesia in the 
successful removal of a large abdominal 
tumour in 1891 at Hotel-Dieu Hos­
pital, Campbellton.9
Dr. Alfred B. Atherton was a dis­
tinguished surgeon of Fredericton (per­
sonal communication, 1969). He per­
formed an esophagotomy successfully 
a few days after the first such operation 
was performed in France. He trained 
under Sir James Simpson of Edinburgh, 
the discoverer of chloroform anesthesia. 
In a conversation with Mrs. Atherton, 
Lady Simpson described how chloro­
form was discovered: “James would lie
t<iu. 3— ur. Wiiiiam Bayard, father of the Samt John General Hernia!, 
landau, circa 1890. (Reproduced by permission from Stewart WB.9)
FIG. 4—First Hotel-Dieu Hospital of Chatham, which had room for only 
three beds.
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In the treatment of shock 
and its pulmonary 
complications
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down and drip chloroform over his 
nose and ask me to record how long 
he was unconscious this time. I would 
be very worried and used to get my 
maid, Jeanie to come in and sit with 
me until he woke up. The Queen 
knighted James, she should have 
knighted Jeanie and me.”
A Scottish confrere whose name I do 
not recall told me in 1972, that after 
Queen Victoria and many others were 
delivered of their children under 
chloroform anesthesia a discussion 
arose concerning Sir James Simpson’s 
coat of arms and motto. One wit sug­
gested, “A wee naked bairn, with the 
caption, does your mither know you’re 
oot?”
Summary
Medicine and surgery owe much to 
the hardy pioneer doctors of New 
Brunswick w ho' suffered great hard­
ships bringing primitive comfort and 
care to their patients. They built a 
medical organization that has done a 
fine job of governing the medical pro­
fession and improving home, office 
and hospital care in our province. May 
we be considered worthy followers of 
these great pioneers.
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Directives 
aux collaborateurs
Toute communication initiale doit etre 
adressee aux coredacteurs, CP 8650, 
Ottawa, Ont. K1G 0G8 sous la mention: 
"Le journal canadien de chirurgie".
Les textes originaux des articles et des 
autres communications y compris un 
nombre limite de rapports sur des cas 
speciaux doivent etre rediges en double 
exemplaire, en frangais ou en anglais, et 
accompagnes d'une lettre demandant 
leur publication dans le Journal. Veuillez 
les dactylographier sur une seule face 
d'une feuille non reglee avec double 
interligne et grandes marges.
Les principales unites de mesure doivent 
etre exprimees selon le Systeme inter­
national d'unites si c'est possible.
Les illustrations telles que des photo­
graphies d'appareils cliniques, des radio- 
graphies, des photomicrographies, des 
graphiques ei des diagrammes doivent 
etre fournies sous la forme d'epreuves 
sur papier glace sans montage, les bor- 
dures intactes, d'un format ne depassant 
pas 20 X 25 cm. Chaque illustration doit 
etre munie d'une legende dactyiogra- 
phiee sur une page separee du texte de 
/'article. S'il s'agit de radiographie, en- 
voyez une copie et non I'original. S'il 
s'agit d'une photomicrographie, indiquez 
le contraste et I'echelle de i ’agrandisse- 
ment. Les lettres qui servent a identifier 
les elements d'une illustration doivent 
etre d'une dimension suffisante afin de 
demeurer visibles lorsque les necessites 
de I’impression imposent une reduction 
de I'image fournie.
II ne faut pas qu'on puisse identifier un 
patient grace a une illustration a moins 
qu'il n'y ait expressement consenti par 
ecrit; faute de permission les traits de 
sa physionomie doivent etre obliteres. 
Les illustrations en couleur ne seront 
publiees qu'aux trais de I'auteur. Si 
I’illustration provient d'une autre source, 
il convient d’obtenir tant de I ’auteur que 
de I'editeur de I'ouvrage dont elle est 
tiree, I'autorisation de s'en servir aux 
fins de la publication.
II faut que les tableaux soient conformes 
au format rectangulaire du Journal et 
rediges sur des feuilles separees du 
texte, un tableau par feuille.
Les references doivent etre citees dans 
le texte au moyen d'un chiffre et grou- 
pees dans I'ordre a la fin de /’article 
selon la maniere de faire adoptee par 
ce Journal. Les references a des perio- 
diques doivent etre conformes a celles 
qu’adopte /'Index Medicus.
Un resume qui ne doit pas depasser 125 
mots doit accompagner chaque article 
sur une feuille separee.
A titre d’approbation, un exemplaire du 
manuscrit redige sera envoye a I'auteur 
mais non les epreuves.
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continued from page 166 
that is, to a large extent, available in 
other publications but provides important 
data on hormonal regulation of sex steroid 
production by the human fetus. Meas­
urements of both pituitary and placental 
hormones are provided and an integrated 
schema elucidates the temporal relations 
between the various hormones and the 
morphologic development of the fetal 
ovary and testis. The study of the main 
nonsexual steroid hormone, the anti-Mul- 
lerian hormone, pioneered by Dr. Nathalie 
Josso, is recognized by inclusion of data 
previously published by her as well as 
some new findings on the chemical nature 
of this intriguing fetal hormone. This 
chapter illustrates how persistent efforts 
with the difficult and tedious bioassay can 
provide important scientific information.
The important contribution of Alfred 
Jost to the field of morphogenesis of the 
genital system of mammals is recognized 
by inclusion of his presentation of iddi- 
tional data regarding freemartins. How­
ever, the application to human fetal phy­
siology does not receive attention.
The section on problems of testosterone- 
mediated cellular responses indicates the 
important role of testosterone-dependent 
differentiation of embryonic tissue.
Some very provocative data are supplied 
on the mechanism of testicular descent, 
including important observations that the 
process is dependent on dihydrotestosterone 
or pituitary gonadotropin (or chorionic 
gonadotropin). The inhibition of testicular 
descent by estradiol is discussed. Other 
chapters deal with the development of the 
human vagina. Brief chapters on surgical 
correction of intersex and on treatment of 
micropenis are included.
This book provides important and de­
tailed observations on the morphogenesis 
of the human genital system. Despite the 
varied scientific background of the con­
tributors, the chapters have surprisingly 
little overlapping material. Each author 
provides important information that will 
add to the reader’s understanding of mal­
formations of the human genital tract. 
This book can serve as an important ref­
erence source for students of human biol­
ogy in many medical specialties. It can 
be commended for providing clear and 
concise information on a difficult topic.
H.J. G uyda, md, frcp[c]
Department of endocrinology,
Montreal Children’s Hospital,
Montreal, PQ
THE PSYCHOLOGICAL REHABILITA­
TION OF THE AMPUTEE. Lawrence
W. Friedmann. 157 pp. Illust. Charles
C Thomas, Publisher, Springfield, IL,
1978. $13.50. ISBN 0-398-03707-8.
It is significant that a specialist in re­
habilitation medicine has collated his ob­
servations on the psychologic and the 
psychiatric aspects of amputee rehabilita­
tion. This area and that of disability have 
been grossly neglected by both the psy­
chiatrists and psychologists. The author 
addresses himself to the entire rehabilita­
tion team. He analyses the complex reac­
tions to amputation, whether due to 
trauma, to pathologic phenomena or to 
congenital etiology.
Friedmann, who apportions a number 
of pages to a discussion on phantom 
pain, deals very lightly with a common 
and increasingly important psychosocial 
and medical problem—that of amputa­
tions in the older age group. Readers 
would also have benefited from a discus­
sion of the attitude to be adopted by the 
physician and his team when, for various 
reasons, a prosthesis is contraindicated. 
Nevertheless, this book is a must for all 
those sharing the treatment and rehabili­
tation of amputees. It will serve well 
those who find themselves in the difficult 
position of dealing with amputees and 
their families, before and after surgery. 
Even our colleagues the surgeons may 
derive benefit from this opus!
G. G ingras, md, frcp[c]
Director,
Rehabilitation Centre,
Charlottetown, PEI
SURGERY ANNUAL. Volume 9. 1977. 
Edited by Lloyd M. Nyhus. 427 pp. 
Illust. Appleton-Century-Crofts, New 
York, 1977. Price not stated. ISBN 
0-8385-8710-0.
Articles in annual surgical publications 
can be divided into three groups: up-to- 
date reviews by experts in the field of 
the surgical management of controversial 
problems, with some understandable bias 
in favour of the authors’ methods; ac­
counts of extensive personal experience in 
the treatment of certain conditions; and 
articles that question the validity of cur­
rent beliefs and may point to future 
trends. This volume has a good balance 
of each type of article. Six of the 19 pa­
pers deal with subjects of general inter­
est and the others provide an excellent 
opportunity for surgeons to acquaint 
themselves with current thinking and ad­
vances in other branches of surgery.
Two articles in the first group, devoted 
to the syndromes of intravascular coagula­
tion and the prophylaxis of pulmonary 
complications after surgery, help to clarify 
thinking in fields where jargon often
DAVIS & GECK SURGICAL ESSAY AWARD 
FOR RESIDENTS
Davis & Geek annually awards $1000.00 to  the surgical resident 
submitting the best paper on a surgical topic to  the Canadian Journal 
of Surgery. This award is intended to promote scientific and literary 
excellence among Canadian surgeons in training.
The conditions of entry for the 1979 award are the following:—
1. Candidates shall be currently engaged in a recognized surgical 
residency program leading to eligibility for the Fellowship of the 
Royal College of Physicians and Surgeons of Canada in one of the 
surgical specialties (cardiovascular and thoracic surgery, general 
surgery, neurosurgery, obstetrics and gynecology, ophthalmology, 
otolaryngology, orthopedic surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form  of a manuscript 
relating to work in which a surgical resident is or has been the 
prime or major investigator. Prior oral presentation at a Royal 
College meeting or a surgical forum meeting will not be a dis­
qualification, but prior publication as a formal paper in a journal 
will. The paper should relate to any field of surgical interest. The 
manuscript must conform to the style requirements of the Journal 
and must not exceed 3000 words of text and six tables an d /o r six 
figures. Coauthors are permitted on the understanding that the 
candidate shall be the first author and that only the first author 
shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than 
June 30, 1979. Each entry must be submitted to the editorial office 
of the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ont. 
K1G 0G8 with a letter stating that the paper is being submitted 
as an entry for the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal 
of Surgery unless returned to the author without publication.
All papers submitted will be judged by an independent committee 
comprising at least one member of the editorial advisory board of the 
Journal, one fellow of the Royal College of Physicians and Surgeons of 
Canada and one representative of the Canadian Medical Association, 
together with other fellows invited to serve at the discretion of the three 
permanent members of the committee. For the purpose of judging, the 
candidates will be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will 
be announced in the November 1979 issue of the Journal.
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conceals ideas. Dr. Polk has contributed 
a common-sense article on infections ac­
quired in the operating room, which con­
siders the value of operating-room ventila­
tion. The time is right for an appraisal 
of bypass procedures for obesity and Dr. 
Lloyd MacLean clearly outlines the ad­
vantages and disadvantages of the tech­
nical variations used at present. The chap­
ters on coronary artery surgery and on 
headaches associated with lesions in the 
neck, both written by surgeons, present 
well-balanced opinions. Pancreatic func­
tion tests are not popular because they 
are believed to be time consuming and 
difficult to interpret, but the chapter on 
this subject may cause some surgeons to 
reconsider this position.
In the second category are articles on 
the surgical treatment of esophageal can­
cer by Dr. Nakayama, neonatal necrotiz­
ing enterocolitis, the salvage of the foot 
affected by diabetes, arthroscopy of the 
knee, axillary femoral arterial bypass by 
Dr. J. Louw, delayed hypersensitivity and 
its relation to malignant disease and ex­
tracorporeal renal surgery by Dr. Lars- 
Erik Gelin. Also provided is a chapter on 
recent advances in the management of 
multiple injuries by Dr. Worthington 
Shenk; this chapter is clear, concise and 
instructive and. itself, is worth the price 
of the book.
Four chapters fall into the third cate­
gory. That entitled “Anaesthesia, alkalosis 
and arrhythmias” points out the possible 
dangers resulting from rapid potassium 
shift in the body when alkalosis is in­
duced under anesthesia. The chapter on 
Barrett’s esophagus outlines some inter­
esting experimental work. Finally, there 
are two chapters on anorectal surgery— 
the first on the trans-sphincteric approach 
to rectal lesions written by Mr. Aubrey 
York Mason, and the second on the 
causes of and management of anorectal 
disease written by Mr. Peter Lord. Both 
authors are enthusiastic supporters of their 
own views and the thoughtful surgeon 
would be well advised to give these two 
chapters careful consideration.
“Surgery Annual” is designed to instruct 
and stimulate, and does both; the mem­
bers of the editorial board are to be 
commended on their choice of topics and 
authors.
H.T.G. W i l l ia m s , m b , c h  b , f r c s , f r c s [c ],
FACS
Professor and chairman,
Department of surgery,
University of Alberta,
Edmonton, Alta.
TOTAL HIP PROSTHESIS. Edited by N. 
Gschwend and H.LI. Debrunner. 328 
pp. Illust. The Williams & Wilkins 
Company, Baltimore; Burns and Mac- 
Eaehern Limited, Don Mills, 1976. 
$34.70, paperbound. ISBN 3-456-80241- 
2.
This translation of a symposium held by 
the Swiss Orthopedic Association in 1974 
represents, in part, information obtained
from a multicentre study designed to de­
termine the long-term results and com­
plications of total hip replacement. As 
such, it has the advantages of a study 
of a large series and the disadvantages of 
a somewhat impersonal and imprecise 
method of analysing data by computer. 
The writing is very spotty, some authors 
going into considerable detail and ref­
erencing their material well and others 
using a narrative style. Little new in­
formation is given and much of it is bet­
ter recorded in individual articles published 
elsewhere. It is unfortunate that more 
comparison between the different surgical 
approaches, devices and postoperative 
regimens could not have, been made, but 
apparently only two or three therapeutic 
regimens were being used in Switzerland 
at the time.
This book is of interest to those doing 
a great deal of hip surgery and to those 
wishing a group of articles that are reas­
onably well referenced. However, it will 
be of little help to either the practising 
orthopedic surgeon or the resident.
R. L. C r u e s s , m d , f r c s [c ]
Orthopedic surgeon-in-chief,
Royal Victoria Hospital,
Montreal, PQ
W OUND REPAIR. 2nd ed. Erie E. Pea­
cock, Jr. and Walton Van Winkle, Jr.
699 pp. Illust. W.B. Saunders Company,
Philadelphia, 1976. Price not stated.
ISBN 0-7216-7124-1.
The first edition of this excellent practical 
text was published in 1970 by the same 
authors.
The title change, omitting “Surgery and 
Biology”, reflects the increasing clinical 
emphasis of the work. The initial five 
chapters are devoted to a review of the 
basic science of cellular responses to in­
jury, epithelialization and wound contrac­
tion. Recent concepts of collagen meta­
bolism emphasize selective control of the 
properties of scar tissue by physical and 
pharmacologic means.
The remaining seven chapters reflect 
the applied basic concepts of wound biol­
ogy in the repair of nerves, tendons, bone, 
fascia and muscle. The discussion of the 
healing of burns and skin grafting is of 
special value.
As in the first edition, the absence of 
reference keys in the text can make it 
difficult to document statements. Each 
chapter, however, is followed by a long 
list of classic and recent reference sources. 
Most of the photos from the previous 
edition are included; these illustrations 
are particularly useful in summarizing the 
basic concepts in the clinical chapters.
The book will be of considerable value 
to all surgeons, but especially to those 
who do orthopedic and plastic surgery.
P a u l  R . B e n o i t , m d , f r c s [c ]
340 McLeod St.,
Ottawa, Ont.
Ste. 104,
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